ulcerative colitis: An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.
Ulcerative colitis (strict definition, require KELA, min 2 HDR)
DOID EFO Endpoint Browser PheWeb
K11_UC_STRICT2
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditions
|
8518 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
7882 |
4. Check minimum number of eventsNone |
7882 |
5. Include endpointsNone |
7882 |
6. Filter based on genotype QC (FinnGen only) |
7648 |
Control definitions (FinnGen only)
- Control conditions
- not K11_KELAUC
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- K50-K52
- Name in latin
- Colitis ulcerosa
Similar endpoints
↥List of similar endpoints to
Ulcerative colitis (strict definition, require KELA, min 2 HDR)
based on the number of shared cases.
Similar with more cases:
- Ulcerative colitis (strict definition, require KELA)
- UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)
- IBD patients in KELA-register
- Inflammatory bowel disease, strict (require KELA)
- Ulcerative colitis
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 41969 | 18869 | 22911 |
| Only index persons | 39683 | 18151 | 21532 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.59 | 0.54 | 0.64 |
| Only index persons | 0.75 | 0.67 | 0.82 |
| Median age at first event (years) | |||
| Whole population | 37.32 | 36.03 | 38.27 |
| Only index persons | 36.56 | 35.57 | 37.40 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 7648 | 3882 | 3766 |
| Unadjusted period prevalence (%) | 1.55 | 1.38 | 1.73 |
| Median age at first event (years) | 39.06 | 35.92 | 42.28 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 7882
- Matched controls
- 78820
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
311.4
2682
13209
256, ,
Kela drug reimbursment
59.6
307.7
209
36
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
10.2
307.7
1092
1223
253, ,
Kela drug reimbursment
139.1
307.7
346
26
D94
ICPC
Chronic enteritis/ulcerative colitis
99.2
307.7
827
93
4AA12, ,
NOMESCO Finland
33.7
307.7
226
69
L01BB02
ATC
mercaptopurine; oral
72.3
307.7
1317
218
H02AB06
ATC
prednisolone; systemic
7.6
307.7
6200
25850
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
820.3
307.7
3296
69
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
336.1
307.7
414
13
A05AA02
ATC
ursodeoxycholic acid; oral
9.1
307.7
445
516
H02AB07
ATC
prednisone; oral
6.0
307.7
2278
4970
A07EA06
ATC
budesonide; oral, local oral
81.5
307.7
3519
772
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
11.1
307.7
2125
2530
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
194.2
307.7
299
16
UJF30
NOMESCO Finland
Ileoscopy through colon
17.0
307.7
3716
3923
K50.1
ICD-10 Finland
Crohn disease of large intestine
30.6
307.7
686
245
L04AG05
ATC
vedolizumab; parenteral
125.0
307.7
289
24
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
268.1
307.7
1428
65
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
687.0
307.7
330
5
ZX120
NOMESCO Finland
Intravenous
4.5
307.7
1311
3381
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
147.4
307.7
612
45
P01AB01
ATC
metronidazole; oral, rectal
2.5
307.7
3828
21575
K50.8
ICD-10 Finland
Other Crohn disease
20.7
307.7
709
374
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
86.9
307.7
317
38
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
45.1
307.7
535
127
K51
ICD-10 Finland
Ulcerative colitis
408.9
307.7
1650
51
L04AB04
ATC
adalimumab; parenteral
8.4
307.7
621
793
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.1
307.7
3565
13119
5568X
ICD-9 Finland
Idiopathic proctocolitis, Other ulcerative colitis
278.5
307.7
269
10
L04AX01
ATC
azathioprine; systemic
48.8
307.7
3181
1079
L04AA33
ATC
[U] vedolizumab
136.1
307.7
199
15
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
32.7
307.7
272
86
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
263.1
307.7
2270
121
L04AC05
ATC
ustekinumab; parenteral
34.7
307.7
339
102
A07EC01
ATC
sulfasalazine; oral, rectal
8.7
307.7
1962
2883
A07EC03
ATC
olsalazine; oral
263.5
307.7
255
10
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
398.2
307.7
4979
338
K51.8
ICD-10 Finland
Other ulcerative colitis
276.5
307.7
2153
107
A07EA02
ATC
hydrocortisone; rectal
227.8
307.7
2864
197
4AB02, ,
NOMESCO Finland
32.4
307.7
227
72
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
+∞
307.7
7882
538
3042, ,
Kela drug reimbursment
139.6
307.7
347
26
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
88.9
307.7
1252
167
L04AB02
ATC
infliximab; parenteral
70.4
307.7
532
81
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
249.9
307.7
1079
50
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
208.5
307.7
415
21
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
10.1
307.7
568
604
K83.0
ICD-10 Finland
Cholangitis
14.4
307.7
428
312
A07EC02
ATC
mesalazine; oral, rectal
1945.0
307.7
7531
860
A07EA01
ATC
prednisolone; oral, rectal
308.1
307.7
598
21
UJF32
NOMESCO Finland
Coloscopy
18.5
307.7
5850
10609
K51.5
ICD-10 Finland
Left sided colitis
723.9
307.7
5126
202
J01MA02
ATC
ciprofloxacin; systemic
2.7
307.7
3676
19351
K50.9
ICD-10 Finland
Crohn disease, unspecified
21.0
307.7
713
372
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
610.2
307.7
351
6
K50.0
ICD-10 Finland
Crohn disease of small intestine
8.6
282.0
367
444
1370
FHL
Colonoscopy, whole colon
31.2
271.5
177
58
L04AF03
ATC
upadacitinib; oral
31.2
266.9
174
57
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
4.3
266.3
735
1833
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
9.1
264.0
328
374
JFH10
NOMESCO Finland
Total colectomy and ileostomy
45.6
258.1
152
34
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
256.9
2151
10306
3005
Kela drug reimbursment
Tofacitinib
29.9
243.6
161
55
Z93.2
ICD-10 Finland
Ileostomy status
25.7
235.8
164
65
L04AD01
ATC
ciclosporin; systemic
6.8
224.5
362
558
298, ,
Kela drug reimbursment
26.9
223.5
153
58
3029
Kela drug reimbursment
Upadacitinib
24.2
213.6
152
64
4AA33, ,
NOMESCO Finland
93.8
212.6
111
12
A07DA03
ATC
loperamide; oral
5.4
207.7
422
814
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
199.9
2182
11542
UJF92
NOMESCO Finland
Capsular endoscopy
5.7
198.2
381
698
L04AA29
ATC
[U] tofacitinib
23.0
187.6
136
60
WX002
NOMESCO Finland
Sedation and analgesia
2.4
186.6
1636
7865
K62.8
ICD-10 Finland
Other specified diseases of anus and rectum
10.3
184.9
208
207
JFF10
NOMESCO Finland
Loop enterostomy
14.9
184.5
164
112
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
173.7
989
3860
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
168.7
3641
24329
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.4
166.1
655
2071
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.6
166.0
589
1741
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.3
164.6
659
2103
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
161.8
1918
10355
6419
FHL
Other measure in this category
79.0
161.0
86
11
A07AA09
ATC
vancomycin; oral
7.4
158.1
232
322
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
9.2
156.6
191
212
L04AB06
ATC
golimumab; parenteral
8.4
155.5
205
251
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.8
154.9
359
774
A02BC02
ATC
pantoprazole; systemic
1.9
151.1
5321
41016
WVA20
NOMESCO Finland
Medicine administration
4.4
149.7
388
915
UJF30, ,
SPAT
8.1
148.0
201
255
K50
ICD-10 Finland
Crohn disease [regional enteritis]
15.0
143.4
127
86
K92.1
ICD-10 Finland
Melaena
3.5
139.0
509
1532
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.0
135.2
295
604
JFH33
NOMESCO Finland
Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy
452.1
134.5
134
*
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
14.2
133.9
122
87
H02AB09
ATC
hydrocortisone; systemic
4.4
130.6
335
783
JFH11
NOMESCO Finland
Laparoscopic colectomy
194.7
129.0
134
7
JGB50
NOMESCO Finland
Mucosal proctectomy and ileoanal anastomosis
218.5
125.1
129
6
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.9
122.8
278
587
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.5
120.6
433
1285
3AC01, ,
NOMESCO Finland
7.6
118.9
169
226
C05AA08
ATC
fluocortolone; rectal, topical
2.2
118.8
1117
5442
5560A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis
307.1
118.5
120
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.5
118.1
294
671
TJF80
NOMESCO Finland
Ostomy education
7.4
116.6
170
234
UJK12
NOMESCO Finland
Peroral cholangioscopy
19.8
116.6
90
46
JFH20
NOMESCO Finland
Proctocolectomy and ileostomy
175.5
115.7
121
7
C10AC01
ATC
colestyramine; oral
4.1
111.1
311
776
D16
ICPC
Rectal bleeding
4.1
111.1
310
772
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
110.7
845
3760
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
21.8
110.7
82
38
M07.5
ICD-10 Finland
Arthropathy in ulcerative colitis
285.5
110.3
112
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.3
109.7
952
4477
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
107.1
1126
5716
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
5.3
105.2
213
408
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.0
104.0
300
765
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
8.4
98.8
129
156
1490
FHL
Sigmoideoscopy (fiberscope)
19.7
98.2
76
39
UJG02
NOMESCO Finland
Proctoscopy
4.4
98.1
252
589
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
9.9
96.4
111
114
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.8
95.9
306
838
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.3
94.2
138
191
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
4.8
90.2
206
438
K51.4
ICD-10 Finland
Inflammatory polyps
295.2
85.8
87
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
5.1
85.3
182
365
UJF34
NOMESCO Finland
Left colonoscopy
8.3
84.6
111
135
L04AX03
ATC
methotrexate; systemic
2.1
83.9
829
4086
L04AA01
ATC
[U] ciclosporin
5.3
82.3
168
324
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
11.6
80.9
83
72
H02AB04
ATC
methylprednisolone; systemic
1.9
80.8
1085
5975
JF1BD
NOMESCO Finland
Very extensive small bowel CT
9.3
77.4
93
101
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
77.0
1100
6176
JFG73
NOMESCO Finland
Excision of ileal pelvic pouch
376.0
74.9
75
*
Z93
ICD-10 Finland
Artificial opening status
13.3
74.1
70
53
JF2AB
NOMESCO Finland
Colongraphy with X-ray
13.1
73.3
70
54
JF1AD
NOMESCO Finland
Small bowel CT
7.3
70.1
103
143
JFF13
NOMESCO Finland
Terminal enterostomy
12.4
70.1
69
56
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
13.8
68.1
63
46
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
13.8
68.1
63
46
UJK02
NOMESCO Finland
ERCP
3.6
68.1
228
645
D18
ICPC
Change in faeces/bowel movements
3.3
67.9
266
832
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
11.2
65.7
69
62
L04AF01
ATC
tofacitinib; oral
21.9
64.9
48
22
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
64.2
2854
21420
56399
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Other
23.1
63.5
46
20
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
12.5
63.2
62
50
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
62.4
1030
6025
M45
ICD-10 Finland
Ankylosing spondylitis
3.4
62.3
232
703
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.3
62.0
163
388
M09.2*K51.9
ICD-10 Finland
Juvenile arthritis in ulcerative colitis
161.3
61.0
64
*
56902
ICD-8 Finland
Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)
85.8
61.0
68
8
K56.7
ICD-10 Finland
Ileus, unspecified
4.2
60.9
163
393
N02AX02
ATC
tramadol; systemic, rectal
1.5
60.5
2997
22927
K61.0
ICD-10 Finland
Anal abscess
3.4
60.0
215
636
56300
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Regional enteritis
18.9
59.6
47
25
D11
ICPC
Diarrhoea
1.8
58.8
1071
6441
JHA00
NOMESCO Finland
Anal or perianal incision
3.7
58.6
185
503
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
10.6
58.5
64
61
L04AA44
ATC
[U] upadacitinib
14.0
57.8
53
38
K60.3
ICD-10 Finland
Anal fistula
3.4
57.8
212
636
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.1
57.3
243
797
Z2221
NOMESCO Finland
Medical doctor
1.6
56.6
1955
13811
A02BC01
ATC
omeprazole; systemic
1.6
56.1
1800
12503
WX402
NOMESCO Finland
General anaesthesia
1.6
55.8
1723
11863
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
13.0
55.4
53
41
Z43.2
ICD-10 Finland
Attention to ileostomy
14.4
55.3
50
35
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
8.1
54.5
73
91
J01MA12
ATC
levofloxacin; systemic
1.7
54.4
1209
7669
ZXC86
NOMESCO Finland
Use of endoscopic device
7.0
54.1
82
118
B01AB05
ATC
enoxaparin; parenteral
1.5
53.6
1983
14192
N02BE01
ATC
paracetamol; systemic, rectal
1.7
53.0
6727
61365
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.2
52.8
475
2245
A02BC03
ATC
lansoprazole; oral
1.5
52.1
1799
12673
R50.9
ICD-10 Finland
Fever, unspecified
1.7
51.8
1173
7470
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
4.1
51.5
140
342
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
4.3
51.4
135
321
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
51.3
3253
25852
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
3.3
50.6
192
589
K55.9
ICD-10 Finland
Vascular disorder of intestine, unspecified
11.4
50.0
52
46
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
49.5
1055
6606
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.8
47.9
730
4149
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
9.3
47.4
57
62
Z94.4
ICD-10 Finland
Liver transplant status
7.4
47.4
68
92
JAH00
NOMESCO Finland
Laparotomy
3.0
47.3
216
739
UJF02
NOMESCO Finland
Peroral enteroscopy
6.1
47.1
81
133
ZXE00
NOMESCO Finland
One hour or less
1.4
47.1
2672
20709
JJC00
NOMESCO Finland
Allogenic transplantation of liver
9.4
47.1
56
60
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
46.4
1626
11450
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
4.1
46.3
129
321
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.0
46.1
547
2863
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.3
44.1
345
1538
A02BC05
ATC
esomeprazole; systemic
1.4
43.6
2734
21499
D06BX01
ATC
metronidazole; topical
1.8
43.4
744
4375
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.4
42.9
318
1385
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
4.5
42.8
103
229
JGB40
NOMESCO Finland
Excision of rectum and end ileostomy
419.9
42.2
42
*
JHD00
NOMESCO Finland
Anal dilatation
5.2
41.3
84
162
5586X
ICD-9 Finland
Other non-infective gastro-enteritis and colitis[KROONINEN INFLAMMATOORINEN SUOLISTOSAIRAUS, NUD]
60.3
41.2
48
8
5551A
ICD-9 Finland
Regional enteritis, Large intestine
110.6
40.7
44
*
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
10.1
39.8
45
45
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.6
38.8
229
897
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
38.8
374
1813
6410
FHL
Panprococolectomy and ileostomy
+∞
38.6
37
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.1
38.5
387
1906
K56.0
ICD-10 Finland
Paralytic ileus
4.8
38.5
86
180
WZC30
NOMESCO Finland
Teaching
1.6
38.2
1118
7531
A06AC51
ATC
ispaghula, combinations; oral
2.2
37.8
327
1519
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
37.7
832
5236
K74.3
ICD-10 Finland
Primary biliary cirrhosis
6.1
37.3
64
105
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
37.0
1723
12763
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
36.9
1547
11234
L01BA01
ATC
methotrexate; systemic
2.4
36.9
255
1077
A07AA11
ATC
rifaximin; oral
7.1
36.8
55
78
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.9
36.4
494
2702
5604
FHL
Vascular preparation or cannulation in the operating room
10.3
36.0
40
39
L88
ICD-10 Finland
Pyoderma gangrenosum
9.4
35.3
42
45
E0000UV, ,
ATC
1.4
35.3
2953
24118
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.3
35.0
272
1209
1380
FHL
Colonoscopy, left side
43.2
34.9
43
10
C05AA01
ATC
hydrocortisone; rectal, topical
2.2
34.5
315
1495
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
6.6
34.4
55
84
K76.9
ICD-10 Finland
Liver disease, unspecified
3.4
34.3
126
379
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.0
33.8
97
247
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
33.7
3033
24994
WW200
NOMESCO Finland
Immunization
2.4
33.7
233
984
JFB00
NOMESCO Finland
Partial resection of small intestine
3.5
33.7
116
335
K59.1
ICD-10 Finland
Functional diarrhoea
2.0
33.7
394
2050
K52.80
ICD-10 Finland
(Hemorrhagic) colitis caused by antibiotics
8.8
33.6
42
48
6525
FHL
Enterostomy occlusion
41.2
33.0
41
10
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
3.3
33.0
126
389
0093A
ICD-9 Finland
Ill-defined intestinal infections, Diarrhoea of presumed infectious origin
3.4
32.7
119
356
JHD33
NOMESCO Finland
Completing incision of fistula-in-ano
6.7
32.6
51
76
J01DB01
ATC
cefalexin; oral
1.4
32.4
6229
57348
A03CA02
ATC
clidinium and psycholeptics; oral
2.1
32.1
301
1444
JHW96
NOMESCO Finland
Other operation on anus or perianal tissue
5.5
31.7
61
112
D99
ICPC
Disease digestive system other
3.6
31.6
103
287
5552A
ICD-9 Finland
Regional enteritis, Small intestine with large intestine
70.2
30.9
35
5
6408
FHL
Colectomy and ileostomy
+∞
30.2
29
*
D07AC01
ATC
betamethasone; topical
1.3
29.8
2445
19774
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
29.6
705
4510
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
29.5
2319
18630
B80
ICPC
Iron deficiency anaemia
2.4
29.1
203
862
JFH00
NOMESCO Finland
Total colectomy and ileorectal anastomosis
8.8
28.9
36
41
SPAT1262
SPAT
Handing over of treatment supplies
1.5
28.7
1009
7040
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
3.6
28.7
94
263
5761C
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]
103.8
28.6
31
*
UJD02
NOMESCO Finland
Gastroscopy
2.1
28.2
286
1413
D07AD01
ATC
clobetasol; topical
1.5
28.2
1077
7638
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.5
27.6
167
664
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
27.3
2526
20726
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
27.2
1263
9288
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
4.1
26.9
73
179
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
26.4
535
3282
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.4
26.1
180
761
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
25.9
2964
24989
UJH02
NOMESCO Finland
Anoscopy
2.1
25.7
262
1298
5563A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctosigmoiditis
93.7
25.6
28
*
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
2.8
25.2
124
444
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
25.2
6238
66034
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
25.0
636
4128
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
30.1
24.9
33
11
SPAT1131
SPAT
Colonoscopy
2.3
24.7
181
785
L52
ICD-10 Finland
Erythema nodosum
4.2
24.7
66
160
M05BA04
ATC
alendronic acid; oral
1.8
24.7
367
2064
OAB50, ,
SPAT
1.7
24.3
518
3219
JFA38
NOMESCO Finland
Endoscopic dilatation of small intestine
24.4
24.3
34
14
J01FA10
ATC
azithromycin; systemic
1.3
24.3
4246
37650
K62.4
ICD-10 Finland
Stenosis of anus and rectum
7.3
24.1
35
48
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.0
24.0
265
1351
B01AB10
ATC
tinzaparin; parenteral
1.6
23.9
648
4270
A07AA02
ATC
nystatin; oral
1.9
23.8
316
1714
ZYC01
NOMESCO Finland
Remote contact by phone
1.7
23.7
451
2720
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
2.5
23.7
149
603
E86
ICD-10 Finland
Volume depletion
2.5
23.7
143
568
J05AB11
ATC
valaciclovir; oral
1.5
23.5
932
6642
SPAT1263
SPAT
Sampling
1.3
23.5
2747
23134
JHD20
NOMESCO Finland
Incision of fistula-in-ano
3.1
23.4
95
305
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
4.9
23.4
51
105
J05AB01
ATC
aciclovir; systemic
1.4
23.3
1381
10560
Y0599
ICD-8 Finland
Investigation of digestive system
3.0
23.0
102
345
JHD30
NOMESCO Finland
Incomplete incision of fistula-in-ano
5.6
23.0
43
77
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
6.5
23.0
37
57
UJF32, ,
SPAT
2.1
22.7
230
1137
SPAT1255
SPAT
Intravenous administration of medicine
1.7
22.5
402
2383
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
2.3
22.5
174
773
M13.9
ICD-10 Finland
Arthritis, unspecified
1.6
22.3
488
3052
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
22.1
602
3967
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
2.2
21.9
185
853
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
5.8
21.8
39
67
D07AC13
ATC
mometasone; topical
1.3
21.7
1848
14896
JGB61
NOMESCO Finland
Laparoscopic excision of rectum and ileoanal anastomosis
220.6
21.6
22
*
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
4.7
21.4
49
105
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
4.2
21.3
56
134
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
21.3
2543
21407
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.7
20.9
405
2456
J02AC01
ATC
fluconazole; systemic
1.3
20.9
2499
21031
L01BB01, ,
ATC
8.0
20.9
28
35
D29
ICPC
Digestive symptom/complaint other
2.2
20.9
175
805
-, ,
ICD-10 Finland
2.4
20.4
137
573
K83.1
ICD-10 Finland
Obstruction of bile duct
3.0
20.3
91
310
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
20.2
415
2554
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
3.1
19.6
82
269
R01AD08
ATC
fluticasone; nasal
1.3
19.3
1956
16089
ZXD05
NOMESCO Finland
Urgent procedure
1.3
19.2
1928
15840
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.3
19.0
1432
11317
WX600
NOMESCO Finland
Single shot through catheter
2.3
18.9
143
631
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.0
18.9
217
1124
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
18.8
2408
20366
Z3231
NOMESCO Finland
Registered nurse
1.3
18.7
1665
13463
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
18.6
2092
17415
WW500
NOMESCO Finland
Blood transfusion
1.9
18.3
225
1192
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
1.9
18.3
218
1143
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.7
18.2
363
2217
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
7.2
17.8
26
36
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
17.7
1884
15564
L04AA45
ATC
[U] filgotinib
95.3
17.6
19
*
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
17.4
605
4194
D01
ICPC
Abdominal pain/cramps general
1.4
17.4
848
6260
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.6
17.1
398
2527
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
2.5
17.1
105
422
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.7
17.0
326
1973
255, ,
Kela drug reimbursment
50.1
17.0
20
*
3048, ,
Kela drug reimbursment
50.1
17.0
20
*
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
1.9
17.0
212
1130
R01AD12
ATC
fluticasone furoate; nasal
1.3
17.0
2283
19373
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
1.9
16.9
221
1196
XJW99
NOMESCO Finland
Other investigative procedure on digestive system
4.9
16.8
36
73
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
16.7
4026
36313
JFH31
NOMESCO Finland
Laparoscopic total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
+∞
16.7
16
*
K60.4
ICD-10 Finland
Rectal fistula
5.4
16.6
32
59
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
5.3
16.5
33
63
K91.8
ICD-10 Finland
Other postprocedural disorders of digestive system, not elsewhere classified
16.3
16.5
26
16
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
2.7
16.5
89
336
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
16.4
560
3868
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.7
16.4
335
2061
B03BA03
ATC
hydroxocobalamin; parenteral
1.8
16.4
262
1508
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
16.4
2082
17541
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
4.4
16.3
40
91
M81.4
ICD-10 Finland
Drug-induced osteoporosis
4.5
16.3
39
87
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
6.8
16.1
25
37
J01CA04
ATC
amoxicillin; systemic
1.3
16.1
6135
57938
D64.9
ICD-10 Finland
Anaemia, unspecified
1.5
16.1
522
3570
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
16.1
607
4278
Z01.2
ICD-10 Finland
Dental examination
1.2
16.0
3383
30060
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
16.0
369
2341
A98
ICPC
Health maint/preventive medicine
1.6
16.0
7574
73896
TPH04, ,
SPAT
2.8
15.8
76
270
J01AA02
ATC
doxycycline; systemic
1.2
15.8
5269
48971
A02BA02
ATC
ranitidine; systemic
1.4
15.7
947
7228
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
2.6
15.7
88
339
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
12.9
15.6
27
21
JFG50
NOMESCO Finland
Laparotomy with revision of enterostomy or colostomy
17.2
15.6
24
14
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
1.9
15.6
209
1141
K85.8
ICD-10 Finland
Other acute pancreatitis
3.2
15.5
60
188
5550A
ICD-9 Finland
Regional enteritis, Small intestine
38.1
15.4
19
5
JJA20
NOMESCO Finland
Open biopsy of liver
5.2
15.3
31
60
R01AD09
ATC
mometasone; nasal
1.2
15.2
3173
28112
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
3.1
15.2
61
196
K61.1
ICD-10 Finland
Rectal abscess
4.1
15.1
40
97
D17
ICPC
Incontinence of bowel
3.2
15.0
58
182
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.8
14.9
206
1135
1470
FHL
Rectoscopy
3.4
14.8
51
149
M25.5
ICD-10 Finland
Pain in joint
1.2
14.7
2215
18963
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
14.7
488
3353
M07.4
ICD-10 Finland
Arthropathy in Crohn disease [regional enteritis]
21.1
14.6
21
10
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
3.8
14.5
43
113
E000001, ,
ATC
1.3
14.3
1241
9961
Z90.4
ICD-10 Finland
Acquired absence of other parts of digestive tract
42.5
14.1
17
*
E87.6
ICD-10 Finland
Hypokalaemia
1.9
14.1
179
961
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
4.8
14.0
31
65
WX004
NOMESCO Finland
Patient-controlled sedation
3.7
14.0
44
121
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.8
13.9
225
1301
SPAT1125
SPAT
Stoma care and guidance
2.7
13.9
72
267
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
13.8
1366
11140
J01FA06
ATC
roxithromycin; oral
1.2
13.7
2402
20862
B02.9
ICD-10 Finland
Zoster without complication
1.6
13.6
352
2294
XX2RW, ,
NOMESCO Finland
2.4
13.6
90
376
6522
FHL
Ileostomy
75.3
13.6
15
*
N82.3
ICD-10 Finland
Fistula of vagina to large intestine
12.0
13.6
24
20
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
2.1
13.5
123
587
4AC05, ,
NOMESCO Finland
34.1
13.5
17
5
N20.1
ICD-10 Finland
Calculus of ureter
1.8
13.5
217
1253
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.7
13.4
253
1527
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
4.0
13.3
37
93
R4190
NOMESCO Finland
Nutritional therapy
1.7
13.3
266
1630
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
1.8
13.3
205
1170
5559X
ICD-9 Finland
Regional enteritis, Unspecified site
40.1
13.1
16
*
A03BA03
ATC
hyoscyamine; oral
3.3
13.1
49
151
D62
ICPC
Digestive, Administrative procedure
4.0
13.1
36
90
S18
ICPC
Laceration/cut
1.2
13.0
2928
26001
D07XC01
ATC
betamethasone; topical
1.4
12.8
682
5101
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.4
12.7
509
3628
JG1JB
NOMESCO Finland
Defekography with X-ray
3.0
12.6
53
175
RD210, ,
NOMESCO Finland
2.1
12.6
122
597
5781A
ICD-9 Finland
Gastro-intestinal haemorrhage, Melaena[MELAENA]
6.0
12.6
22
37
K75.4
ICD-10 Finland
Autoimmune hepatitis
4.8
12.6
28
59
N82.4
ICD-10 Finland
Other female intestinal-genital tract fistulae
32.1
12.6
16
5
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.3
12.5
813
6264
6437
FHL
Rectum resection and sphincter-sparing through-anastomosis
+∞
12.5
12
*
JFA70
NOMESCO Finland
Suture of small intestine
4.1
12.5
33
80
ZX112
NOMESCO Finland
Subcutaneous
2.1
12.5
119
579
L88
ICPC
Rheumatoid/seropositive arthritis
1.7
12.4
222
1321
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
2.9
12.4
58
204
H20.1
ICD-10 Finland
Chronic iridocyclitis
2.6
12.3
70
272
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
2.9
12.3
57
199
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.5
12.3
351
2337
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.1
12.3
113
542
JAG41
NOMESCO Finland
Repair of stomal hernia, laparoscopic
11.6
12.3
22
19
WX110
NOMESCO Finland
Infiltration anesthesia
1.2
12.3
5275
49504
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.5
12.2
75
303
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.7
12.2
232
1403
K43.5
ICD-10 Finland
Parastomal hernia without obstruction or gangrene
9.6
12.2
24
25
JJ5AT, ,
NOMESCO Finland
9.6
12.2
24
25
JFA76
NOMESCO Finland
Closure of fistula of small intestine
37.6
12.2
15
*
B82
ICPC
Anaemia other/unspecified
1.9
12.2
151
806
A04.6
ICD-10 Finland
Enteritis due to Yersinia enterocolitica
6.0
12.1
21
35
Z98.8
ICD-10 Finland
Other specified postsurgical states
2.3
12.0
89
391
J01MA01
ATC
ofloxacin; systemic
1.5
12.0
391
2676
K90.0
ICD-10 Finland
Coeliac disease
1.8
12.0
172
960
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
4.1
12.0
32
78
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.4
12.0
478
3404
5589X
ICD-9 Finland
Other non-infective gastro-enteritis and colitis, Other and unspecified non-infectious gastro-enteritis and colitis
9.3
11.9
24
26
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.4
11.9
486
3473
D07AB08
ATC
desonide; topical
1.4
11.9
634
4742
R03AC02
ATC
salbutamol; inhalant
1.2
11.9
3731
34032
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
11.9
5044
47206
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
11.9
615
4579
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
1.8
11.8
168
936
SPAT1325
SPAT
Vaccination
1.2
11.8
1748
14883
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
3.7
11.8
36
97
SPAT1153
SPAT
Removal of sutures
1.2
11.8
1692
14360
WX892
NOMESCO Finland
Monitored bed care
1.5
11.8
400
2762
6455
FHL
Perianal fistula surgery
4.2
11.7
30
71
127
Kela drug reimbursment
Transplant complication
2.1
11.7
109
526
B81
ICPC
Anaemia vit B12/folate deficiency
1.8
11.7
170
954
H01.0
ICD-10 Finland
Blepharitis
1.4
11.7
455
3226
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
5.5
11.6
22
40
K83
ICD-10 Finland
Other diseases of biliary tract
22.9
11.5
16
7
H26.3
ICD-10 Finland
Drug-induced cataract
3.2
11.5
45
143
4AG05, ,
NOMESCO Finland
+∞
11.5
11
*
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
3.5
11.4
38
109
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.5
11.4
381
2625
L71.0
ICD-10 Finland
Perioral dermatitis
2.0
11.3
120
607
A01AB09
ATC
miconazole; local oral
1.4
11.3
417
2925
UKC02
NOMESCO Finland
Cystoscopy
1.3
11.3
755
5840
78570
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Melaena (not of newborn)
5.1
11.2
23
45
J01DA01
ATC
[U] cefalexin
1.2
11.2
4086
37658
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.3
11.2
811
6346
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
3.8
11.2
33
87
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.3
11.1
1094
8903
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.5
11.1
363
2490
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.0
11.1
116
585
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
11.0
2438
21534
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
11.0
5352
50478
K85
ICD-10 Finland
Acute pancreatitis
2.2
11.0
85
381
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
4.6
10.9
25
54
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
2.2
10.9
85
383
K63.9
ICD-10 Finland
Disease of intestine, unspecified
3.3
10.8
39
118
K52.1
ICD-10 Finland
Toxic gastroenteritis and colitis
10.5
10.7
20
19
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.4
10.7
410
2897
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.2
10.6
1636
13963
S01BA04
ATC
prednisolone; ophthalmic
2.1
10.6
103
505
JHA20
NOMESCO Finland
Excision of lesion of anal canal or perianal tissue
2.4
10.6
71
299
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.8
10.6
148
821
SPAT1301
SPAT
No procedures
1.2
10.6
1762
15154
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
5.3
10.6
21
40
-44
ICPC
Preventive immunization/medic
1.5
10.5
379
2648
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.6
10.4
209
3312
JGB60
NOMESCO Finland
Excision of rectum and ileoanal anastomosis
110.2
10.4
11
*
M075, K515,
ICD-10 Finland
+∞
10.4
10
*
L04AD02
ATC
tacrolimus; systemic
2.2
10.4
82
371
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
2.3
10.4
75
327
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
1.7
10.3
202
1233
A07AA12
ATC
fidaxomicin; oral
12.0
10.3
18
15
N82.2
ICD-10 Finland
Fistula of vagina to small intestine
32.5
10.3
13
*
K80.3
ICD-10 Finland
Calculus of bile duct with cholangitis
2.9
10.3
46
158
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
10.3
3814
35092
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.6
10.3
218
1358
H15.1
ICD-10 Finland
Episcleritis
2.1
10.3
99
485
J31.0
ICD-10 Finland
Chronic rhinitis
1.4
10.3
544
4065
Z22.30
ICD-10 Finland
Latent tuberculosis
18.8
10.2
15
8
M09.1*K50.9
ICD-10 Finland
Juvenile arthritis in Crohn's disease [regional enteritis]
18.8
10.2
15
8
K62.6
ICD-10 Finland
Ulcer of anus and rectum
2.4
10.2
70
298
K83.3
ICD-10 Finland
Fistula of bile duct
23.4
10.2
14
6
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.6
10.2
257
1667
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
1.8
10.0
136
748
Z01.9
ICD-10 Finland
Special examination, unspecified
1.5
10.0
328
2250
TGC00
NOMESCO Finland
Bronchial lavation
1.9
10.0
129
700
WVA20, ,
SPAT
1.6
9.9
204
1261
D48
ICPC
Digestive, Clarification/discussion RFE/demand
4.0
9.9
27
67
A02BA03
ATC
famotidine; systemic
1.8
9.9
152
869
K86.1
ICD-10 Finland
Other chronic pancreatitis
2.6
9.8
55
213
WZA90
NOMESCO Finland
Other medical or dental certificate
1.2
9.8
1483
12623
6403
FHL
Ileocal resection
26.0
9.8
13
5
71240
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica
4.5
9.8
23
51
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.3
9.7
549
4144
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
3.2
9.7
37
116
N03AX16
ATC
[U] pregabalin
1.2
9.7
1255
10518
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.2
9.7
1060
8724
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.3
9.6
605
4639
M81.8
ICD-10 Finland
Other osteoporosis
2.6
9.6
53
204
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
1.9
9.4
121
655
J45.9
ICD-10 Finland
Asthma, unspecified
1.2
9.4
1092
9042
392
Kela drug reimbursment
Ferric maltol
+∞
9.4
9
*
JFG70
NOMESCO Finland
Conversion of continent ileostomy to conventional ileostomy
+∞
9.4
9
*
JFG53
NOMESCO Finland
Revision of ileal pelvic pouch
+∞
9.4
9
*
J01FA09
ATC
clarithromycin; systemic
1.2
9.4
1945
17040
JFG96
NOMESCO Finland
Other operation on intestinal stoma or pouch
21.7
9.3
13
6
56500
ICD-8 Finland
Anal fissure and fistula, Anal fissure
2.8
9.3
45
162
R06AE07
ATC
cetirizine; oral
1.2
9.3
2944
26690
K52
ICD-10 Finland
Other noninfective gastroenteritis and colitis
4.7
9.3
21
45
JHD96
NOMESCO Finland
Other incision of anal sphincter
4.7
9.3
21
45
D04
ICPC
Rectal/anal pain
2.0
9.3
95
477
F29
ICD-10 Finland
Unspecified nonorganic psychosis
0.5
9.2
93
1772
N05CF01
ATC
zopiclone; oral
1.2
9.2
1720
14927
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
1.7
9.2
177
1078
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
4.1
9.2
24
58
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.4
9.2
341
2400
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
3.9
9.1
26
67
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
3.1
9.1
37
121
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
4.6
9.0
21
46
JHB96
NOMESCO Finland
Other procedure for haemorrhoids or prolapse of mucosa
3.0
9.0
38
127
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
2.8
8.9
44
160
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.2
8.9
1696
14741
K92.9
ICD-10 Finland
Disease of digestive system, unspecified
3.0
8.9
38
128
R11
ICD-10 Finland
Nausea and vomiting
1.3
8.8
502
3796
JD1AB
NOMESCO Finland
Gastro-duodenography with X-ray
9.5
8.8
17
18
JH1CM
NOMESCO Finland
Perianal extensive MRI with 3 Tesla magnet
9.5
8.8
17
18
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
2.7
8.7
44
162
L04AA06
ATC
mycophenolic acid; systemic
1.8
8.7
121
672
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.4
8.7
319
2239
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
1.5
8.7
264
1787
L04AF04
ATC
filgotinib; oral
50.0
8.7
10
*
S29
ICPC
Skin symptom/complaint other
1.2
8.6
1186
9992
D05AX02
ATC
calcipotriol; topical
1.6
8.6
182
1135
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.6
8.6
174
1074
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.4
8.5
412
3034
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
2.5
8.5
49
193
6611
FHL
Needle biopsy in the operating room
9.0
8.5
17
19
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.3
8.5
705
5612
K62.9
ICD-10 Finland
Disease of anus and rectum, unspecified
2.6
8.5
46
176
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic
2.3
8.5
59
254
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
3.3
8.5
30
90
M03BX02
ATC
tizanidine; oral
1.2
8.5
4267
39915
5781B
ICD-9 Finland
Gastro-intestinal haemorrhage, Melaena[HAEMORRHAGIA EX ANO]
6.4
8.5
21
33
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.2
8.4
1838
16146
LEE20
NOMESCO Finland
Closure of urovaginal fistula using graft or flap
90.2
8.4
9
*
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
8.4
159
966
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.6
8.4
169
1043
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
3.1
8.3
33
106
D15
ICPC
Melaena
3.5
8.3
28
81
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
4.6
8.3
19
41
UJF14, ,
SPAT
+∞
8.3
8
*
JFH40
NOMESCO Finland
Proctocolectomy and continent ileostomy
+∞
8.3
8
*
H20
ICD-10 Finland
Iridocyclitis
2.7
8.3
42
155
SPAT1138
SPAT
Guidance concerning bowel function
2.1
8.3
73
347
K62.1
ICD-10 Finland
Rectal polyp
2.4
8.3
53
220
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.5
8.3
244
1642
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.6
8.3
169
1046
SPAT1260
SPAT
Consultation of another employee
1.2
8.2
925
7628
JN4AD
NOMESCO Finland
Body CT examination
1.3
8.2
547
4229
H04.10
ICD-10 Finland
Dry eye syndrome
1.3
8.2
657
5208
SFA20
NOMESCO Finland
Two-surface restoration
1.1
8.2
4206
39354
WX419
NOMESCO Finland
Other general anesthesy
2.3
8.2
57
246
D50.8
ICD-10 Finland
Other iron deficiency anaemias
1.9
8.1
90
465
D82
ICPC
Teeth/gum disease
1.2
8.1
2629
23808
WX720
NOMESCO Finland
Own respiration
1.5
8.1
265
1821
1CB02, ,
NOMESCO Finland
33.4
8.1
10
*
JFA56
NOMESCO Finland
Faecal microbiota transplantation
6.8
8.0
19
28
K03.64
ICD-10 Finland
Dental calculus supragingival
1.2
8.0
2307
20702
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
8.0
1730
15178
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.7
8.0
145
871
54099
ICD-8 Finland
Acute appendicitis, Without mention of peritonitis
0.4
7.9
32
862
D07AA02
ATC
hydrocortisone; topical
1.2
7.9
848
6958
M03BC51
ATC
orphenadrine, combinations; systemic
1.2
7.9
1623
14181
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
1.7
7.9
133
784
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
1.7
7.8
124
718
1280
FHL
Endoscopic retrograde cholangiography and pancreaticography
8.4
7.8
16
19
SPAT1312
SPAT
General health counselling
1.2
7.8
1928
17100
E000006, ,
ATC
1.4
7.7
326
2349
A01AB04
ATC
amphotericin B; local oral
1.6
7.7
172
1089
A03
ICPC
Fever
1.2
7.7
1208
10305
JGB96
NOMESCO Finland
Other proctectomy or excision of rectum
7.4
7.7
17
23
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
7.4
7.7
17
23
1310
FHL
Esophagogastroscopy
3.4
7.6
26
76
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.5
7.6
246
1687
Z93.3
ICD-10 Finland
Colostomy status
2.5
7.6
46
186
D05AX52
ATC
calcipotriol, combinations; topical
1.4
7.6
294
2086
56398
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Alia definita
18.4
7.6
11
6
E000002, ,
ATC
1.3
7.6
646
5159
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.2
7.6
2320
20904
A02BA04
ATC
nizatidine; systemic
1.4
7.6
304
2173
R01BA52
ATC
pseudoephedrine, combinations; oral
1.2
7.5
1659
14570
A07EB01
ATC
cromoglicic acid; oral
10.0
7.5
14
14
D28
ICPC
Limited function/disability (D)
3.8
7.5
22
58
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
3.4
7.5
26
77
D10AX03
ATC
azelaic acid; topical
1.3
7.5
490
3781
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.2
7.5
1216
10404
EB1VA, ,
NOMESCO Finland
1.2
7.5
1145
9743
SPAT1134
SPAT
Anoscopy
2.9
7.5
34
119
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
7.4
1522
13286
JEA01
NOMESCO Finland
Laparoscopic appendectomy
1.5
7.4
248
1713
N20.0
ICD-10 Finland
Calculus of kidney
1.8
7.4
110
625
M075, K509,
ICD-10 Finland
80.2
7.4
8
*
6407
FHL
Colectomy and ileorectostomy
80.2
7.4
8
*
JL5AM
NOMESCO Finland
Bile and pancreas ducts simple MRI examination with 3 Tesla magnet
13.4
7.4
12
9
JFB96
NOMESCO Finland
Other partial excision of intestine
13.4
7.4
12
9
K43.3
ICD-10 Finland
Parastomal hernia with obstruction, without gangrene
13.4
7.4
12
9
JAG43
NOMESCO Finland
Repair of stomal hernia with mesh
13.4
7.4
12
9
R4110
NOMESCO Finland
Physiotherapy
1.2
7.3
1558
13638
SFA10
NOMESCO Finland
One-surface restoration
1.1
7.3
3904
36497
S01BA01
ATC
dexamethasone; ophthalmic
1.6
7.3
157
985
R05
ICPC
Cough
1.2
7.3
1517
13257
5761A
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SUPPURATIVA]
+∞
7.3
7
*
O996, K515,
ICD-10 Finland
+∞
7.3
7
*
M073, K519,
ICD-10 Finland
+∞
7.3
7
*
4AB06, ,
NOMESCO Finland
+∞
7.3
7
*
Z71.8
ICD-10 Finland
Other specified counselling
1.2
7.3
2258
20348
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.4
7.3
311
2247
K63.3
ICD-10 Finland
Ulcer of intestine
6.8
7.3
17
25
M02AA10
ATC
ketoprofen; topical
1.2
7.3
798
6563
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.3
7.3
467
3595
L04AC18
ATC
risankizumab; parenteral
3.4
7.2
25
74
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.3
7.2
603
4805
R01AD05
ATC
budesonide; nasal
1.3
7.2
391
2936
M05BA07
ATC
risedronic acid; oral
1.9
7.2
88
471
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
1.8
7.2
92
500
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
3.1
7.1
29
95
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
1.7
7.1
117
685
K52.8
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
20.0
7.1
10
5
D95
ICPC
Anal fissure/perianal abscess
2.1
7.1
66
321
R10.0
ICD-10 Finland
Acute abdomen
1.5
7.1
183
1199
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
3.3
7.1
25
75
J01MA14
ATC
moxifloxacin; systemic
1.3
7.1
455
3503
WX320
NOMESCO Finland
Spinalanesthesy
1.2
7.1
1283
11080
K85.3
ICD-10 Finland
Drug-induced acute pancreatitis
12.0
7.1
12
10
R06.0
ICD-10 Finland
Dyspnoea
1.2
7.1
1443
12590
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.2
7.0
976
8222
N05AH02
ATC
clozapine; systemic
0.4
7.0
30
786
SFA30
NOMESCO Finland
Three-surface restoration
1.1
7.0
2716
24841
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
1.9
7.0
89
483
M02AA07
ATC
piroxicam; topical
1.2
7.0
1816
16148
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
1.9
7.0
82
434
JFA42
NOMESCO Finland
Endoscopic injection in colon
3.4
7.0
24
71
K02.0
ICD-10 Finland
Caries limited to enamel
1.2
6.9
1432
12501
6451
FHL
Dilatation
2.6
6.9
37
141
K56.2
ICD-10 Finland
Volvulus
2.6
6.9
38
147
WGA11
NOMESCO Finland
Planning of pain management
2.5
6.9
40
159
JFH01
NOMESCO Finland
Laparoscopic colectomy with ileorectal anastomosis
13.8
6.9
11
8
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
2.9
6.9
31
108
SAA03
NOMESCO Finland
Extended examination of mouth
1.1
6.9
2665
24371
H05AA02
ATC
teriparatide; parenteral
3.4
6.8
23
67
K02.1
ICD-10 Finland
Caries of dentine
1.1
6.8
4336
40917
TAB24
NOMESCO Finland
Implantation of epidural injection gate
10.9
6.8
12
11
D02AE01
ATC
carbamide; topical
1.4
6.8
328
2421
E000003, ,
ATC
1.5
6.8
227
1571
-69
ICPC
Other reason for encounter NEC
1.5
6.8
172
1124
K86.2
ICD-10 Finland
Cyst of pancreas
2.3
6.8
49
216
JJC60
NOMESCO Finland
Total excision of transplanted liver
40.1
6.8
8
*
R03AK07
ATC
formoterol and budesonide; inhalant
1.2
6.8
1329
11555
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
3.6
6.7
21
58
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.3
6.7
554
4407
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.2
6.7
676
5506
EB4VA, ,
NOMESCO Finland
1.2
6.7
1187
10225
N01BB02
ATC
lidocaine; parenteral
2.3
6.7
47
204
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.2
6.7
1117
9571
NG1DA
NOMESCO Finland
X-ray of knees
1.9
6.7
83
447
R31
ICD-10 Finland
Unspecified haematuria
1.3
6.7
464
3610
B02
ICD-10 Finland
Zoster [herpes zoster]
1.5
6.7
224
1550
K83.2
ICD-10 Finland
Perforation of bile duct
22.5
6.7
9
*
JAG40
NOMESCO Finland
Repair of stomal hernia with suture
22.5
6.7
9
*
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.4
6.7
31
780
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
1.6
6.7
127
775
JFA15, ,
SPAT
2.3
6.6
45
193
JKA20
NOMESCO Finland
Cholecystectomy
1.7
6.6
105
610
S70
ICPC
Herpes zoster
1.7
6.6
121
731
S97
ICPC
Chronic ulcer skin
1.4
6.6
271
1947
L71.9
ICD-10 Finland
Rosacea, unspecified
1.6
6.5
143
903
318
Kela drug reimbursment
Teriparatide
3.3
6.5
24
74
K60.2
ICD-10 Finland
Anal fissure, unspecified
1.7
6.5
109
642
JL5BM
NOMESCO Finland
Bile and pancreas ducts MRI examination with 3 Tesla magnet
10.0
6.5
12
12
R53
ICD-10 Finland
Malaise and fatigue
1.2
6.5
1523
13423
R01AD58
ATC
fluticasone, combinations; nasal
1.2
6.5
1730
15397
45599
ICD-8 Finland
Haemorrhoids
1.9
6.5
76
402
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.3
6.5
494
3893
K30
ICD-10 Finland
Functional dyspepsia
1.3
6.5
634
5150
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.4
6.4
33
797
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
1.6
6.4
148
946
JHD50
NOMESCO Finland
Excision of fistula-in-ano with advancement flap of mucosa
5.7
6.4
17
30
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
5.7
6.4
17
30
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.4
6.4
254
1813
K86.8
ICD-10 Finland
Other specified diseases of pancreas
3.2
6.4
24
75
J01FF01
ATC
clindamycin; systemic
1.2
6.4
1583
14014
G04CA02
ATC
tamsulosin; oral
1.2
6.4
1078
9248
TQW40
NOMESCO Finland
Remowal of suture of skin
1.3
6.4
358
2705
L71
ICD-10 Finland
Rosacea
1.6
6.4
151
972
SCA01
NOMESCO Finland
Preventive oral health care, short
1.1
6.4
1964
17665
R2110
NOMESCO Finland
Giving the first information
1.3
6.4
352
2654
WX723
NOMESCO Finland
CPAP therapy
1.4
6.3
258
1851
00919
ICD-8 Finland
Diarrhoeal disease, Diarrhoea
3.0
6.3
26
86
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.3
6.3
436
3391
M01AB05
ATC
diclofenac; systemic, rectal
0.9
6.3
3920
41547
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
6.5
6.3
15
23
JN1DM
NOMESCO Finland
Upper part of abdomen very extensive MRI examination with 3 Tesla magnet
8.1
6.3
13
16
ZX120, ,
SPAT
1.9
6.3
69
357
R03DC03
ATC
montelukast; oral
1.2
6.3
969
8243
6402
FHL
Small bowel resection
5.9
6.3
16
27
WX704
NOMESCO Finland
Intubation
1.3
6.3
439
3422
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
2.0
6.3
67
344
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.2
6.3
1388
12180
M79.6
ICD-10 Finland
Pain in limb
1.1
6.3
2789
25695
JFK00
NOMESCO Finland
Division of adhesive band in intestinal obstruction
3.8
6.2
18
47
A08.5
ICD-10 Finland
Other specified intestinal infections
2.3
6.2
44
192
5694X
ICD-9 Finland
Other disorders of intestine, Other specified disorders of rectum and anus
26.7
6.2
8
*
A03DA02
ATC
pitofenone and analgesics; systemic
2.0
6.2
67
345
N20.9
ICD-10 Finland
Urinary calculus, unspecified
1.6
6.2
140
891
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.4
6.2
298
2199
L30.0
ICD-10 Finland
Nummular dermatitis
1.5
6.2
197
1351
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
1.9
6.2
75
402
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.8
6.2
929
10882
K55.1
ICD-10 Finland
Chronic vascular disorders of intestine
5.7
6.1
16
28
SPAT1104
SPAT
Monitoring of emergency patient
1.4
6.1
300
2221
R10.2
ICD-10 Finland
Pelvic and perineal pain
1.6
6.1
142
911
JFA52
NOMESCO Finland
Other endoscopic haemostatic procedure in colon
3.0
6.1
26
88
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
2.4
6.1
39
163
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
2.0
6.1
64
327
M05BB03
ATC
alendronic acid and colecalciferol; oral
1.9
6.1
66
341
D70.82
ICD-10 Finland
Drug-induced neutropenia
1.9
6.0
74
398
R03BA05
ATC
fluticasone; inhalant
1.2
6.0
1045
8985
M01AH01
ATC
celecoxib; oral
1.2
6.0
844
7118
JAD10
NOMESCO Finland
Repair of incisional hernia
2.4
6.0
38
158
M04AA01
ATC
allopurinol; systemic
1.3
6.0
539
4335
KH1AD
NOMESCO Finland
CT of urinary organs
1.5
6.0
190
1302
OAB75
NOMESCO Finland
Nutritional guidance related to maintaining health
3.2
6.0
23
73
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
mesalazine; oral, rectal
A07EC02 [21600664]
A07EC02 [21600664]
4.6e+00
6.0e+00
6.7e+00
1.0e+50
7.8e+00
7.9e+00
7.5e+00
cases:20.18%
controls:0.25%
cases:35.26%
controls:0.14%
cases:22.97%
controls:0.04%
cases:22.34%
controls:0.00%
cases:51.13%
controls:0.04%
cases:80.45%
controls:0.15%
cases:80.77%
controls:0.24%
1486
186
5876
72948
2596
102
4766
73037
1691
28
5671
73111
1645
0
5717
73139
3764
31
3597
73075
5905
106
1435
72642
5583
163
1329
67809
Ulcerative colitis, unspecified
K51.9 [45605941]
K51.9 [45605941]
2.5e+00
4.4e+00
5.1e+00
1.0e+50
7.7e+00
7.5e+00
6.5e+00
cases:0.92%
controls:0.08%
cases:2.11%
controls:0.03%
cases:1.55%
controls:0.01%
cases:28.21%
controls:0.00%
cases:14.06%
controls:0.01%
cases:25.46%
controls:0.02%
cases:31.55%
controls:0.07%
68
55
7294
73079
155
20
7207
73119
114
7
7248
73132
2077
0
5285
73139
1035
5
6326
73101
1869
14
5471
72734
2181
47
4731
67925
Gastroenterology
10 [38004455]
10 [38004455]
7.8e-01
1.8e+00
3.1e+00
8.8e+00
5.0e+00
4.4e+00
3.7e+00
cases:5.31%
controls:2.50%
cases:6.64%
controls:1.11%
cases:4.75%
controls:0.21%
cases:40.55%
controls:0.01%
cases:25.30%
controls:0.22%
cases:48.94%
controls:1.11%
cases:59.71%
controls:3.39%
391
1826
6971
71308
489
810
6873
72329
350
157
7012
72982
2985
7
4377
73132
1862
163
5499
72943
3592
806
3748
71942
4127
2306
2785
65666
Ulcerative colitis and Crohn's disease
208 [2001600206]
208 [2001600206]
5.0e+00
6.7e+00
—
1.0e+50
—
8.7e+00
4.8e+00
cases:11.41%
controls:0.09%
cases:9.98%
controls:0.01%
—
—
cases:0.67%
controls:0.00%
—
—
cases:30.19%
controls:0.01%
cases:6.31%
controls:0.06%
840
63
6522
73071
735
10
6627
73129
—
49
0
7313
73139
—
2216
5
5124
72743
436
39
6476
67933
Ulcerative (chronic) rectosigmoiditis
K51.3 [45533603]
K51.3 [45533603]
4.0e+00
5.3e+00
1.0e+50
1.0e+50
—
7.6e+00
7.8e+00
cases:0.71%
controls:0.01%
cases:1.36%
controls:0.01%
cases:0.76%
controls:0.00%
cases:15.54%
controls:0.00%
—
—
cases:19.70%
controls:0.01%
cases:26.29%
controls:0.01%
52
10
7310
73124
100
5
7262
73134
56
0
7306
73139
1144
0
6218
73139
—
1446
9
5894
72739
1817
10
5095
67962
Left sided colitis
K51.5 [45533604]
K51.5 [45533604]
3.4e+00
4.8e+00
—
1.0e+50
—
8.0e+00
7.6e+00
cases:1.24%
controls:0.04%
cases:2.21%
controls:0.02%
—
—
cases:22.53%
controls:0.00%
—
—
cases:32.29%
controls:0.02%
cases:42.49%
controls:0.04%
91
32
7271
73102
163
13
7199
73126
—
1659
0
5703
73139
—
2370
12
4970
72736
2937
25
3975
67947
budesonide; oral, sublingual
A07EA06 [21600658]
A07EA06 [21600658]
2.3e+00
3.5e+00
4.0e+00
—
4.8e+00
4.6e+00
4.4e+00
cases:2.04%
controls:0.21%
cases:3.00%
controls:0.09%
cases:1.66%
controls:0.03%
—
—
cases:2.87%
controls:0.02%
cases:8.72%
controls:0.10%
cases:16.13%
controls:0.24%
150
151
7212
72983
221
69
7141
73070
122
22
7240
73117
—
211
17
7150
73089
640
72
6700
72676
1115
163
5797
67809
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
1.1e+00
1.9e+00
3.1e+00
7.2e+00
4.1e+00
2.9e+00
2.3e+00
cases:15.72%
controls:6.11%
cases:15.55%
controls:2.62%
cases:8.03%
controls:0.39%
cases:9.55%
controls:0.01%
cases:20.23%
controls:0.41%
cases:32.33%
controls:2.65%
cases:43.48%
controls:7.33%
1157
4468
6205
68666
1145
1917
6217
71222
591
284
6771
72855
703
6
6659
73133
1489
301
5872
72805
2373
1929
4967
70819
3005
4982
3907
62990
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
9.4e-01
1.8e+00
3.0e+00
7.1e+00
4.1e+00
2.8e+00
2.2e+00
cases:14.24%
controls:6.08%
cases:14.30%
controls:2.61%
cases:7.53%
controls:0.39%
cases:9.24%
controls:0.01%
cases:19.55%
controls:0.41%
cases:31.42%
controls:2.65%
cases:42.35%
controls:7.29%
1048
4447
6314
68687
1053
1909
6309
71230
554
283
6808
72856
680
6
6682
73133
1439
301
5922
72805
2306
1925
5034
70823
2927
4958
3985
63014
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
38445-3 [3048689]
1.3e+00
3.0e+00
5.5e+00
—
4.8e+00
4.0e+00
3.3e+00
cases:4.41%
controls:1.19%
cases:11.19%
controls:0.64%
cases:13.95%
controls:0.07%
—
—
cases:6.24%
controls:0.05%
cases:25.93%
controls:0.63%
cases:36.78%
controls:2.07%
325
870
7037
72264
824
471
6538
72668
1027
48
6335
73091
—
459
40
6902
73066
1903
455
5437
72293
2542
1408
4370
66564
Crohn disease of large intestine
K50.1 [45601173]
K50.1 [45601173]
2.3e+00
3.3e+00
3.9e+00
—
3.9e+00
4.0e+00
4.1e+00
cases:0.54%
controls:0.06%
cases:0.99%
controls:0.04%
cases:0.60%
controls:0.01%
—
—
cases:0.33%
controls:0.01%
cases:1.78%
controls:0.03%
cases:3.69%
controls:0.06%
40
42
7322
73092
73
27
7289
73112
44
9
7318
73130
—
24
5
7337
73101
131
24
7209
72724
255
42
6657
67930
Other ulcerative colitis
K51.8 [45586720]
K51.8 [45586720]
2.9e+00
4.1e+00
1.0e+50
1.0e+50
—
7.2e+00
6.5e+00
cases:0.35%
controls:0.02%
cases:0.52%
controls:0.01%
cases:0.34%
controls:0.00%
cases:6.75%
controls:0.00%
—
—
cases:8.61%
controls:0.01%
cases:12.63%
controls:0.02%
26
14
7336
73120
38
6
7324
73133
25
0
7337
73139
497
0
6865
73139
—
632
5
6708
72743
873
15
6039
67957
budesonide
D07AC09 [21602128]
D07AC09 [21602128]
3.6e+00
5.0e+00
—
1.0e+50
—
5.9e+00
5.7e+00
cases:1.07%
controls:0.03%
cases:1.64%
controls:0.01%
—
—
cases:0.71%
controls:0.00%
—
—
cases:3.84%
controls:0.01%
cases:8.06%
controls:0.03%
79
21
7283
73113
121
8
7241
73131
—
52
0
7310
73139
—
282
8
7058
72740
557
20
6355
67952
mercaptopurine
L01BB02 [21601428]
L01BB02 [21601428]
1.4e-01
1.9e+00
2.8e+00
1.0e+50
4.4e+00
5.3e+00
5.5e+00
cases:0.08%
controls:0.07%
cases:0.20%
controls:0.03%
cases:0.14%
controls:0.01%
cases:0.07%
controls:0.00%
cases:0.64%
controls:0.01%
cases:4.90%
controls:0.03%
cases:8.28%
controls:0.04%
6
52
7356
73082
15
23
7347
73116
10
6
7352
73133
5
0
7357
73139
47
6
7314
73100
360
19
6980
72729
572
25
6340
67947
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
54067-4 [3051552]
9.2e-01
2.6e+00
4.9e+00
1.0e+50
5.1e+00
3.6e+00
2.7e+00
cases:1.01%
controls:0.40%
cases:2.27%
controls:0.17%
cases:3.33%
controls:0.03%
cases:0.95%
controls:0.00%
cases:2.83%
controls:0.02%
cases:5.42%
controls:0.16%
cases:9.84%
controls:0.70%
74
294
7288
72840
167
126
7195
73013
245
19
7117
73120
70
0
7292
73139
208
13
7153
73093
398
118
6942
72630
680
473
6232
67499
Colonoscopy Study observation
28023-0 [3022145]
28023-0 [3022145]
1.5e+00
3.0e+00
4.9e+00
1.0e+50
4.3e+00
3.0e+00
2.9e+00
cases:3.23%
controls:0.72%
cases:5.35%
controls:0.29%
cases:2.42%
controls:0.02%
cases:8.46%
controls:0.00%
cases:1.97%
controls:0.03%
cases:6.09%
controls:0.31%
cases:18.42%
controls:1.18%
238
529
7124
72605
394
211
6968
72928
178
14
7184
73125
623
0
6739
73139
145
20
7216
73086
447
224
6893
72524
1273
799
5639
67173
Ileoscopy through colon
UJF30 [2001305028]
UJF30 [2001305028]
8.5e-01
2.2e+00
4.3e+00
1.0e+50
4.5e+00
3.9e+00
3.5e+00
cases:1.26%
controls:0.55%
cases:1.47%
controls:0.16%
cases:0.83%
controls:0.01%
cases:9.33%
controls:0.00%
cases:1.14%
controls:0.01%
cases:6.99%
controls:0.16%
cases:16.28%
controls:0.59%
93
399
7269
72735
108
120
7254
73019
61
8
7301
73131
687
0
6675
73139
84
9
7277
73097
513
116
6827
72632
1125
399
5787
67573
Coloscopy
UJF32 [2001305029]
UJF32 [2001305029]
1.1e+00
2.4e+00
4.2e+00
—
4.4e+00
3.7e+00
3.2e+00
cases:4.50%
controls:1.57%
cases:5.08%
controls:0.48%
cases:2.72%
controls:0.04%
—
—
cases:3.50%
controls:0.04%
cases:15.76%
controls:0.45%
cases:33.96%
controls:2.03%
331
1151
7031
71983
374
354
6988
72785
200
30
7162
73109
—
258
31
7103
73075
1157
324
6183
72424
2347
1381
4565
66591
prednisone; oral
H02AB07 [21602735]
H02AB07 [21602735]
1.7e+00
2.7e+00
3.8e+00
1.0e+50
4.7e+00
3.4e+00
2.7e+00
cases:4.75%
controls:0.94%
cases:4.35%
controls:0.31%
cases:2.09%
controls:0.05%
cases:2.11%
controls:0.00%
cases:5.01%
controls:0.05%
cases:8.86%
controls:0.31%
cases:12.14%
controls:0.95%
350
688
7012
72446
320
230
7042
72909
154
35
7208
73104
155
0
7207
73139
369
34
6992
73072
650
228
6690
72520
839
648
6073
67324
prednisone
A07EA03 [21600655]
A07EA03 [21600655]
1.7e+00
2.7e+00
3.8e+00
1.0e+50
4.7e+00
3.4e+00
2.7e+00
cases:4.75%
controls:0.94%
cases:4.35%
controls:0.31%
cases:2.09%
controls:0.05%
cases:2.11%
controls:0.00%
cases:5.01%
controls:0.05%
cases:8.86%
controls:0.31%
cases:12.14%
controls:0.95%
350
688
7012
72446
320
230
7042
72909
154
35
7208
73104
155
0
7207
73139
369
34
6992
73072
650
228
6690
72520
839
648
6073
67324
azathioprine; oral, parenteral
L04AX01 [21603927]
L04AX01 [21603927]
1.5e+00
1.9e+00
2.3e+00
—
4.0e+00
4.4e+00
4.5e+00
cases:1.48%
controls:0.34%
cases:1.70%
controls:0.27%
cases:0.71%
controls:0.07%
—
—
cases:4.05%
controls:0.08%
cases:17.75%
controls:0.26%
cases:25.14%
controls:0.35%
109
248
7253
72886
125
195
7237
72944
52
54
7310
73085
—
298
58
7063
73048
1303
189
6037
72559
1738
241
5174
67731
Pediatric Gastroenterology
OMOP4822029 [45756810]
OMOP4822029 [45756810]
9.4e-01
2.2e+00
2.9e+00
—
4.5e+00
3.6e+00
3.9e+00
cases:0.24%
controls:0.10%
cases:0.35%
controls:0.04%
cases:0.29%
controls:0.02%
—
—
cases:0.71%
controls:0.01%
cases:1.43%
controls:0.04%
cases:1.71%
controls:0.04%
18
70
7344
73064
26
29
7336
73110
21
12
7341
73127
—
52
6
7309
73100
105
28
7235
72720
118
24
6794
67948
Noninfective gastroenteritis and colitis, unspecified
K52.9 [45572215]
K52.9 [45572215]
2.2e+00
4.4e+00
—
1.0e+50
4.9e+00
3.9e+00
2.3e+00
cases:1.26%
controls:0.15%
cases:4.62%
controls:0.06%
—
—
cases:1.39%
controls:0.00%
cases:1.13%
controls:0.01%
cases:2.29%
controls:0.05%
cases:2.03%
controls:0.20%
93
107
7269
73027
340
42
7022
73097
—
102
0
7260
73139
83
6
7278
73100
168
34
7172
72714
140
136
6772
67836
prednisolone
C05AA04 [21601609]
C05AA04 [21601609]
3.7e+00
5.0e+00
—
1.0e+50
—
5.2e+00
3.8e+00
cases:2.28%
controls:0.06%
cases:1.59%
controls:0.01%
—
—
cases:0.31%
controls:0.00%
—
—
cases:1.43%
controls:0.01%
cases:1.92%
controls:0.05%
168
41
7194
73093
117
8
7245
73131
—
23
0
7339
73139
—
105
6
7235
72742
133
31
6779
67941
Ulcerative (chronic) proctitis
K51.2 [45596329]
K51.2 [45596329]
3.9e+00
—
—
1.0e+50
—
7.1e+00
6.6e+00
cases:1.25%
controls:0.02%
—
—
—
—
cases:15.44%
controls:0.00%
—
—
cases:14.29%
controls:0.01%
cases:16.36%
controls:0.03%
92
18
7270
73116
—
—
1137
0
6225
73139
—
1049
10
6291
72738
1131
18
5781
67954
Chronic enteritis/ulcerative colitis
D94 [2002000392]
D94 [2002000392]
2.8e+00
4.3e+00
—
—
—
4.3e+00
5.1e+00
cases:0.24%
controls:0.02%
cases:0.50%
controls:0.01%
—
—
—
—
—
—
cases:0.80%
controls:0.01%
cases:2.56%
controls:0.02%
18
11
7344
73123
37
5
7325
73134
—
—
—
59
8
7281
72740
177
11
6735
67961
Internal Medicine
11 [38004456]
11 [38004456]
1.0e-01
6.4e-01
1.8e+00
7.2e+00
2.7e+00
2.2e+00
1.7e+00
cases:17.64%
controls:16.20%
cases:12.69%
controls:7.15%
cases:6.64%
controls:1.17%
cases:43.86%
controls:0.06%
cases:16.00%
controls:1.21%
cases:41.36%
controls:6.95%
cases:52.59%
controls:16.38%
1299
11851
6063
61283
934
5227
6428
67912
489
854
6873
72285
3229
41
4133
73098
1178
883
6183
72223
3036
5053
4304
67695
3635
11135
3277
56837
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
9.4e-02
8.8e-01
3.4e+00
4.2e+00
3.1e+00
2.4e+00
2.0e+00
cases:4.13%
controls:3.77%
cases:5.07%
controls:2.17%
cases:9.90%
controls:0.35%
cases:1.13%
controls:0.02%
cases:6.90%
controls:0.33%
cases:20.34%
controls:2.16%
cases:31.89%
controls:5.98%
304
2758
7058
70376
373
1588
6989
71551
729
256
6633
72883
83
12
7279
73127
508
242
6853
72864
1493
1573
5847
71175
2204
4067
4708
63905
Melaena
K92.1 [45533624]
K92.1 [45533624]
1.1e+00
3.3e+00
5.1e+00
1.0e+50
3.7e+00
1.9e+00
8.8e-01
cases:0.62%
controls:0.21%
cases:1.63%
controls:0.06%
cases:1.75%
controls:0.01%
cases:0.54%
controls:0.00%
cases:0.29%
controls:0.01%
cases:0.33%
controls:0.05%
cases:0.56%
controls:0.23%
46
151
7316
72983
120
43
7242
73096
129
8
7233
73131
40
0
7322
73139
21
5
7340
73101
24
35
7316
72713
39
159
6873
67813
Bacteria identified in Stool by Culture
625-4 [3025941]
625-4 [3025941]
7.6e-01
2.8e+00
5.1e+00
—
3.6e+00
2.1e+00
1.5e+00
cases:1.34%
controls:0.64%
cases:3.10%
controls:0.20%
cases:2.36%
controls:0.02%
—
—
cases:0.99%
controls:0.03%
cases:1.43%
controls:0.18%
cases:3.40%
controls:0.80%
99
465
7263
72669
228
148
7134
72991
174
11
7188
73128
—
73
20
7288
73086
105
129
7235
72619
235
542
6677
67430
Ova and parasites identified in Stool by Light microscopy
10704-5 [3003327]
10704-5 [3003327]
8.6e-01
2.4e+00
4.7e+00
1.0e+50
4.3e+00
2.2e+00
1.2e+00
cases:0.84%
controls:0.36%
cases:1.48%
controls:0.13%
cases:1.41%
controls:0.01%
cases:0.12%
controls:0.00%
cases:0.90%
controls:0.01%
cases:1.08%
controls:0.12%
cases:1.77%
controls:0.55%
62
261
7300
72873
109
95
7253
73044
104
10
7258
73129
9
0
7353
73139
66
9
7295
73097
79
90
7261
72658
122
375
6790
67597
ursodeoxycholic acid; oral
A05AA02 [21600513]
A05AA02 [21600513]
1.5e+00
2.3e+00
2.3e+00
1.0e+50
3.4e+00
3.2e+00
2.7e+00
cases:0.53%
controls:0.12%
cases:0.73%
controls:0.07%
cases:0.24%
controls:0.02%
cases:0.15%
controls:0.00%
cases:0.75%
controls:0.02%
cases:1.80%
controls:0.08%
cases:2.76%
controls:0.19%
39
86
7323
73048
54
53
7308
73086
18
18
7344
73121
11
0
7351
73139
55
18
7306
73088
132
57
7208
72691
191
129
6721
67843
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
2.2e-01
9.4e-01
2.1e+00
6.6e+00
2.6e+00
1.5e+00
1.3e+00
cases:6.03%
controls:4.89%
cases:4.66%
controls:1.88%
cases:2.39%
controls:0.31%
cases:6.33%
controls:0.01%
cases:3.21%
controls:0.25%
cases:8.17%
controls:1.93%
cases:19.97%
controls:6.13%
444
3578
6918
69556
343
1374
7019
71765
176
226
7186
72913
466
7
6896
73132
236
184
7125
72922
600
1407
6740
71341
1380
4170
5532
63802
Crohn disease, unspecified
K50.9 [45562490]
K50.9 [45562490]
1.5e+00
2.7e+00
3.3e+00
1.0e+50
—
3.8e+00
3.8e+00
cases:0.42%
controls:0.09%
cases:0.65%
controls:0.04%
cases:0.33%
controls:0.01%
cases:0.24%
controls:0.00%
—
—
cases:1.25%
controls:0.03%
cases:3.13%
controls:0.07%
31
67
7331
73067
48
31
7314
73108
24
9
7338
73130
18
0
7344
73139
—
92
21
7248
72727
216
50
6696
67922
Cholangitis
K83.0 [45552955]
K83.0 [45552955]
2.7e+00
4.0e+00
—
1.0e+50
—
4.6e+00
3.8e+00
cases:0.43%
controls:0.03%
cases:0.75%
controls:0.01%
—
—
cases:0.50%
controls:0.00%
—
—
cases:1.68%
controls:0.02%
cases:2.69%
controls:0.06%
32
22
7330
73112
55
10
7307
73129
—
37
0
7325
73139
—
123
13
7217
72735
186
41
6726
67931
sulfasalazine; oral, rectal
A07EC01 [21600663]
A07EC01 [21600663]
2.1e+00
2.3e+00
2.4e+00
—
2.8e+00
2.6e+00
2.5e+00
cases:6.68%
controls:0.84%
cases:5.58%
controls:0.61%
cases:1.98%
controls:0.18%
—
—
cases:2.76%
controls:0.17%
cases:7.72%
controls:0.62%
cases:11.33%
controls:0.99%
492
617
6870
72517
411
449
6951
72690
146
132
7216
73007
—
203
124
7158
72982
567
453
6773
72295
783
675
6129
67297
Flexible sigmoidoscopy with biopsy
UJF45 [2001305031]
UJF45 [2001305031]
1.0e+00
2.0e+00
4.1e+00
1.0e+50
—
4.1e+00
3.4e+00
cases:1.13%
controls:0.40%
cases:0.90%
controls:0.12%
cases:0.50%
controls:0.01%
cases:4.05%
controls:0.00%
—
—
cases:6.40%
controls:0.11%
cases:10.79%
controls:0.40%
83
291
7279
72843
66
90
7296
73049
37
6
7325
73133
298
0
7064
73139
—
470
79
6870
72669
746
273
6166
67699
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
5159-9 [3007844]
-2.9e-02
8.9e-01
4.0e+00
1.0e+50
4.4e+00
3.0e+00
2.3e+00
cases:0.24%
controls:0.25%
cases:0.30%
controls:0.12%
cases:0.45%
controls:0.01%
cases:0.11%
controls:0.00%
cases:0.53%
controls:0.01%
cases:1.68%
controls:0.09%
cases:3.24%
controls:0.33%
18
184
7344
72950
22
90
7340
73049
33
6
7329
73133
8
0
7354
73139
39
5
7322
73101
123
64
7217
72684
224
223
6688
67749
Other specified noninfective gastroenteritis and colitis
K52.88 [2000502923]
K52.88 [2000502923]
1.8e+00
3.1e+00
—
—
4.1e+00
2.9e+00
2.3e+00
cases:0.50%
controls:0.08%
cases:1.17%
controls:0.05%
—
—
—
—
cases:0.48%
controls:0.01%
cases:0.97%
controls:0.05%
cases:1.26%
controls:0.13%
37
62
7325
73072
86
39
7276
73100
—
—
35
6
7326
73100
71
38
7269
72710
87
88
6825
67884
Campylobacter sp identified in Tissue by Organism specific culture
20740-7 [3006418]
20740-7 [3006418]
4.0e-01
2.5e+00
4.3e+00
1.0e+50
3.8e+00
2.1e+00
1.4e+00
cases:0.58%
controls:0.39%
cases:1.21%
controls:0.10%
cases:1.10%
controls:0.02%
cases:0.10%
controls:0.00%
cases:0.37%
controls:0.01%
cases:0.69%
controls:0.09%
cases:1.16%
controls:0.29%
43
287
7319
72847
89
74
7273
73065
81
11
7281
73128
7
0
7355
73139
27
6
7334
73100
51
63
7289
72685
80
197
6832
67775
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
1.2e-01
9.1e-01
3.3e+00
3.1e+00
2.9e+00
2.1e+00
1.7e+00
cases:2.17%
controls:1.92%
cases:2.46%
controls:1.01%
cases:3.42%
controls:0.13%
cases:0.29%
controls:0.01%
cases:2.46%
controls:0.14%
cases:8.19%
controls:1.10%
cases:16.30%
controls:3.60%
160
1407
7202
71727
181
736
7181
72403
252
92
7110
73047
21
9
7341
73130
181
101
7180
73005
601
797
6739
71951
1127
2450
5785
65522
Shigella sp [Presence] in Stool by Culture
82300-5 [42529406]
82300-5 [42529406]
4.1e-01
2.5e+00
4.3e+00
1.0e+50
3.7e+00
2.1e+00
1.4e+00
cases:0.60%
controls:0.40%
cases:1.22%
controls:0.10%
cases:1.11%
controls:0.02%
cases:0.10%
controls:0.00%
cases:0.38%
controls:0.01%
cases:0.69%
controls:0.09%
cases:1.17%
controls:0.30%
44
292
7318
72842
90
76
7272
73063
82
11
7280
73128
7
0
7355
73139
28
7
7333
73099
51
63
7289
72685
81
201
6831
67771
Yersinia sp identified in Stool by Organism specific culture
28549-4 [3014765]
28549-4 [3014765]
3.9e-01
2.5e+00
4.3e+00
1.0e+50
3.6e+00
2.1e+00
1.4e+00
cases:0.58%
controls:0.40%
cases:1.22%
controls:0.10%
cases:1.11%
controls:0.02%
cases:0.10%
controls:0.00%
cases:0.37%
controls:0.01%
cases:0.69%
controls:0.09%
cases:1.16%
controls:0.30%
43
291
7319
72843
90
75
7272
73064
82
11
7280
73128
7
0
7355
73139
27
7
7334
73099
51
63
7289
72685
80
201
6832
67771
Other Crohn disease
K50.8 [45533599]
K50.8 [45533599]
1.6e+00
2.0e+00
2.1e+00
—
2.3e+00
2.5e+00
3.3e+00
cases:0.73%
controls:0.15%
cases:0.83%
controls:0.11%
cases:0.30%
controls:0.04%
—
—
cases:0.41%
controls:0.04%
cases:1.58%
controls:0.13%
cases:4.20%
controls:0.16%
54
113
7308
73021
61
84
7301
73055
22
27
7340
73112
—
30
29
7331
73077
116
94
7224
72654
290
110
6622
67862
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
1.7e-01
8.9e-01
2.9e+00
4.0e+00
2.5e+00
1.9e+00
1.4e+00
cases:10.49%
controls:9.00%
cases:13.01%
controls:5.80%
cases:15.69%
controls:1.02%
cases:2.69%
controls:0.05%
cases:10.49%
controls:0.97%
cases:28.68%
controls:5.90%
cases:41.32%
controls:14.61%
772
6581
6590
66553
958
4242
6404
68897
1155
745
6207
72394
198
36
7164
73103
772
711
6589
72395
2105
4293
5235
68455
2856
9930
4056
58042
Other specified diseases of anus and rectum
K62.8 [45581907]
K62.8 [45581907]
2.9e+00
4.9e+00
1.0e+50
1.0e+50
—
3.5e+00
2.4e+00
cases:0.48%
controls:0.03%
cases:0.88%
controls:0.01%
cases:0.53%
controls:0.00%
cases:0.11%
controls:0.00%
—
—
cases:0.33%
controls:0.01%
cases:0.38%
controls:0.03%
35
19
7327
73115
65
5
7297
73134
39
0
7323
73139
8
0
7354
73139
—
24
7
7316
72741
26
23
6886
67949
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
2.1e-01
5.3e-01
2.6e+00
4.1e+00
2.5e+00
1.9e+00
1.7e+00
cases:4.07%
controls:3.34%
cases:3.78%
controls:2.25%
cases:5.22%
controls:0.41%
cases:0.58%
controls:0.01%
cases:4.66%
controls:0.42%
cases:13.91%
controls:2.32%
cases:23.50%
controls:5.24%
300
2442
7062
70692
278
1644
7084
71495
384
301
6978
72838
43
7
7319
73132
343
307
7018
72799
1021
1691
6319
71057
1624
3561
5288
64411
calcium (different salts in combination); oral
A12AA20 [21600872]
A12AA20 [21600872]
3.7e-01
6.7e-01
1.2e+00
4.5e+00
2.2e+00
1.8e+00
1.8e+00
cases:4.74%
controls:3.33%
cases:4.73%
controls:2.47%
cases:1.79%
controls:0.56%
cases:1.75%
controls:0.02%
cases:5.01%
controls:0.56%
cases:13.92%
controls:2.61%
cases:22.06%
controls:4.39%
349
2432
7013
70702
348
1804
7014
71335
132
406
7230
72733
129
14
7233
73125
369
408
6992
72698
1022
1901
6318
70847
1525
2986
5387
64986
Granulocytes [#/volume] in Blood
30394-1 [3035715]
30394-1 [3035715]
-1.6e-01
8.5e-02
3.9e+00
1.0e+50
3.2e+00
2.7e+00
2.8e+00
cases:0.23%
controls:0.27%
cases:0.11%
controls:0.10%
cases:0.46%
controls:0.01%
cases:0.07%
controls:0.00%
cases:0.33%
controls:0.01%
cases:1.24%
controls:0.08%
cases:2.85%
controls:0.19%
17
198
7345
72936
8
73
7354
73066
34
7
7328
73132
5
0
7357
73139
24
10
7337
73096
91
59
7249
72689
197
126
6715
67846
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
2.7e-01
1.1e+00
2.9e+00
3.9e+00
2.0e+00
1.3e+00
1.0e+00
cases:11.49%
controls:9.03%
cases:12.88%
controls:4.85%
cases:10.09%
controls:0.63%
cases:0.94%
controls:0.02%
cases:4.40%
controls:0.59%
cases:16.80%
controls:5.04%
cases:31.94%
controls:14.38%
846
6603
6516
66531
948
3548
6414
69591
743
463
6619
72676
69
14
7293
73125
324
434
7037
72672
1233
3668
6107
69080
2208
9777
4704
58195
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 [36304997]
88518-6 [36304997]
5.0e-01
9.7e-01
—
—
4.6e+00
3.9e+00
3.0e+00
cases:0.38%
controls:0.23%
cases:0.26%
controls:0.10%
—
—
—
—
cases:1.67%
controls:0.02%
cases:4.67%
controls:0.10%
cases:7.06%
controls:0.39%
28
169
7334
72965
19
72
7343
73067
—
—
123
12
7238
73094
343
71
6997
72677
488
265
6424
67707
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
7.6e-02
5.7e-01
2.4e+00
3.8e+00
2.3e+00
1.9e+00
1.6e+00
cases:5.58%
controls:5.20%
cases:5.66%
controls:3.30%
cases:6.57%
controls:0.61%
cases:0.87%
controls:0.02%
cases:6.10%
controls:0.65%
cases:18.05%
controls:3.34%
cases:29.43%
controls:8.07%
411
3801
6951
69333
417
2412
6945
70727
484
447
6878
72692
64
15
7298
73124
449
476
6912
72630
1325
2431
6015
70317
2034
5485
4878
62487
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
7.6e-02
5.6e-01
2.4e+00
3.8e+00
2.3e+00
1.9e+00
1.6e+00
cases:5.56%
controls:5.17%
cases:5.61%
controls:3.29%
cases:6.57%
controls:0.61%
cases:0.87%
controls:0.02%
cases:6.09%
controls:0.65%
cases:18.04%
controls:3.34%
cases:29.40%
controls:8.06%
409
3781
6953
69353
413
2406
6949
70733
484
446
6878
72693
64
15
7298
73124
448
475
6913
72631
1324
2427
6016
70321
2032
5481
4880
62491
Rectal bleeding
D16 [2002000315]
D16 [2002000315]
1.8e+00
3.7e+00
4.3e+00
1.0e+50
—
1.5e+00
1.1e+00
cases:0.50%
controls:0.09%
cases:0.95%
controls:0.02%
cases:0.50%
controls:0.01%
cases:0.08%
controls:0.00%
—
—
cases:0.15%
controls:0.03%
cases:0.36%
controls:0.12%
37
63
7325
73071
70
17
7292
73122
37
5
7325
73134
6
0
7356
73139
—
11
24
7329
72724
25
79
6887
67893
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
7.6e-02
5.6e-01
2.4e+00
3.8e+00
2.3e+00
1.9e+00
1.6e+00
cases:5.61%
controls:5.22%
cases:5.66%
controls:3.30%
cases:6.55%
controls:0.62%
cases:0.87%
controls:0.02%
cases:6.10%
controls:0.66%
cases:18.11%
controls:3.36%
cases:29.53%
controls:8.10%
413
3818
6949
69316
417
2417
6945
70722
482
450
6880
72689
64
15
7298
73124
449
479
6912
72627
1329
2443
6011
70305
2041
5507
4871
62465
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
2.8e-01
7.1e-01
2.5e+00
3.6e+00
2.1e+00
1.8e+00
1.4e+00
cases:2.77%
controls:2.12%
cases:2.49%
controls:1.24%
cases:2.50%
controls:0.22%
cases:0.39%
controls:0.01%
cases:2.11%
controls:0.25%
cases:8.05%
controls:1.39%
cases:15.52%
controls:4.18%
204
1547
7158
71587
183
909
7179
72230
184
160
7178
72979
29
8
7333
73131
155
186
7206
72920
591
1013
6749
71735
1073
2838
5839
65134
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
7.6e-02
5.5e-01
2.4e+00
3.6e+00
2.3e+00
1.9e+00
1.6e+00
cases:5.84%
controls:5.44%
cases:5.91%
controls:3.50%
cases:6.95%
controls:0.65%
cases:0.88%
controls:0.02%
cases:6.33%
controls:0.67%
cases:19.70%
controls:3.58%
cases:31.81%
controls:8.94%
430
3977
6932
69157
435
2560
6927
70579
512
476
6850
72663
65
17
7297
73122
466
492
6895
72614
1446
2607
5894
70141
2199
6076
4713
61896
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
8.7e-02
5.6e-01
2.4e+00
3.6e+00
2.3e+00
1.9e+00
1.6e+00
cases:5.92%
controls:5.45%
cases:5.99%
controls:3.50%
cases:6.98%
controls:0.66%
cases:0.88%
controls:0.02%
cases:6.34%
controls:0.68%
cases:19.70%
controls:3.59%
cases:31.83%
controls:8.97%
436
3989
6926
69145
441
2560
6921
70579
514
480
6848
72659
65
17
7297
73122
467
497
6894
72609
1446
2611
5894
70137
2200
6097
4712
61875
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
5.3e-02
5.7e-01
2.4e+00
3.8e+00
2.3e+00
1.8e+00
1.5e+00
cases:5.76%
controls:5.48%
cases:5.94%
controls:3.45%
cases:6.64%
controls:0.63%
cases:0.91%
controls:0.02%
cases:6.06%
controls:0.66%
cases:18.04%
controls:3.50%
cases:29.40%
controls:8.54%
424
4005
6938
69129
437
2520
6925
70619
489
462
6873
72677
67
15
7295
73124
446
485
6915
72621
1324
2546
6016
70202
2032
5808
4880
62164
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
6.1e-02
5.6e-01
2.4e+00
3.7e+00
2.3e+00
1.9e+00
1.5e+00
cases:6.14%
controls:5.80%
cases:6.25%
controls:3.67%
cases:7.08%
controls:0.67%
cases:0.91%
controls:0.02%
cases:6.41%
controls:0.71%
cases:19.81%
controls:3.73%
cases:31.99%
controls:9.33%
452
4239
6910
68895
460
2681
6902
70458
521
490
6841
72649
67
17
7295
73122
472
518
6889
72588
1454
2717
5886
70031
2211
6343
4701
61629
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
30395-8 [3035933]
-1.7e-01
3.6e-01
4.0e+00
1.0e+50
3.2e+00
2.6e+00
2.6e+00
cases:0.27%
controls:0.32%
cases:0.16%
controls:0.11%
cases:0.52%
controls:0.01%
cases:0.11%
controls:0.00%
cases:0.35%
controls:0.02%
cases:1.29%
controls:0.10%
cases:2.99%
controls:0.24%
20
236
7342
72898
12
83
7350
73056
38
7
7324
73132
8
0
7354
73139
26
11
7335
73095
95
73
7245
72675
207
161
6705
67811
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
4.6e-02
5.7e-01
2.4e+00
3.7e+00
2.2e+00
1.8e+00
1.5e+00
cases:5.54%
controls:5.31%
cases:5.81%
controls:3.36%
cases:6.29%
controls:0.61%
cases:0.80%
controls:0.02%
cases:5.75%
controls:0.65%
cases:17.43%
controls:3.40%
cases:28.89%
controls:8.35%
408
3880
6954
69254
428
2458
6934
70681
463
446
6899
72693
59
15
7303
73124
423
478
6938
72628
1279
2470
6061
70278
1997
5673
4915
62299
Outpatient Visit
OP [9202]
OP [9202]
7.2e-02
2.9e-01
6.5e-01
5.9e+00
1.8e+00
1.8e+00
1.6e+00
cases:57.53%
controls:55.75%
cases:43.60%
controls:36.58%
cases:15.24%
controls:8.55%
cases:59.41%
controls:0.40%
cases:36.07%
controls:8.27%
cases:78.84%
controls:37.51%
cases:91.03%
controls:66.91%
4235
40770
3127
32364
3210
26757
4152
46382
1122
6254
6240
66885
4374
290
2988
72849
2655
6048
4706
67058
5787
27291
1553
45457
6292
45482
620
22490
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
8.1e-02
5.5e-01
2.4e+00
3.5e+00
2.2e+00
1.9e+00
1.5e+00
cases:6.21%
controls:5.75%
cases:6.19%
controls:3.65%
cases:7.06%
controls:0.71%
cases:0.90%
controls:0.03%
cases:6.44%
controls:0.74%
cases:20.00%
controls:3.78%
cases:32.49%
controls:9.33%
457
4208
6905
68926
456
2673
6906
70466
520
520
6842
72619
66
19
7296
73120
474
544
6887
72562
1468
2747
5872
70001
2246
6339
4666
61633
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
1.8e-01
1.0e+00
2.6e+00
4.1e+00
2.2e+00
1.3e+00
8.6e-01
cases:3.27%
controls:2.75%
cases:3.55%
controls:1.30%
cases:2.02%
controls:0.16%
cases:0.87%
controls:0.02%
cases:1.29%
controls:0.14%
cases:4.43%
controls:1.27%
cases:10.55%
controls:4.76%
241
2014
7121
71120
261
950
7101
72189
149
114
7213
73025
64
11
7298
73128
95
102
7266
73004
325
925
7015
71823
729
3233
6183
64739
infliximab; parenteral
L04AB02 [21603909]
L04AB02 [21603909]
-2.4e-01
3.1e-01
1.0e+00
—
3.4e+00
4.2e+00
4.5e+00
cases:0.08%
controls:0.10%
cases:0.10%
controls:0.07%
cases:0.08%
controls:0.03%
—
—
cases:0.62%
controls:0.02%
cases:3.95%
controls:0.06%
cases:8.75%
controls:0.10%
6
76
7356
73058
7
51
7355
73088
6
22
7356
73117
—
46
16
7315
73090
290
47
7050
72701
605
70
6307
67902
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
326 [2001600287]
326 [2001600287]
4.1e-01
2.1e+00
—
—
—
5.1e+00
4.8e+00
cases:0.07%
controls:0.05%
cases:0.08%
controls:0.01%
—
—
—
—
—
—
cases:1.98%
controls:0.01%
cases:5.28%
controls:0.05%
5
33
7357
73101
6
7
7356
73132
—
—
—
145
9
7195
72739
365
31
6547
67941
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
6968-2 [3009445]
2.8e-01
9.9e-01
3.8e+00
—
2.8e+00
2.4e+00
1.9e+00
cases:0.45%
controls:0.34%
cases:0.42%
controls:0.16%
cases:0.30%
controls:0.01%
—
—
cases:0.26%
controls:0.02%
cases:1.01%
controls:0.09%
cases:2.46%
controls:0.39%
33
247
7329
72887
31
115
7331
73024
22
5
7340
73134
—
19
12
7342
73094
74
64
7266
72684
170
267
6742
67705
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
J01MA02 [21603009]
5.6e-01
1.3e+00
3.1e+00
—
3.6e+00
1.9e+00
1.3e+00
cases:6.87%
controls:4.03%
cases:3.94%
controls:1.10%
cases:2.43%
controls:0.11%
—
—
cases:4.24%
controls:0.13%
cases:7.52%
controls:1.17%
cases:14.44%
controls:4.25%
506
2949
6856
70185
290
801
7072
72338
179
80
7183
73059
—
312
92
7049
73014
552
852
6788
71896
998
2887
5914
65085
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
72493-0 [43055120]
2.1e-01
5.6e-01
2.2e+00
1.0e+50
3.9e+00
3.1e+00
2.6e+00
cases:0.23%
controls:0.19%
cases:0.18%
controls:0.10%
cases:0.16%
controls:0.02%
cases:0.10%
controls:0.00%
cases:1.10%
controls:0.02%
cases:2.32%
controls:0.11%
cases:3.80%
controls:0.30%
17
137
7345
72997
13
74
7349
73065
12
13
7350
73126
7
0
7355
73139
81
16
7280
73090
170
78
7170
72670
263
204
6649
67768
methylprednisolone; oral, parenteral
H02AB04 [21602732]
H02AB04 [21602732]
4.3e-01
7.6e-01
1.8e+00
3.6e+00
2.2e+00
1.6e+00
1.1e+00
cases:2.08%
controls:1.36%
cases:1.13%
controls:0.53%
cases:0.42%
controls:0.07%
cases:0.24%
controls:0.01%
cases:0.82%
controls:0.09%
cases:2.19%
controls:0.46%
cases:4.07%
controls:1.36%
153
998
7209
72136
83
387
7279
72752
31
50
7331
73089
18
5
7344
73134
60
64
7301
73042
161
337
7179
72411
281
924
6631
67048
Gastrointestinal haemorrhage, unspecified
K92.2 [45533625]
K92.2 [45533625]
1.3e+00
3.7e+00
4.4e+00
1.0e+50
—
2.1e+00
6.0e-01
cases:0.34%
controls:0.09%
cases:0.90%
controls:0.02%
cases:0.56%
controls:0.01%
cases:0.20%
controls:0.00%
—
—
cases:0.12%
controls:0.02%
cases:0.20%
controls:0.11%
25
67
7337
73067
66
17
7296
73122
41
5
7321
73134
15
0
7347
73139
—
9
11
7331
72737
14
76
6898
67896
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
68438-1 [40771025]
3.1e-02
3.5e-01
2.9e+00
2.5e+00
2.4e+00
1.8e+00
1.5e+00
cases:3.48%
controls:3.37%
cases:2.81%
controls:1.99%
cases:4.10%
controls:0.23%
cases:0.16%
controls:0.01%
cases:2.64%
controls:0.25%
cases:12.79%
controls:2.33%
cases:26.66%
controls:7.53%
256
2467
7106
70667
207
1458
7155
71681
302
167
7060
72972
12
10
7350
73129
194
184
7167
72922
939
1698
6401
71050
1843
5117
5069
62855
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
JKE98 [2001305336]
JKE98 [2001305336]
1.9e+00
2.1e+00
—
—
—
4.0e+00
3.4e+00
cases:0.22%
controls:0.03%
cases:0.14%
controls:0.02%
—
—
—
—
—
—
cases:0.64%
controls:0.01%
cases:1.37%
controls:0.05%
16
23
7346
73111
10
12
7352
73127
—
—
—
47
9
7293
72739
95
32
6817
67940
Haemorrhage of anus and rectum
K62.5 [45596339]
K62.5 [45596339]
1.8e+00
3.8e+00
—
1.0e+50
3.1e+00
1.9e+00
7.1e-01
cases:1.13%
controls:0.19%
cases:2.92%
controls:0.06%
—
—
cases:0.35%
controls:0.00%
cases:0.19%
controls:0.01%
cases:0.41%
controls:0.06%
cases:0.74%
controls:0.36%
83
142
7279
72992
215
47
7147
73092
—
26
0
7336
73139
14
6
7347
73100
30
46
7310
72702
51
248
6861
67724
Sacroiliitis, not elsewhere classified
M46.1 [45577263]
M46.1 [45577263]
1.1e+00
1.4e+00
2.5e+00
1.0e+50
2.8e+00
1.9e+00
1.5e+00
cases:0.34%
controls:0.11%
cases:0.20%
controls:0.05%
cases:0.10%
controls:0.01%
cases:0.08%
controls:0.00%
cases:0.14%
controls:0.01%
cases:0.35%
controls:0.05%
cases:0.56%
controls:0.13%
25
80
7337
73054
15
38
7347
73101
7
6
7355
73133
6
0
7356
73139
10
6
7351
73100
26
37
7314
72711
39
85
6873
67887
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
1.4e-01
7.5e-01
2.5e+00
3.7e+00
2.0e+00
1.2e+00
7.7e-01
cases:17.74%
controls:15.74%
cases:19.89%
controls:10.51%
cases:18.96%
controls:1.83%
cases:4.07%
controls:0.10%
cases:11.51%
controls:1.81%
cases:30.00%
controls:11.00%
cases:43.68%
controls:26.51%
1306
11514
6056
61620
1464
7689
5898
65450
1396
1342
5966
71797
300
74
7062
73065
847
1320
6514
71786
2202
8001
5138
64747
3019
18022
3893
49950
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
49178-7 [3048929]
-9.4e-03
6.7e-01
3.3e+00
1.0e+50
3.8e+00
2.3e+00
1.7e+00
cases:0.49%
controls:0.49%
cases:0.39%
controls:0.20%
cases:0.48%
controls:0.02%
cases:0.12%
controls:0.00%
cases:0.54%
controls:0.01%
cases:1.69%
controls:0.18%
cases:3.70%
controls:0.69%
36
361
7326
72773
29
148
7333
72991
35
13
7327
73126
9
0
7353
73139
40
9
7321
73097
124
129
7216
72619
256
469
6656
67503
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
-4.3e-02
3.9e-01
2.3e+00
3.6e+00
2.1e+00
1.4e+00
1.2e+00
cases:4.20%
controls:4.37%
cases:5.19%
controls:3.57%
cases:6.95%
controls:0.75%
cases:1.14%
controls:0.03%
cases:5.50%
controls:0.72%
cases:14.39%
controls:3.80%
cases:23.19%
controls:8.25%
309
3199
7053
69935
382
2609
6980
70530
512
546
6850
72593
84
23
7278
73116
405
524
6956
72582
1056
2765
6284
69983
1603
5606
5309
62366
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
20483-4 [3034770]
6.7e-01
1.8e+00
—
—
3.7e+00
2.4e+00
2.4e+00
cases:0.46%
controls:0.24%
cases:0.58%
controls:0.09%
—
—
—
—
cases:0.29%
controls:0.01%
cases:1.14%
controls:0.10%
cases:3.37%
controls:0.32%
34
174
7328
72960
43
69
7319
73070
—
—
21
5
7340
73101
84
76
7256
72672
233
218
6679
67754
fluocortolone
C05AA08 [21601612]
C05AA08 [21601612]
1.2e+00
2.4e+00
3.3e+00
—
1.9e+00
1.4e+00
7.6e-01
cases:2.64%
controls:0.82%
cases:3.10%
controls:0.28%
cases:0.91%
controls:0.03%
—
—
cases:0.16%
controls:0.02%
cases:0.98%
controls:0.25%
cases:2.18%
controls:1.03%
194
597
7168
72537
228
202
7134
72937
67
24
7295
73115
—
12
18
7349
73088
72
181
7268
72567
151
702
6761
67270
Inpatient Hospital
21 [8717]
21 [8717]
1.1e-02
3.1e-01
1.3e+00
5.8e+00
1.8e+00
9.9e-01
7.4e-01
cases:27.68%
controls:27.46%
cases:11.98%
controls:9.10%
cases:3.79%
controls:1.09%
cases:15.39%
controls:0.05%
cases:5.98%
controls:1.02%
cases:19.37%
controls:8.20%
cases:38.67%
controls:23.12%
2038
20084
5324
53050
882
6655
6480
66484
279
800
7083
72339
1133
39
6229
73100
440
748
6921
72358
1422
5967
5918
66781
2673
15715
4239
52257
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
O99.6 [45572910]
O99.6 [45572910]
2.9e+00
3.3e+00
—
1.0e+50
—
—
4.8e+00
cases:0.24%
controls:0.01%
cases:0.22%
controls:0.01%
—
—
cases:0.22%
controls:0.00%
—
—
—
—
cases:2.89%
controls:0.03%
18
10
7344
73124
16
6
7346
73133
—
16
0
7346
73139
—
—
200
17
6712
67955
colestyramine; oral
C10AC01 [21601876]
C10AC01 [21601876]
1.4e+00
1.5e+00
2.3e+00
—
2.1e+00
2.0e+00
1.8e+00
cases:0.43%
controls:0.11%
cases:0.22%
controls:0.05%
cases:0.11%
controls:0.01%
—
—
cases:0.11%
controls:0.01%
cases:0.37%
controls:0.05%
cases:0.95%
controls:0.16%
32
81
7330
73053
16
37
7346
73102
8
8
7354
73131
—
8
10
7353
73096
27
38
7313
72710
66
112
6846
67860
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
4.8e-02
4.1e-01
1.6e+00
4.7e+00
1.7e+00
1.4e+00
1.1e+00
cases:4.41%
controls:4.22%
cases:2.36%
controls:1.59%
cases:0.71%
controls:0.15%
cases:1.34%
controls:0.01%
cases:0.94%
controls:0.17%
cases:5.40%
controls:1.42%
cases:12.98%
controls:4.64%
325
3084
7037
70050
174
1161
7188
71978
52
110
7310
73029
99
9
7263
73130
69
124
7292
72982
396
1031
6944
71717
897
3155
6015
64817
Emergency Room Visit
ER [9203]
ER [9203]
8.3e-02
4.9e-01
1.8e+00
5.7e+00
1.4e+00
8.6e-01
6.0e-01
cases:29.20%
controls:27.51%
cases:15.02%
controls:9.75%
cases:6.51%
controls:1.15%
cases:10.53%
controls:0.04%
cases:4.56%
controls:1.18%
cases:19.65%
controls:9.39%
cases:40.05%
controls:26.73%
2150
20118
5212
53016
1106
7131
6256
66008
479
842
6883
72297
775
29
6587
73110
336
866
7025
72240
1442
6832
5898
65916
2768
18168
4144
49804
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2472-9 [3028026]
2.2e-01
1.0e+00
3.0e+00
—
3.0e+00
2.0e+00
1.8e+00
cases:0.61%
controls:0.49%
cases:0.76%
controls:0.27%
cases:0.34%
controls:0.02%
—
—
cases:0.43%
controls:0.02%
cases:1.54%
controls:0.21%
cases:4.28%
controls:0.73%
45
360
7317
72774
56
199
7306
72940
25
13
7337
73126
—
32
16
7329
73090
113
156
7227
72592
296
494
6616
67478
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
1.6e-02
4.2e-01
1.9e+00
3.5e+00
1.8e+00
1.7e+00
1.4e+00
cases:6.66%
controls:6.56%
cases:6.48%
controls:4.34%
cases:6.87%
controls:1.07%
cases:1.28%
controls:0.04%
cases:6.43%
controls:1.10%
cases:19.36%
controls:4.34%
cases:32.45%
controls:10.19%
490
4797
6872
68337
477
3171
6885
69968
506
780
6856
72359
94
30
7268
73109
473
803
6888
72303
1421
3156
5919
69592
2243
6928
4669
61044
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
8095-2 [3007566]
5.8e-01
1.8e+00
—
—
4.0e+00
2.5e+00
2.4e+00
cases:0.43%
controls:0.24%
cases:0.58%
controls:0.10%
—
—
—
—
cases:0.37%
controls:0.01%
cases:1.25%
controls:0.11%
cases:3.49%
controls:0.33%
32
178
7330
72956
43
72
7319
73067
—
—
27
5
7334
73101
92
77
7248
72671
241
221
6671
67751
Salmonella sp identified in Stool by Organism specific culture
20955-1 [3004716]
20955-1 [3004716]
3.1e-01
1.7e+00
3.8e+00
1.0e+50
3.0e+00
1.3e+00
8.1e-01
cases:1.25%
controls:0.92%
cases:1.37%
controls:0.25%
cases:1.14%
controls:0.03%
cases:0.10%
controls:0.00%
cases:0.39%
controls:0.02%
cases:0.86%
controls:0.24%
cases:1.91%
controls:0.86%
92
670
7270
72464
101
186
7261
72953
84
19
7278
73120
7
0
7355
73139
29
14
7332
73092
63
171
7277
72577
132
586
6780
67386
Varicella zoster virus Ab [Titer] in Serum
21594-7 [3014148]
21594-7 [3014148]
2.3e-01
1.1e+00
3.5e+00
—
—
3.7e+00
2.3e+00
cases:0.20%
controls:0.16%
cases:0.20%
controls:0.07%
cases:0.23%
controls:0.01%
—
—
—
—
cases:1.36%
controls:0.03%
cases:1.78%
controls:0.19%
15
119
7347
73015
15
52
7347
73087
17
5
7345
73134
—
—
100
24
7240
72724
123
128
6789
67844
Ankylosing spondylitis
M45 [45591841]
M45 [45591841]
1.5e+00
1.3e+00
2.4e+00
—
2.1e+00
1.7e+00
1.6e+00
cases:0.99%
controls:0.22%
cases:0.54%
controls:0.15%
cases:0.24%
controls:0.02%
—
—
cases:0.24%
controls:0.03%
cases:0.78%
controls:0.14%
cases:1.24%
controls:0.26%
73
158
7289
72976
40
113
7322
73026
18
17
7344
73122
—
18
22
7343
73084
57
104
7283
72644
86
174
6826
67798
metronidazole; oral, rectal
P01AB01 [21604857]
P01AB01 [21604857]
5.1e-01
1.2e+00
2.8e+00
—
3.0e+00
1.8e+00
1.2e+00
cases:8.95%
controls:5.59%
cases:5.13%
controls:1.56%
cases:2.54%
controls:0.15%
—
—
cases:3.60%
controls:0.18%
cases:8.46%
controls:1.56%
cases:16.36%
controls:5.63%
659
4086
6703
69048
378
1143
6984
71996
187
112
7175
73027
—
265
134
7096
72972
621
1133
6719
71615
1131
3829
5781
64143
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
A09 [45605189]
4.4e-01
1.9e+00
4.3e+00
1.0e+50
2.4e+00
9.8e-01
4.8e-01
cases:2.46%
controls:1.60%
cases:3.31%
controls:0.51%
cases:3.02%
controls:0.04%
cases:1.71%
controls:0.00%
cases:0.53%
controls:0.05%
cases:1.58%
controls:0.60%
cases:4.09%
controls:2.57%
181
1167
7181
71967
244
374
7118
72765
222
31
7140
73108
126
0
7236
73139
39
35
7322
73071
116
434
7224
72314
283
1745
6629
66227
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
1.8e-02
7.1e-01
1.9e+00
4.0e+00
1.8e+00
1.2e+00
8.6e-01
cases:4.82%
controls:4.74%
cases:5.46%
controls:2.77%
cases:3.42%
controls:0.51%
cases:1.52%
controls:0.03%
cases:2.88%
controls:0.50%
cases:8.43%
controls:2.81%
cases:17.26%
controls:8.08%
355
3465
7007
69669
402
2023
6960
71116
252
372
7110
72767
112
20
7250
73119
212
367
7149
72739
619
2044
6721
70704
1193
5494
5719
62478
loperamide oxide; oral
A07DA05 [21600648]
A07DA05 [21600648]
1.0e+00
1.7e+00
2.8e+00
1.0e+50
1.3e+00
1.6e+00
1.9e+00
cases:1.49%
controls:0.53%
cases:1.63%
controls:0.30%
cases:0.92%
controls:0.06%
cases:0.07%
controls:0.00%
cases:0.23%
controls:0.07%
cases:1.43%
controls:0.30%
cases:4.43%
controls:0.69%
110
391
7252
72743
120
217
7242
72922
68
43
7294
73096
5
0
7357
73139
17
48
7344
73058
105
220
7235
72528
306
469
6606
67503
loperamide; oral
A07DA03 [21600646]
A07DA03 [21600646]
1.0e+00
1.7e+00
2.8e+00
1.0e+50
1.3e+00
1.6e+00
1.9e+00
cases:1.49%
controls:0.53%
cases:1.63%
controls:0.30%
cases:0.92%
controls:0.06%
cases:0.07%
controls:0.00%
cases:0.23%
controls:0.07%
cases:1.43%
controls:0.30%
cases:4.43%
controls:0.69%
110
391
7252
72743
120
217
7242
72922
68
43
7294
73096
5
0
7357
73139
17
48
7344
73058
105
220
7235
72528
306
469
6606
67503
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
31374-2 [3007080]
-3.0e-02
9.0e-01
4.0e+00
1.0e+50
—
3.0e+00
2.3e+00
cases:0.23%
controls:0.24%
cases:0.27%
controls:0.11%
cases:0.43%
controls:0.01%
cases:0.11%
controls:0.00%
—
—
cases:1.63%
controls:0.08%
cases:3.07%
controls:0.32%
17
174
7345
72960
20
81
7342
73058
32
6
7330
73133
8
0
7354
73139
—
120
60
7220
72688
212
216
6700
67756
vedolizumab; parenteral
L04AG05 [955244]
L04AG05 [955244]
—
-1.0e+50
—
—
—
4.6e+00
5.5e+00
—
—
cases:0.00%
controls:0.01%
—
—
—
—
—
—
cases:0.68%
controls:0.01%
cases:3.07%
controls:0.01%
—
0
6
7362
73133
—
—
—
50
5
7290
72743
212
9
6700
67963
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
-5.8e-02
4.3e-01
2.1e+00
3.4e+00
2.0e+00
1.2e+00
8.9e-01
cases:3.61%
controls:3.82%
cases:3.06%
controls:2.00%
cases:2.21%
controls:0.28%
cases:0.42%
controls:0.01%
cases:1.79%
controls:0.25%
cases:6.44%
controls:1.96%
cases:14.27%
controls:6.39%
266
2795
7096
70339
225
1465
7137
71674
163
203
7199
72936
31
10
7331
73129
132
184
7229
72922
473
1426
6867
71322
986
4342
5926
63630
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
2.4e-01
7.8e-01
1.0e+00
3.3e+00
1.8e+00
1.7e+00
1.1e+00
cases:88.17%
controls:85.38%
cases:84.53%
controls:71.37%
cases:56.02%
controls:31.29%
cases:30.06%
controls:1.50%
cases:74.13%
controls:31.21%
cases:93.64%
controls:72.96%
cases:96.72%
controls:91.01%
6491
62444
871
10690
6223
52199
1139
20940
4124
22887
3238
50252
2213
1099
5149
72040
5457
22814
1904
50292
6873
53074
467
19674
6685
61859
227
6113
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
K57.3 [45567316]
5.7e-01
1.2e+00
2.3e+00
—
2.9e+00
1.7e+00
1.2e+00
cases:1.48%
controls:0.84%
cases:1.06%
controls:0.31%
cases:0.45%
controls:0.04%
—
—
cases:0.67%
controls:0.04%
cases:1.91%
controls:0.34%
cases:4.05%
controls:1.27%
109
617
7253
72517
78
224
7284
72915
33
32
7329
73107
—
49
28
7312
73078
140
249
7200
72499
280
864
6632
67108
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
7.0e-02
6.6e-01
2.7e+00
—
3.0e+00
1.9e+00
1.7e+00
cases:0.71%
controls:0.66%
cases:0.71%
controls:0.37%
cases:0.60%
controls:0.04%
—
—
cases:0.65%
controls:0.03%
cases:1.98%
controls:0.30%
cases:4.80%
controls:0.94%
52
482
7310
72652
52
269
7310
72870
44
31
7318
73108
—
48
24
7313
73082
145
216
7195
72532
332
639
6580
67333
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
7852-7 [3010130]
-3.9e-02
8.4e-01
3.1e+00
—
2.8e+00
1.6e+00
1.5e+00
cases:0.20%
controls:0.21%
cases:0.27%
controls:0.12%
cases:0.15%
controls:0.01%
—
—
cases:0.18%
controls:0.01%
cases:0.48%
controls:0.09%
cases:1.32%
controls:0.30%
15
155
7347
72979
20
86
7342
73053
11
5
7351
73134
—
13
8
7348
73098
35
69
7305
72679
91
206
6821
67766
Hepatitis B virus core IgM Ab [Presence] in Serum
31204-1 [3013527]
31204-1 [3013527]
4.0e-01
6.4e-01
2.5e+00
—
3.6e+00
2.5e+00
1.1e+00
cases:0.24%
controls:0.16%
cases:0.18%
controls:0.09%
cases:0.15%
controls:0.01%
—
—
cases:0.31%
controls:0.01%
cases:0.86%
controls:0.07%
cases:1.40%
controls:0.45%
18
120
7344
73014
13
68
7349
73071
11
9
7351
73130
—
23
6
7338
73100
63
54
7277
72694
97
308
6815
67664
Outpatient Hospital
22 [8756]
22 [8756]
4.4e-02
3.0e-01
1.1e+00
5.3e+00
1.5e+00
8.5e-01
6.4e-01
cases:20.44%
controls:19.74%
cases:7.85%
controls:5.92%
cases:1.89%
controls:0.65%
cases:5.95%
controls:0.03%
cases:2.72%
controls:0.61%
cases:11.42%
controls:5.24%
cases:27.34%
controls:16.58%
1505
14439
5857
58695
578
4330
6784
68809
139
475
7223
72664
438
22
6924
73117
200
447
7161
72659
838
3813
6502
68935
1890
11273
5022
56699
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
UJD10 [2001304788]
2.5e-01
1.2e+00
2.7e+00
—
2.6e+00
1.8e+00
1.3e+00
cases:2.97%
controls:2.34%
cases:2.16%
controls:0.69%
cases:0.96%
controls:0.07%
—
—
cases:1.14%
controls:0.09%
cases:3.80%
controls:0.67%
cases:8.56%
controls:2.51%
219
1709
7143
71425
159
505
7203
72634
71
49
7291
73090
—
84
65
7277
73041
279
489
7061
72259
592
1703
6320
66269
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
2.9e-01
6.7e-01
1.2e+00
3.7e+00
1.9e+00
1.1e+00
8.2e-01
cases:12.12%
controls:9.36%
cases:9.45%
controls:5.05%
cases:3.06%
controls:0.91%
cases:1.17%
controls:0.03%
cases:5.80%
controls:0.94%
cases:13.81%
controls:5.07%
cases:24.51%
controls:12.46%
892
6842
6470
66292
696
3694
6666
69445
225
666
7137
72473
86
22
7276
73117
427
690
6934
72416
1014
3687
6326
69061
1694
8466
5218
59506
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
2458-8 [3007164]
3.9e-01
1.7e+00
3.4e+00
—
2.4e+00
1.1e+00
6.5e-01
cases:3.06%
controls:2.09%
cases:4.85%
controls:0.92%
cases:2.59%
controls:0.09%
—
—
cases:0.95%
controls:0.08%
cases:2.75%
controls:0.91%
cases:6.66%
controls:3.60%
225
1532
7137
71602
357
675
7005
72464
191
67
7171
73072
—
70
62
7291
73044
202
660
7138
72088
460
2446
6452
65526
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
8.0e-02
5.4e-01
2.3e+00
3.5e+00
1.8e+00
1.0e+00
5.6e-01
cases:17.96%
controls:16.81%
cases:19.49%
controls:12.42%
cases:17.58%
controls:2.14%
cases:2.85%
controls:0.09%
cases:11.59%
controls:2.19%
cases:30.71%
controls:13.51%
cases:43.81%
controls:30.71%
1322
12294
6040
60840
1435
9082
5927
64057
1294
1567
6068
71572
210
68
7152
73071
853
1598
6508
71508
2254
9828
5086
62920
3028
20877
3884
47095
General Surgery
2 [38004447]
2 [38004447]
1.0e-01
5.2e-01
1.4e+00
5.4e+00
1.2e+00
6.3e-01
4.8e-01
cases:16.64%
controls:15.29%
cases:7.40%
controls:4.55%
cases:2.40%
controls:0.62%
cases:4.75%
controls:0.02%
cases:2.02%
controls:0.63%
cases:8.38%
controls:4.63%
cases:20.38%
controls:13.73%
1225
11182
6137
61952
545
3331
6817
69808
177
453
7185
72686
350
17
7012
73122
149
462
7212
72644
615
3370
6725
69378
1409
9333
5503
58639
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
77190-7 [46237023]
-2.3e-01
3.0e-01
2.3e+00
1.0e+50
3.6e+00
2.2e+00
1.5e+00
cases:0.37%
controls:0.46%
cases:0.30%
controls:0.22%
cases:0.26%
controls:0.03%
cases:0.07%
controls:0.00%
cases:0.57%
controls:0.02%
cases:1.36%
controls:0.15%
cases:2.46%
controls:0.56%
27
337
7335
72797
22
162
7340
72977
19
19
7343
73120
5
0
7357
73139
42
12
7319
73094
100
112
7240
72636
170
381
6742
67591
Chronic active hepatitis, not elsewhere classified
K73.2 [45543340]
K73.2 [45543340]
2.2e+00
2.1e+00
—
1.0e+50
—
2.8e+00
2.4e+00
cases:0.14%
controls:0.02%
cases:0.14%
controls:0.02%
—
—
cases:0.07%
controls:0.00%
—
—
cases:0.20%
controls:0.01%
cases:0.30%
controls:0.03%
10
11
7352
73123
10
12
7352
73127
—
5
0
7357
73139
—
15
9
7325
72739
21
19
6891
67953
IgG subclass 4 [Mass/volume] in Serum
2469-5 [3024980]
2469-5 [3024980]
4.2e-01
1.7e+00
—
—
2.8e+00
2.9e+00
2.2e+00
cases:0.27%
controls:0.18%
cases:0.34%
controls:0.06%
—
—
—
—
cases:0.11%
controls:0.01%
cases:0.67%
controls:0.04%
cases:1.74%
controls:0.20%
20
131
7342
73003
25
47
7337
73092
—
—
8
5
7353
73101
49
28
7291
72720
120
135
6792
67837
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
1.6e-01
8.7e-01
2.5e+00
—
2.7e+00
1.7e+00
1.6e+00
cases:0.80%
controls:0.68%
cases:0.94%
controls:0.39%
cases:0.50%
controls:0.04%
—
—
cases:0.58%
controls:0.04%
cases:1.92%
controls:0.35%
cases:4.96%
controls:1.01%
59
499
7303
72635
69
288
7293
72851
37
30
7325
73109
—
43
28
7318
73078
141
253
7199
72495
343
687
6569
67285
Rheumatology
66 [38004491]
66 [38004491]
5.1e-01
4.9e-01
9.3e-01
4.2e+00
1.2e+00
1.0e+00
1.1e+00
cases:3.23%
controls:1.96%
cases:2.06%
controls:1.28%
cases:0.62%
controls:0.25%
cases:0.46%
controls:0.01%
cases:0.71%
controls:0.22%
cases:3.32%
controls:1.21%
cases:7.32%
controls:2.52%
238
1434
7124
71700
152
937
7210
72202
46
181
7316
72958
34
5
7328
73134
52
164
7309
72942
244
882
7096
71866
506
1716
6406
66256
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
75622-1 [46235355]
-6.4e-02
4.6e-02
1.4e+00
3.5e+00
2.5e+00
1.2e+00
7.6e-01
cases:3.48%
controls:3.70%
cases:1.87%
controls:1.79%
cases:0.80%
controls:0.20%
cases:0.22%
controls:0.01%
cases:1.85%
controls:0.15%
cases:5.41%
controls:1.62%
cases:11.10%
controls:5.50%
256
2704
7106
70430
138
1310
7224
71829
59
148
7303
72991
16
5
7346
73134
136
109
7225
72997
397
1175
6943
71573
767
3738
6145
64234
Gastroscopy
UJD02 [2001304787]
UJD02 [2001304787]
3.5e-01
1.8e+00
2.5e+00
1.0e+50
2.7e+00
1.5e+00
8.9e-01
cases:0.27%
controls:0.19%
cases:0.31%
controls:0.05%
cases:0.08%
controls:0.01%
cases:0.19%
controls:0.00%
cases:0.15%
controls:0.01%
cases:0.33%
controls:0.08%
cases:0.52%
controls:0.21%
20
140
7342
72994
23
38
7339
73101
6
5
7356
73134
14
0
7348
73139
11
7
7350
73099
24
55
7316
72693
36
146
6876
67826
MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
72872-5 [43534045]
72872-5 [43534045]
6.7e-01
2.4e+00
3.5e+00
—
2.8e+00
6.9e-01
-7.0e-01
cases:1.24%
controls:0.63%
cases:2.01%
controls:0.19%
cases:0.92%
controls:0.03%
—
—
cases:0.26%
controls:0.02%
cases:0.40%
controls:0.20%
cases:0.45%
controls:0.90%
91
464
7271
72670
148
138
7214
73001
68
20
7294
73119
—
19
12
7342
73094
29
144
7311
72604
31
611
6881
67361
Extensive abdominal CT
JN3BD [2001305556]
JN3BD [2001305556]
-3.5e-02
9.5e-01
2.7e+00
1.0e+50
2.3e+00
1.8e+00
1.6e+00
cases:0.67%
controls:0.69%
cases:0.46%
controls:0.18%
cases:0.30%
controls:0.02%
cases:0.39%
controls:0.00%
cases:0.15%
controls:0.02%
cases:0.82%
controls:0.14%
cases:2.24%
controls:0.47%
49
504
7313
72630
34
131
7328
73008
22
15
7340
73124
29
0
7333
73139
11
11
7350
73095
60
99
7280
72649
155
320
6757
67652
vancomycin; oral
A07AA09 [21600611]
A07AA09 [21600611]
6.5e-01
2.4e+00
—
—
—
4.2e+00
2.6e+00
cases:0.07%
controls:0.04%
cases:0.11%
controls:0.01%
—
—
—
—
—
—
cases:0.48%
controls:0.01%
cases:0.74%
controls:0.05%
5
26
7357
73108
8
7
7354
73132
—
—
—
35
5
7305
72743
51
37
6861
67935
budesonide; inhalant
R03BA02 [21603285]
R03BA02 [21603285]
4.1e-01
6.6e-01
1.1e+00
3.5e+00
1.3e+00
1.0e+00
1.2e+00
cases:6.04%
controls:4.09%
cases:4.33%
controls:2.29%
cases:1.40%
controls:0.48%
cases:0.76%
controls:0.02%
cases:1.82%
controls:0.48%
cases:6.36%
controls:2.34%
cases:13.19%
controls:4.21%
445
2989
6917
70145
319
1678
7043
71461
103
349
7259
72790
56
17
7306
73122
134
350
7227
72756
467
1699
6873
71049
912
2864
6000
65108
Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
29662-4 [3012220]
29662-4 [3012220]
2.6e-01
8.9e-01
3.3e+00
—
—
3.7e+00
2.2e+00
cases:0.22%
controls:0.17%
cases:0.19%
controls:0.08%
cases:0.23%
controls:0.01%
—
—
—
—
cases:1.35%
controls:0.03%
cases:1.78%
controls:0.20%
16
123
7346
73011
14
57
7348
73082
17
6
7345
73133
—
—
99
25
7241
72723
123
135
6789
67837
Diarrhoea
D11 [2002000310]
D11 [2002000310]
5.4e-01
1.8e+00
3.6e+00
1.0e+50
2.1e+00
6.6e-01
5.7e-01
cases:2.00%
controls:1.17%
cases:2.09%
controls:0.36%
cases:1.58%
controls:0.04%
cases:0.15%
controls:0.00%
cases:0.16%
controls:0.02%
cases:0.68%
controls:0.35%
cases:2.26%
controls:1.29%
147
857
7215
72277
154
261
7208
72878
116
32
7246
73107
11
0
7351
73139
12
15
7349
73091
50
258
7290
72490
156
880
6756
67092
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
2.3e-02
4.2e-01
2.1e+00
3.4e+00
1.6e+00
9.0e-01
5.3e-01
cases:17.96%
controls:17.63%
cases:19.57%
controls:13.81%
cases:17.97%
controls:2.55%
cases:4.02%
controls:0.13%
cases:12.09%
controls:2.63%
cases:30.60%
controls:15.14%
cases:44.08%
controls:31.74%
1322
12891
6040
60243
1441
10101
5921
63038
1323
1866
6039
71273
296
98
7066
73041
890
1926
6471
71180
2246
11017
5094
61731
3047
21577
3865
46395
Pediatric Medicine
37 [38004477]
37 [38004477]
-5.7e-01
1.1e-01
1.2e+00
5.1e+00
1.6e+00
8.2e-01
8.0e-01
cases:2.06%
controls:3.59%
cases:1.49%
controls:1.34%
cases:0.96%
controls:0.29%
cases:1.82%
controls:0.01%
cases:1.44%
controls:0.29%
cases:2.37%
controls:1.05%
cases:2.72%
controls:1.24%
152
2623
7210
70511
110
983
7252
72156
71
210
7291
72929
134
8
7228
73131
106
215
7255
72891
174
767
7166
71981
188
842
6724
67130
omeprazole; oral, parenteral
A02BC01 [21600096]
A02BC01 [21600096]
3.2e-01
7.0e-01
1.0e+00
3.4e+00
1.8e+00
9.7e-01
7.4e-01
cases:4.05%
controls:2.97%
cases:2.53%
controls:1.26%
cases:0.57%
controls:0.20%
cases:0.33%
controls:0.01%
cases:1.54%
controls:0.25%
cases:3.20%
controls:1.24%
cases:6.26%
controls:3.08%
298
2172
7064
70962
186
925
7176
72214
42
147
7320
72992
24
8
7338
73131
113
184
7248
72922
235
904
7105
71844
433
2094
6479
65878
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
7974-9 [3008909]
4.0e-01
1.8e+00
3.2e+00
1.0e+50
—
2.4e+00
1.6e+00
cases:0.19%
controls:0.13%
cases:0.34%
controls:0.06%
cases:0.31%
controls:0.01%
cases:0.14%
controls:0.00%
—
—
cases:0.67%
controls:0.06%
cases:1.33%
controls:0.27%
14
93
7348
73041
25
43
7337
73096
23
9
7339
73130
10
0
7352
73139
—
49
45
7291
72703
92
182
6820
67790
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
-1.7e-01
1.4e-01
1.6e+00
3.2e+00
1.8e+00
1.3e+00
1.1e+00
cases:2.62%
controls:3.10%
cases:2.01%
controls:1.75%
cases:1.97%
controls:0.39%
cases:0.46%
controls:0.02%
cases:2.15%
controls:0.37%
cases:5.40%
controls:1.60%
cases:10.81%
controls:3.94%
193
2270
7169
70864
148
1278
7214
71861
145
282
7217
72857
34
14
7328
73125
158
270
7203
72836
396
1163
6944
71585
747
2675
6165
65297
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
48404-8 [3049804]
4.5e-01
1.0e+00
—
—
2.9e+00
2.9e+00
2.1e+00
cases:0.37%
controls:0.23%
cases:0.30%
controls:0.11%
—
—
—
—
cases:0.20%
controls:0.01%
cases:0.90%
controls:0.05%
cases:2.13%
controls:0.26%
27
171
7335
72963
22
80
7340
73059
—
—
15
8
7346
73098
66
37
7274
72711
147
174
6765
67798
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
7853-5 [3015635]
-2.0e-01
8.0e-01
3.1e+00
—
2.8e+00
1.6e+00
1.5e+00
cases:0.19%
controls:0.23%
cases:0.27%
controls:0.12%
cases:0.15%
controls:0.01%
—
—
cases:0.18%
controls:0.01%
cases:0.49%
controls:0.10%
cases:1.36%
controls:0.32%
14
169
7348
72965
20
89
7342
73050
11
5
7351
73134
—
13
8
7348
73098
36
72
7304
72676
94
215
6818
67757
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
28541-1 [3002179]
2.2e-02
5.1e-01
2.5e+00
—
2.5e+00
1.9e+00
1.9e+00
cases:0.38%
controls:0.37%
cases:0.53%
controls:0.32%
cases:0.67%
controls:0.05%
—
—
cases:0.80%
controls:0.06%
cases:2.66%
controls:0.39%
cases:6.94%
controls:1.10%
28
272
7334
72862
39
233
7323
72906
49
40
7313
73099
—
59
47
7302
73059
195
283
7145
72465
480
747
6432
67225
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
-6.2e-02
7.4e-01
2.6e+00
—
2.5e+00
1.7e+00
1.3e+00
cases:0.75%
controls:0.79%
cases:0.71%
controls:0.34%
cases:0.48%
controls:0.03%
—
—
cases:0.41%
controls:0.03%
cases:1.84%
controls:0.35%
cases:4.17%
controls:1.20%
55
581
7307
72553
52
248
7310
72891
35
25
7327
73114
—
30
24
7331
73082
135
252
7205
72496
288
819
6624
67153
Blasts/Leukocytes in Blood
26446-5 [3025159]
26446-5 [3025159]
1.7e-01
5.2e-01
2.6e+00
—
2.5e+00
1.9e+00
1.9e+00
cases:0.43%
controls:0.37%
cases:0.54%
controls:0.32%
cases:0.75%
controls:0.06%
—
—
cases:0.83%
controls:0.07%
cases:2.77%
controls:0.42%
cases:6.92%
controls:1.15%
32
269
7330
72865
40
236
7322
72903
55
42
7307
73097
—
61
50
7300
73056
203
305
7137
72443
478
784
6434
67188
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
3.8e-02
3.7e-01
2.1e+00
3.3e+00
1.6e+00
8.9e-01
6.0e-01
cases:11.45%
controls:11.07%
cases:12.63%
controls:9.06%
cases:11.76%
controls:1.67%
cases:2.42%
controls:0.09%
cases:7.88%
controls:1.70%
cases:21.31%
controls:10.03%
cases:34.23%
controls:22.23%
843
8095
6519
65039
930
6630
6432
66509
866
1223
6496
71916
178
67
7184
73072
580
1246
6781
71860
1564
7298
5776
65450
2366
15112
4546
52860
Endomysium IgA Ab [Titer] in Serum
10863-9 [3020961]
10863-9 [3020961]
6.9e-01
1.9e+00
3.6e+00
—
1.9e+00
7.4e-01
3.5e-01
cases:1.05%
controls:0.53%
cases:1.36%
controls:0.20%
cases:0.91%
controls:0.03%
—
—
cases:0.11%
controls:0.02%
cases:0.38%
controls:0.18%
cases:1.16%
controls:0.82%
77
387
7285
72747
100
149
7262
72990
67
19
7295
73120
—
8
12
7353
73094
28
133
7312
72615
80
554
6832
67418
Iron deficiency anaemia, unspecified
D50.9 [45605373]
D50.9 [45605373]
1.1e-01
1.5e+00
2.8e+00
—
2.2e+00
1.4e+00
8.4e-01
cases:0.38%
controls:0.34%
cases:0.58%
controls:0.13%
cases:0.37%
controls:0.02%
—
—
cases:0.18%
controls:0.02%
cases:0.59%
controls:0.14%
cases:1.36%
controls:0.59%
28
249
7334
72885
43
92
7319
73047
27
16
7335
73123
—
13
15
7348
73091
43
103
7297
72645
94
402
6818
67570
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
JN1AE [2001305517]
3.3e-01
1.2e+00
1.9e+00
1.0e+50
1.9e+00
2.0e+00
1.7e+00
cases:0.73%
controls:0.53%
cases:0.56%
controls:0.16%
cases:0.11%
controls:0.02%
cases:0.16%
controls:0.00%
cases:0.10%
controls:0.01%
cases:0.98%
controls:0.14%
cases:2.82%
controls:0.50%
54
387
7308
72747
41
120
7321
73019
8
12
7354
73127
12
0
7350
73139
7
10
7354
73096
72
101
7268
72647
195
342
6717
67630
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
22246-3 [3017918]
-1.6e-01
7.8e-01
2.9e+00
—
2.8e+00
1.6e+00
1.5e+00
cases:0.20%
controls:0.24%
cases:0.27%
controls:0.12%
cases:0.15%
controls:0.01%
—
—
cases:0.18%
controls:0.01%
cases:0.49%
controls:0.10%
cases:1.39%
controls:0.32%
15
175
7347
72959
20
91
7342
73048
11
6
7351
73133
—
13
8
7348
73098
36
72
7304
72676
96
218
6816
67754
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
26524-9 [3021440]
1.7e-01
4.7e-01
2.5e+00
—
2.4e+00
1.9e+00
1.9e+00
cases:0.48%
controls:0.40%
cases:0.54%
controls:0.34%
cases:0.73%
controls:0.06%
—
—
cases:0.84%
controls:0.07%
cases:2.77%
controls:0.42%
cases:7.15%
controls:1.14%
35
293
7327
72841
40
249
7322
72890
54
46
7308
73093
—
62
54
7299
73052
203
307
7137
72441
494
777
6418
67195
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
26498-6 [3017181]
1.0e-01
4.7e-01
2.4e+00
—
2.4e+00
1.9e+00
1.9e+00
cases:0.48%
controls:0.43%
cases:0.56%
controls:0.35%
cases:0.72%
controls:0.06%
—
—
cases:0.84%
controls:0.07%
cases:2.78%
controls:0.43%
cases:7.39%
controls:1.19%
35
314
7327
72820
41
256
7321
72883
53
46
7309
73093
—
62
54
7299
73052
204
316
7136
72432
511
806
6401
67166
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
31017-7 [3019050]
4.5e-01
1.9e+00
3.4e+00
—
2.3e+00
5.8e-01
1.6e-01
cases:3.94%
controls:2.55%
cases:6.19%
controls:1.02%
cases:3.06%
controls:0.10%
—
—
cases:0.83%
controls:0.08%
cases:2.00%
controls:1.13%
cases:5.34%
controls:4.60%
290
1868
7072
71266
456
748
6906
72391
225
75
7137
73064
—
61
60
7300
73046
147
824
7193
71924
369
3128
6543
64844
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
9.2e-02
8.0e-01
2.7e+00
—
2.3e+00
1.5e+00
1.3e+00
cases:1.48%
controls:1.35%
cases:1.15%
controls:0.52%
cases:0.42%
controls:0.03%
—
—
cases:0.43%
controls:0.04%
cases:2.29%
controls:0.50%
cases:6.57%
controls:1.89%
109
989
7253
72145
85
381
7277
72758
31
21
7331
73118
—
32
32
7329
73074
168
363
7172
72385
454
1287
6458
66685
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
-1.1e-02
1.7e-01
1.9e+00
—
3.2e+00
2.0e+00
1.4e+00
cases:1.70%
controls:1.72%
cases:0.92%
controls:0.78%
cases:0.64%
controls:0.09%
—
—
cases:1.78%
controls:0.08%
cases:4.82%
controls:0.65%
cases:8.59%
controls:2.21%
125
1255
7237
71879
68
568
7294
72571
47
67
7315
73072
—
131
55
7230
73051
354
473
6986
72275
594
1499
6318
66473
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]
24108-3 [3022914]
3.6e-01
9.0e-01
2.0e+00
—
2.3e+00
1.6e+00
1.8e+00
cases:0.29%
controls:0.20%
cases:0.27%
controls:0.11%
cases:0.14%
controls:0.02%
—
—
cases:0.18%
controls:0.02%
cases:0.54%
controls:0.11%
cases:1.59%
controls:0.27%
21
145
7341
72989
20
81
7342
73058
10
14
7352
73125
—
13
13
7348
73093
40
78
7300
72670
110
183
6802
67789
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
4.7e-02
5.9e-01
1.9e+00
2.2e+00
1.9e+00
1.2e+00
8.4e-01
cases:4.18%
controls:4.00%
cases:4.55%
controls:2.59%
cases:2.66%
controls:0.39%
cases:0.19%
controls:0.02%
cases:2.36%
controls:0.38%
cases:9.10%
controls:2.96%
cases:19.08%
controls:9.28%
308
2924
7054
70210
335
1892
7027
71247
196
286
7166
72853
14
16
7348
73123
174
277
7187
72829
668
2153
6672
70595
1319
6308
5593
61664
Tissue transglutaminase IgG Ab [Units/volume] in Serum
32998-7 [3046870]
32998-7 [3046870]
7.9e-01
2.1e+00
3.1e+00
—
2.4e+00
5.5e-01
-1.7e-01
cases:0.46%
controls:0.21%
cases:0.91%
controls:0.11%
cases:0.29%
controls:0.01%
—
—
cases:0.11%
controls:0.01%
cases:0.27%
controls:0.16%
cases:0.78%
controls:0.93%
34
153
7328
72981
67
79
7295
73060
21
9
7341
73130
—
8
7
7353
73099
20
115
7320
72633
54
629
6858
67343
inFLIXimab [Mass/volume] in Serum or Plasma
39803-2 [3042299]
39803-2 [3042299]
-1.0e+50
—
—
—
—
4.0e+00
4.4e+00
cases:0.00%
controls:0.04%
—
—
—
—
—
—
—
—
cases:1.92%
controls:0.03%
cases:5.24%
controls:0.06%
0
30
7362
73104
—
—
—
—
141
25
7199
72723
362
44
6550
67928
Clostridioides difficile [Presence] in Stool by Organism specific culture
562-9 [3013566]
562-9 [3013566]
1.2e+00
2.9e+00
1.0e+50
—
—
3.1e+00
2.4e+00
cases:0.10%
controls:0.03%
cases:0.15%
controls:0.01%
cases:0.08%
controls:0.00%
—
—
—
—
cases:0.19%
controls:0.01%
cases:0.23%
controls:0.02%
7
20
7355
73114
11
6
7351
73133
6
0
7356
73139
—
—
14
6
7326
72742
16
14
6896
67958
Celiac disease serology panel - Serum
94494-2 [36660697]
94494-2 [36660697]
5.6e-01
1.8e+00
3.2e+00
1.0e+50
2.9e+00
4.5e-01
4.4e-02
cases:1.29%
controls:0.74%
cases:1.71%
controls:0.28%
cases:0.68%
controls:0.03%
cases:0.07%
controls:0.00%
cases:0.24%
controls:0.01%
cases:0.53%
controls:0.34%
cases:1.52%
controls:1.46%
95
543
7267
72591
126
204
7236
72935
50
21
7312
73118
5
0
7357
73139
18
10
7343
73096
39
248
7301
72500
105
989
6807
66983
Hemolysis interference index of Serum or Plasma
46424-8 [3052851]
46424-8 [3052851]
-2.9e-01
7.2e-01
2.4e+00
—
2.1e+00
2.1e+00
1.7e+00
cases:0.30%
controls:0.40%
cases:0.23%
controls:0.11%
cases:0.12%
controls:0.01%
—
—
cases:0.08%
controls:0.01%
cases:0.38%
controls:0.05%
cases:0.93%
controls:0.17%
22
292
7340
72842
17
82
7345
73057
9
8
7353
73131
—
6
7
7355
73099
28
33
7312
72715
64
116
6848
67856
inFLIXimab Ab [Units/volume] in Serum by Immunoassay
90780-8 [1175556]
90780-8 [1175556]
-1.0e+50
—
—
—
—
4.0e+00
4.4e+00
cases:0.00%
controls:0.04%
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.03%
cases:4.24%
controls:0.05%
0
27
7362
73107
—
—
—
—
105
20
7235
72728
293
37
6619
67935
Functional diarrhoea
K59.1 [45543327]
K59.1 [45543327]
1.0e+00
3.0e+00
—
—
2.8e+00
1.5e+00
4.4e-01
cases:0.64%
controls:0.23%
cases:1.60%
controls:0.08%
—
—
—
—
cases:0.14%
controls:0.01%
cases:0.35%
controls:0.08%
cases:0.54%
controls:0.35%
47
171
7315
72963
118
61
7244
73078
—
—
10
6
7351
73100
26
55
7314
72693
37
235
6875
67737
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
-8.8e-02
3.1e-01
1.9e+00
3.2e+00
1.5e+00
8.5e-01
5.1e-01
cases:12.12%
controls:13.08%
cases:13.66%
controls:10.38%
cases:13.31%
controls:2.21%
cases:3.12%
controls:0.13%
cases:9.22%
controls:2.17%
cases:22.66%
controls:11.12%
cases:34.48%
controls:23.95%
892
9568
6470
63566
1006
7595
6356
65544
980
1613
6382
71526
230
95
7132
73044
679
1585
6682
71521
1663
8088
5677
64660
2383
16280
4529
51692
Crohn disease [regional enteritis]
K50 [45755435]
K50 [45755435]
1.4e+00
1.9e+00
—
—
—
2.4e+00
2.6e+00
cases:0.23%
controls:0.05%
cases:0.10%
controls:0.01%
—
—
—
—
—
—
cases:0.18%
controls:0.02%
cases:0.91%
controls:0.07%
17
40
7345
73094
7
10
7355
73129
—
—
—
13
12
7327
72736
63
48
6849
67924
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
5128-4 [3001334]
3.6e-01
8.8e-01
—
—
2.9e+00
2.6e+00
1.9e+00
cases:0.48%
controls:0.33%
cases:0.33%
controls:0.14%
—
—
—
—
cases:0.26%
controls:0.01%
cases:0.99%
controls:0.07%
cases:2.20%
controls:0.35%
35
242
7327
72892
24
99
7338
73040
—
—
19
10
7342
73096
73
52
7267
72696
152
237
6760
67735
Salmonella sp identified in Specimen by Organism specific culture
17563-8 [3024522]
17563-8 [3024522]
1.1e+00
2.3e+00
—
1.0e+50
—
2.6e+00
2.2e+00
cases:0.22%
controls:0.07%
cases:0.43%
controls:0.04%
—
—
cases:0.11%
controls:0.00%
—
—
cases:0.64%
controls:0.05%
cases:0.94%
controls:0.11%
16
52
7346
73082
32
31
7330
73108
—
8
0
7354
73139
—
47
34
7293
72714
65
73
6847
67899
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
3.3e-02
4.6e-01
2.0e+00
3.3e+00
1.4e+00
6.7e-01
4.1e-01
cases:18.17%
controls:17.69%
cases:18.04%
controls:12.15%
cases:13.56%
controls:2.06%
cases:2.76%
controls:0.11%
cases:7.80%
controls:1.98%
cases:21.88%
controls:12.53%
cases:38.17%
controls:29.13%
1338
12935
6024
60199
1328
8884
6034
64255
998
1509
6364
71630
203
79
7159
73060
574
1448
6787
71658
1606
9115
5734
63633
2638
19802
4274
48170
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
50949-7 [3029937]
9.4e-02
3.1e-01
1.9e+00
3.5e+00
1.2e+00
7.7e-01
6.2e-01
cases:3.18%
controls:2.90%
cases:2.11%
controls:1.56%
cases:1.24%
controls:0.19%
cases:0.27%
controls:0.01%
cases:0.73%
controls:0.23%
cases:3.71%
controls:1.76%
cases:9.43%
controls:5.29%
234
2122
7128
71012
155
1141
7207
71998
91
141
7271
72998
20
6
7342
73133
54
166
7307
72940
272
1277
7068
71471
652
3594
6260
64378
Campylobacter sp identified in Specimen by Organism specific culture
6332-1 [3012568]
6332-1 [3012568]
1.1e+00
2.4e+00
—
1.0e+50
—
2.6e+00
2.2e+00
cases:0.22%
controls:0.08%
cases:0.48%
controls:0.04%
—
—
cases:0.11%
controls:0.00%
—
—
cases:0.64%
controls:0.05%
cases:0.95%
controls:0.11%
16
55
7346
73079
35
32
7327
73107
—
8
0
7354
73139
—
47
35
7293
72713
66
75
6846
67897
ispaghula (psylla seeds); oral
A06AC01 [21600555]
A06AC01 [21600555]
8.4e-01
1.5e+00
1.9e+00
—
1.6e+00
1.3e+00
1.1e+00
cases:4.01%
controls:1.76%
cases:3.88%
controls:0.88%
cases:0.94%
controls:0.14%
—
—
cases:0.75%
controls:0.16%
cases:3.41%
controls:0.98%
cases:7.10%
controls:2.48%
295
1289
7067
71845
286
642
7076
72497
69
103
7293
73036
—
55
116
7306
72990
250
716
7090
72032
491
1684
6421
66288
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
6.6e-02
7.5e-01
2.8e+00
—
2.4e+00
1.2e+00
1.1e+00
cases:1.25%
controls:1.17%
cases:0.65%
controls:0.31%
cases:0.31%
controls:0.02%
—
—
cases:0.19%
controls:0.02%
cases:0.89%
controls:0.28%
cases:2.97%
controls:1.00%
92
856
7270
72278
48
227
7314
72912
23
14
7339
73125
—
14
13
7347
73093
65
203
7275
72545
205
678
6707
67294
Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
70242-3 [42868716]
70242-3 [42868716]
1.1e+00
2.2e+00
—
1.0e+50
—
2.6e+00
2.2e+00
cases:0.22%
controls:0.07%
cases:0.41%
controls:0.04%
—
—
cases:0.11%
controls:0.00%
—
—
cases:0.64%
controls:0.05%
cases:0.95%
controls:0.11%
16
52
7346
73082
30
32
7332
73107
—
8
0
7354
73139
—
47
35
7293
72713
66
73
6846
67899
ciclosporin; oral, parenteral
L04AD01 [21603924]
L04AD01 [21603924]
2.2e-01
6.5e-01
4.6e-01
—
3.3e+00
2.8e+00
2.0e+00
cases:0.26%
controls:0.21%
cases:0.29%
controls:0.15%
cases:0.10%
controls:0.06%
—
—
cases:1.24%
controls:0.05%
cases:2.60%
controls:0.16%
cases:1.82%
controls:0.24%
19
151
7343
72983
21
109
7341
73030
7
44
7355
73095
—
91
34
7270
73072
191
117
7149
72631
126
165
6786
67807
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
3.2e-02
4.3e-01
2.0e+00
3.2e+00
1.4e+00
7.3e-01
3.4e-01
cases:21.52%
controls:20.97%
cases:24.02%
controls:17.04%
cases:21.04%
controls:3.53%
cases:4.37%
controls:0.19%
cases:13.27%
controls:3.51%
cases:31.95%
controls:18.43%
cases:44.99%
controls:36.74%
1584
15339
5778
57795
1768
12461
5594
60678
1549
2584
5813
70555
322
141
7040
72998
977
2564
6384
70542
2345
13409
4995
59339
3110
24972
3802
43000
Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
82198-3 [21493466]
82198-3 [21493466]
1.1e+00
2.3e+00
—
1.0e+50
—
2.5e+00
2.1e+00
cases:0.22%
controls:0.07%
cases:0.45%
controls:0.04%
—
—
cases:0.11%
controls:0.00%
—
—
cases:0.56%
controls:0.04%
cases:0.85%
controls:0.10%
16
53
7346
73081
33
32
7329
73107
—
8
0
7354
73139
—
41
32
7299
72716
59
71
6853
67901
Stomach Pathology biopsy report
66114-0 [40768797]
66114-0 [40768797]
1.8e-01
8.6e-01
2.5e+00
1.0e+50
2.6e+00
1.3e+00
8.7e-01
cases:1.25%
controls:1.05%
cases:0.91%
controls:0.39%
cases:0.30%
controls:0.02%
cases:0.29%
controls:0.00%
cases:0.41%
controls:0.03%
cases:1.42%
controls:0.39%
cases:3.44%
controls:1.47%
92
765
7270
72369
67
283
7295
72856
22
18
7340
73121
21
0
7341
73139
30
23
7331
73083
104
287
7236
72461
238
1000
6674
66972
Extensive MRI of small bowel
JF1CG [2001304816]
JF1CG [2001304816]
—
2.6e+00
—
—
—
2.9e+00
2.5e+00
—
—
cases:0.10%
controls:0.01%
—
—
—
—
—
—
cases:0.31%
controls:0.02%
cases:0.54%
controls:0.04%
—
7
5
7355
73134
—
—
—
23
12
7317
72736
37
30
6875
67942
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
43730-1 [3043849]
-1.4e-01
6.1e-01
2.0e+00
—
3.2e+00
1.5e+00
1.4e+00
cases:0.12%
controls:0.14%
cases:0.14%
controls:0.07%
cases:0.08%
controls:0.01%
—
—
cases:0.26%
controls:0.01%
cases:0.37%
controls:0.08%
cases:0.93%
controls:0.24%
9
103
7353
73031
10
54
7352
73085
6
8
7356
73131
—
19
8
7342
73098
27
57
7313
72691
64
164
6848
67808
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
3.0e-02
4.3e-01
2.0e+00
3.2e+00
1.4e+00
7.3e-01
3.4e-01
cases:21.56%
controls:21.05%
cases:24.10%
controls:17.11%
cases:21.07%
controls:3.54%
cases:4.37%
controls:0.19%
cases:13.27%
controls:3.52%
cases:31.95%
controls:18.51%
cases:45.04%
controls:36.89%
1587
15397
5775
57737
1774
12511
5588
60628
1551
2588
5811
70551
322
142
7040
72997
977
2572
6384
70534
2345
13464
4995
59284
3113
25078
3799
42894
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
3.1e-02
4.3e-01
2.0e+00
3.2e+00
1.4e+00
7.3e-01
3.4e-01
cases:21.57%
controls:21.05%
cases:24.08%
controls:17.11%
cases:21.07%
controls:3.54%
cases:4.37%
controls:0.19%
cases:13.27%
controls:3.52%
cases:31.95%
controls:18.52%
cases:45.04%
controls:36.90%
1588
15397
5774
57737
1773
12511
5589
60628
1551
2589
5811
70550
322
142
7040
72997
977
2571
6384
70535
2345
13472
4995
59276
3113
25081
3799
42891
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
3.1e-02
4.3e-01
2.0e+00
3.2e+00
1.4e+00
7.3e-01
3.4e-01
cases:21.57%
controls:21.05%
cases:24.03%
controls:17.10%
cases:21.05%
controls:3.53%
cases:4.36%
controls:0.19%
cases:13.27%
controls:3.52%
cases:31.95%
controls:18.50%
cases:45.02%
controls:36.88%
1588
15396
5774
57738
1769
12507
5593
60632
1550
2583
5812
70556
321
142
7041
72997
977
2570
6384
70536
2345
13460
4995
59288
3112
25070
3800
42902
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
3.0e-02
4.3e-01
2.0e+00
3.2e+00
1.4e+00
7.3e-01
3.4e-01
cases:21.53%
controls:21.02%
cases:24.00%
controls:17.08%
cases:21.04%
controls:3.53%
cases:4.36%
controls:0.19%
cases:13.26%
controls:3.51%
cases:31.92%
controls:18.48%
cases:45.02%
controls:36.87%
1585
15373
5777
57761
1767
12491
5595
60648
1549
2583
5813
70556
321
142
7041
72997
976
2567
6385
70539
2343
13446
4997
59302
3112
25063
3800
42909
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
60517-0 [40763571]
4.3e-02
5.1e-01
2.1e+00
—
2.5e+00
1.6e+00
1.2e+00
cases:0.90%
controls:0.86%
cases:0.87%
controls:0.52%
cases:0.57%
controls:0.07%
—
—
cases:0.82%
controls:0.06%
cases:2.68%
controls:0.54%
cases:5.90%
controls:1.79%
66
628
7296
72506
64
382
7298
72757
42
49
7320
73090
—
60
47
7301
73059
197
394
7143
72354
408
1218
6504
66754
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
3.0e-02
4.3e-01
2.0e+00
3.2e+00
1.4e+00
7.2e-01
3.3e-01
cases:21.61%
controls:21.11%
cases:24.12%
controls:17.14%
cases:21.14%
controls:3.55%
cases:4.37%
controls:0.20%
cases:13.35%
controls:3.52%
cases:31.95%
controls:18.56%
cases:45.05%
controls:36.98%
1591
15435
5771
57699
1776
12535
5586
60604
1556
2597
5806
70542
322
143
7040
72996
983
2576
6378
70530
2345
13502
4995
59246
3114
25136
3798
42836
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
2.7e-02
4.3e-01
2.0e+00
3.2e+00
1.4e+00
7.3e-01
3.4e-01
cases:21.54%
controls:21.09%
cases:24.16%
controls:17.15%
cases:21.14%
controls:3.56%
cases:4.37%
controls:0.19%
cases:13.27%
controls:3.54%
cases:31.99%
controls:18.55%
cases:45.08%
controls:36.96%
1586
15421
5776
57713
1779
12540
5583
60599
1556
2606
5806
70533
322
142
7040
72997
977
2586
6384
70520
2348
13493
4992
59255
3116
25121
3796
42851
Vibrio sp identified in Specimen by Organism specific culture
6581-3 [3005988]
6581-3 [3005988]
1.1e+00
2.3e+00
—
1.0e+50
—
2.5e+00
2.1e+00
cases:0.22%
controls:0.07%
cases:0.43%
controls:0.04%
—
—
cases:0.11%
controls:0.00%
—
—
cases:0.56%
controls:0.04%
cases:0.85%
controls:0.10%
16
53
7346
73081
32
32
7330
73107
—
8
0
7354
73139
—
41
32
7299
72716
59
71
6853
67901
Yersinia sp identified in Specimen by Organism specific culture
701-3 [3025468]
701-3 [3025468]
1.1e+00
2.3e+00
—
1.0e+50
—
2.5e+00
2.1e+00
cases:0.22%
controls:0.07%
cases:0.43%
controls:0.04%
—
—
cases:0.11%
controls:0.00%
—
—
cases:0.56%
controls:0.04%
cases:0.85%
controls:0.10%
16
53
7346
73081
32
32
7330
73107
—
8
0
7354
73139
—
41
32
7299
72716
59
71
6853
67901
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
ZY020 [2001311600]
3.2e-01
6.0e-01
1.8e+00
—
2.6e+00
2.0e+00
1.7e+00
cases:0.65%
controls:0.47%
cases:0.24%
controls:0.13%
cases:0.10%
controls:0.02%
—
—
cases:0.29%
controls:0.02%
cases:1.08%
controls:0.15%
cases:2.40%
controls:0.45%
48
347
7314
72787
18
98
7344
73041
7
12
7355
73127
—
21
16
7340
73090
79
108
7261
72640
166
305
6746
67667
Intravenous
ZX120 [2001311495]
ZX120 [2001311495]
-1.3e-01
2.6e-01
1.0e+00
—
2.5e+00
2.9e+00
2.6e+00
cases:0.56%
controls:0.63%
cases:0.33%
controls:0.25%
cases:0.15%
controls:0.05%
—
—
cases:0.72%
controls:0.06%
cases:3.34%
controls:0.19%
cases:6.84%
controls:0.55%
41
462
7321
72672
24
184
7338
72955
11
40
7351
73099
—
53
43
7308
73063
245
136
7095
72612
473
377
6439
67595
Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32785-8 [3043405]
32785-8 [3043405]
1.0e+00
2.1e+00
—
—
—
3.2e+00
2.7e+00
cases:0.15%
controls:0.05%
cases:0.11%
controls:0.01%
—
—
—
—
—
—
cases:0.38%
controls:0.02%
cases:1.10%
controls:0.08%
11
39
7351
73095
8
10
7354
73129
—
—
—
28
11
7312
72737
76
51
6836
67921
Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]
202 [2001600200]
6.2e-01
1.1e+00
2.1e+00
—
3.2e+00
1.8e+00
1.2e+00
cases:1.14%
controls:0.62%
cases:0.50%
controls:0.16%
cases:0.07%
controls:0.01%
—
—
cases:0.30%
controls:0.01%
cases:0.82%
controls:0.14%
cases:1.82%
controls:0.55%
84
453
7278
72681
37
119
7325
73020
5
6
7357
73133
—
22
9
7339
73097
60
99
7280
72649
126
375
6786
67597
racecadotril
A07XA04 [21600677]
A07XA04 [21600677]
9.1e-01
2.5e+00
3.5e+00
—
—
—
1.0e+00
cases:0.27%
controls:0.11%
cases:0.46%
controls:0.04%
cases:0.31%
controls:0.01%
—
—
—
—
—
—
cases:0.32%
controls:0.12%
20
80
7342
73054
34
27
7328
73112
23
7
7339
73132
—
—
—
22
79
6890
67893
Emergency Medicine
93 [38004510]
93 [38004510]
8.9e-02
3.0e-01
1.4e+00
4.5e+00
9.5e-01
5.2e-01
3.1e-01
cases:7.69%
controls:7.08%
cases:5.43%
controls:4.06%
cases:2.24%
controls:0.57%
cases:2.21%
controls:0.03%
cases:1.45%
controls:0.57%
cases:7.10%
controls:4.36%
cases:18.20%
controls:14.00%
566
5178
6796
67956
400
2972
6962
70167
165
419
7197
72720
163
19
7199
73120
107
415
7254
72691
521
3172
6819
69576
1258
9513
5654
58459
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
8.8e-02
5.3e-01
2.2e+00
—
2.4e+00
1.5e+00
1.1e+00
cases:1.14%
controls:1.05%
cases:1.06%
controls:0.62%
cases:0.67%
controls:0.07%
—
—
cases:0.86%
controls:0.08%
cases:2.89%
controls:0.63%
cases:6.39%
controls:2.14%
84
765
7278
72369
78
456
7284
72683
49
52
7313
73087
—
63
57
7298
73049
212
460
7128
72288
442
1452
6470
66520
Astrovirus RNA [Presence] in Stool by NAA with probe detection
92691-5 [37020445]
92691-5 [37020445]
1.8e+00
2.6e+00
—
—
—
3.0e+00
2.2e+00
cases:0.07%
controls:0.01%
cases:0.10%
controls:0.01%
—
—
—
—
—
—
cases:0.16%
controls:0.01%
cases:0.23%
controls:0.03%
5
8
7357
73126
7
5
7355
73134
—
—
—
12
6
7328
72742
16
18
6896
67954
Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
92690-7 [37021247]
92690-7 [37021247]
1.8e+00
2.6e+00
—
—
—
3.0e+00
2.2e+00
cases:0.07%
controls:0.01%
cases:0.10%
controls:0.01%
—
—
—
—
—
—
cases:0.16%
controls:0.01%
cases:0.23%
controls:0.03%
5
8
7357
73126
7
5
7355
73134
—
—
—
12
6
7328
72742
16
18
6896
67954
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3034-6 [3004789]
2.4e-02
4.8e-01
2.1e+00
—
2.5e+00
1.6e+00
1.2e+00
cases:0.96%
controls:0.94%
cases:0.94%
controls:0.58%
cases:0.58%
controls:0.07%
—
—
cases:0.84%
controls:0.07%
cases:2.70%
controls:0.58%
cases:6.08%
controls:2.00%
71
689
7291
72445
69
425
7293
72714
43
54
7319
73085
—
62
51
7299
73055
198
419
7142
72329
420
1362
6492
66610
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
60026-2 [40763086]
1.3e-01
4.4e-01
1.6e+00
3.5e+00
1.1e+00
6.6e-01
4.5e-01
cases:4.75%
controls:4.21%
cases:3.22%
controls:2.09%
cases:1.37%
controls:0.29%
cases:0.33%
controls:0.01%
cases:0.87%
controls:0.30%
cases:4.59%
controls:2.42%
cases:11.65%
controls:7.79%
350
3076
7012
70058
237
1531
7125
71608
101
209
7261
72930
24
7
7338
73132
64
217
7297
72889
337
1764
7003
70984
805
5292
6107
62680
Enterocolitis due to Clostridium difficile
A04.7 [45552153]
A04.7 [45552153]
8.2e-01
1.8e+00
—
1.0e+50
—
3.7e+00
2.2e+00
cases:0.15%
controls:0.07%
cases:0.14%
controls:0.02%
—
—
cases:0.16%
controls:0.00%
—
—
cases:0.75%
controls:0.02%
cases:1.04%
controls:0.11%
11
48
7351
73086
10
16
7352
73123
—
12
0
7350
73139
—
55
14
7285
72734
72
78
6840
67894
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
64084-7 [40766800]
64084-7 [40766800]
4.5e-01
6.9e-01
—
—
—
4.3e+00
3.4e+00
cases:0.12%
controls:0.08%
cases:0.07%
controls:0.03%
—
—
—
—
—
—
cases:1.59%
controls:0.02%
cases:2.76%
controls:0.10%
9
57
7353
73077
5
25
7357
73114
—
—
—
117
16
7223
72732
191
67
6721
67905
Multidisciplinary treatment meeting
WZC20 [2001310890]
WZC20 [2001310890]
-7.4e-01
5.7e-01
2.0e+00
—
2.8e+00
1.6e+00
1.2e+00
cases:0.10%
controls:0.20%
cases:0.11%
controls:0.06%
cases:0.08%
controls:0.01%
—
—
cases:0.11%
controls:0.01%
cases:0.37%
controls:0.07%
cases:0.78%
controls:0.23%
7
145
7355
72989
8
45
7354
73094
6
8
7356
73131
—
8
5
7353
73101
27
52
7313
72696
54
159
6858
67813
cinchocaine
C05AD04 [21601621]
C05AD04 [21601621]
9.0e-01
1.7e+00
2.7e+00
—
—
1.6e+00
7.0e-01
cases:0.60%
controls:0.24%
cases:0.39%
controls:0.07%
cases:0.12%
controls:0.01%
—
—
—
—
cases:0.26%
controls:0.05%
cases:0.42%
controls:0.21%
44
179
7318
72955
29
53
7333
73086
9
6
7353
73133
—
—
19
38
7321
72710
29
142
6883
67830
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
-6.2e-02
1.2e-01
1.8e+00
—
2.9e+00
1.8e+00
1.1e+00
cases:2.49%
controls:2.64%
cases:1.44%
controls:1.27%
cases:0.80%
controls:0.13%
—
—
cases:1.93%
controls:0.11%
cases:5.82%
controls:1.04%
cases:10.68%
controls:3.91%
183
1932
7179
71202
106
932
7256
72207
59
94
7303
73045
—
142
80
7219
73026
427
753
6913
71995
738
2659
6174
65313
Microorganisms panel - Urine sediment
58435-9 [40761536]
58435-9 [40761536]
2.5e-01
5.3e-01
2.7e+00
—
1.4e+00
1.5e+00
1.4e+00
cases:1.22%
controls:0.95%
cases:0.83%
controls:0.49%
cases:0.87%
controls:0.06%
—
—
cases:0.31%
controls:0.08%
cases:1.99%
controls:0.45%
cases:4.82%
controls:1.19%
90
697
7272
72437
61
357
7301
72782
64
44
7298
73095
—
23
56
7338
73050
146
330
7194
72418
333
807
6579
67165
lansoprazole; oral
A02BC03 [21600098]
A02BC03 [21600098]
3.7e-01
8.7e-01
7.9e-01
2.7e+00
1.3e+00
8.2e-01
6.5e-01
cases:4.39%
controls:3.08%
cases:3.14%
controls:1.33%
cases:0.61%
controls:0.28%
cases:0.12%
controls:0.01%
cases:1.07%
controls:0.29%
cases:3.20%
controls:1.44%
cases:6.35%
controls:3.42%
323
2254
7039
70880
231
976
7131
72163
45
203
7317
72936
9
6
7353
73133
79
210
7282
72896
235
1047
7105
71701
439
2327
6473
65645
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
7.9e-02
5.3e-01
1.8e+00
1.0e+50
2.0e+00
1.6e+00
1.5e+00
cases:1.59%
controls:1.47%
cases:0.90%
controls:0.53%
cases:0.38%
controls:0.06%
cases:1.11%
controls:0.00%
cases:0.57%
controls:0.07%
cases:2.79%
controls:0.56%
cases:7.45%
controls:1.81%
117
1075
7245
72059
66
388
7296
72751
28
45
7334
73094
82
0
7280
73139
42
54
7319
73052
205
404
7135
72344
515
1231
6397
66741
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
-1.0e-01
1.1e-01
1.1e+00
3.7e+00
1.4e+00
6.9e-01
6.1e-01
cases:2.57%
controls:2.84%
cases:1.51%
controls:1.36%
cases:0.50%
controls:0.17%
cases:0.27%
controls:0.01%
cases:0.60%
controls:0.15%
cases:2.23%
controls:1.14%
cases:7.23%
controls:4.05%
189
2077
7173
71057
111
992
7251
72147
37
126
7325
73013
20
5
7342
73134
44
108
7317
72998
164
826
7176
71922
500
2751
6412
65221
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
-2.0e-01
1.8e-01
1.2e+00
3.8e+00
1.2e+00
6.6e-01
5.3e-01
cases:2.72%
controls:3.30%
cases:2.04%
controls:1.71%
cases:0.75%
controls:0.22%
cases:0.42%
controls:0.01%
cases:0.79%
controls:0.23%
cases:3.22%
controls:1.68%
cases:8.61%
controls:5.26%
200
2415
7162
70719
150
1252
7212
71887
55
163
7307
72976
31
7
7331
73132
58
166
7303
72940
236
1224
7104
71524
595
3573
6317
64399
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
3.5e-01
9.1e-01
2.5e+00
—
1.7e+00
1.3e+00
6.6e-01
cases:2.50%
controls:1.78%
cases:1.43%
controls:0.58%
cases:0.71%
controls:0.06%
—
—
cases:0.34%
controls:0.06%
cases:2.15%
controls:0.61%
cases:4.38%
controls:2.32%
184
1304
7178
71830
105
423
7257
72716
52
42
7310
73097
—
25
45
7336
73061
158
443
7182
72305
303
1576
6609
66396
Inflammatory spondylopathy, unspecified
M46.9 [45533846]
M46.9 [45533846]
9.5e-01
1.4e+00
—
1.0e+50
2.2e+00
1.5e+00
1.3e+00
cases:0.24%
controls:0.09%
cases:0.20%
controls:0.05%
—
—
cases:0.08%
controls:0.00%
cases:0.10%
controls:0.01%
cases:0.22%
controls:0.05%
cases:0.43%
controls:0.11%
18
69
7344
73065
15
37
7347
73102
—
6
0
7356
73139
7
8
7354
73098
16
35
7324
72713
30
77
6882
67895
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
29760-6 [3005772]
2.1e-02
7.6e-01
2.1e+00
—
2.0e+00
1.3e+00
1.1e+00
cases:1.07%
controls:1.05%
cases:0.95%
controls:0.45%
cases:0.46%
controls:0.06%
—
—
cases:0.46%
controls:0.06%
cases:1.62%
controls:0.44%
cases:4.21%
controls:1.41%
79
769
7283
72365
70
326
7292
72813
34
42
7328
73097
—
34
44
7327
73062
119
322
7221
72426
291
960
6621
67012
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
4.9e-04
5.3e-01
1.7e+00
3.2e+00
1.2e+00
4.3e-01
2.9e-01
cases:8.48%
controls:8.47%
cases:7.28%
controls:4.42%
cases:2.72%
controls:0.51%
cases:0.58%
controls:0.02%
cases:1.66%
controls:0.53%
cases:7.11%
controls:4.72%
cases:19.33%
controls:15.25%
624
6196
6738
66938
536
3232
6826
69907
200
376
7162
72763
43
17
7319
73122
122
387
7239
72719
522
3436
6818
69312
1336
10365
5576
57607
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
-2.1e-01
1.2e-01
1.2e+00
3.8e+00
1.1e+00
6.6e-01
5.9e-01
cases:1.92%
controls:2.35%
cases:1.44%
controls:1.27%
cases:0.50%
controls:0.16%
cases:0.37%
controls:0.01%
cases:0.50%
controls:0.17%
cases:2.33%
controls:1.22%
cases:6.44%
controls:3.66%
141
1720
7221
71414
106
932
7256
72207
37
114
7325
73025
27
6
7335
73133
37
125
7324
72981
171
890
7169
71858
445
2487
6467
65485
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
-1.5e-02
3.2e-01
1.6e+00
3.5e+00
1.2e+00
3.9e-01
3.1e-01
cases:15.31%
controls:15.50%
cases:15.13%
controls:11.47%
cases:8.67%
controls:1.97%
cases:3.34%
controls:0.10%
cases:6.45%
controls:2.01%
cases:17.38%
controls:12.43%
cases:34.06%
controls:27.51%
1127
11338
6235
61796
1114
8388
6248
64751
638
1439
6724
71700
246
75
7116
73064
475
1467
6886
71639
1276
9042
6064
63706
2354
18697
4558
49275
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
3.8e-03
2.5e-01
1.5e+00
3.8e+00
1.1e+00
4.2e-01
1.7e-01
cases:24.99%
controls:24.92%
cases:28.38%
controls:23.61%
cases:25.03%
controls:6.78%
cases:14.44%
controls:0.36%
cases:17.86%
controls:6.81%
cases:34.41%
controls:25.71%
cases:46.73%
controls:42.44%
1840
18227
5522
54907
2089
17269
5273
55870
1843
4960
5519
68179
1063
262
6299
72877
1315
4975
6046
68131
2526
18700
4814
54048
3230
28844
3682
39128
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
-8.9e-02
1.7e-01
1.5e+00
2.9e+00
1.4e+00
7.8e-01
7.3e-01
cases:2.06%
controls:2.25%
cases:1.60%
controls:1.36%
cases:0.81%
controls:0.18%
cases:0.22%
controls:0.01%
cases:0.87%
controls:0.21%
cases:3.07%
controls:1.43%
cases:7.86%
controls:3.96%
152
1648
7210
71486
118
992
7244
72147
60
135
7302
73004
16
9
7346
73130
64
154
7297
72952
225
1042
7115
71706
543
2689
6369
65283
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
J01EE01 [21602961]
-9.2e-02
-4.6e-01
—
—
3.6e+00
2.4e+00
1.3e+00
cases:0.35%
controls:0.39%
cases:0.10%
controls:0.15%
—
—
—
—
cases:0.87%
controls:0.02%
cases:1.59%
controls:0.15%
cases:1.59%
controls:0.45%
26
283
7336
72851
7
110
7355
73029
—
—
64
17
7297
73089
117
110
7223
72638
110
304
6802
67668
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
-2.3e-01
1.4e-01
1.1e+00
3.8e+00
1.1e+00
6.5e-01
6.0e-01
cases:1.90%
controls:2.39%
cases:1.48%
controls:1.29%
cases:0.49%
controls:0.17%
cases:0.38%
controls:0.01%
cases:0.54%
controls:0.18%
cases:2.37%
controls:1.25%
cases:6.76%
controls:3.84%
140
1745
7222
71389
109
947
7253
72192
36
122
7326
73017
28
6
7334
73133
40
131
7321
72975
174
912
7166
71836
467
2609
6445
65363
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
2.5e-01
1.3e+00
2.8e+00
—
1.7e+00
7.3e-01
5.7e-01
cases:5.08%
controls:4.01%
cases:4.60%
controls:1.33%
cases:2.35%
controls:0.15%
—
—
cases:0.68%
controls:0.13%
cases:2.78%
controls:1.36%
cases:8.42%
controls:4.93%
374
2931
6988
70203
339
970
7023
72169
173
111
7189
73028
—
50
93
7311
73013
204
986
7136
71762
582
3349
6330
64623
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
-1.5e-01
1.7e-01
1.5e+00
3.0e+00
1.4e+00
7.2e-01
6.9e-01
cases:3.22%
controls:3.73%
cases:2.55%
controls:2.17%
cases:1.22%
controls:0.28%
cases:0.35%
controls:0.02%
cases:1.30%
controls:0.33%
cases:4.35%
controls:2.17%
cases:11.31%
controls:6.02%
237
2725
7125
70409
188
1584
7174
71555
90
207
7272
72932
26
13
7336
73126
96
239
7265
72867
319
1577
7021
71171
782
4094
6130
63878
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
-8.6e-02
2.2e-01
1.3e+00
3.8e+00
1.1e+00
4.6e-01
3.6e-01
cases:5.24%
controls:5.69%
cases:3.90%
controls:3.17%
cases:1.36%
controls:0.38%
cases:0.99%
controls:0.02%
cases:1.22%
controls:0.40%
cases:4.82%
controls:3.11%
cases:13.67%
controls:9.92%
386
4158
6976
68976
287
2316
7075
70823
100
280
7262
72859
73
16
7289
73123
90
295
7271
72811
354
2264
6986
70484
945
6744
5967
61228
cycloSPORINE [Mass/volume] in Blood
3520-4 [3010375]
3520-4 [3010375]
9.9e-02
5.6e-01
1.2e+00
—
2.9e+00
2.8e+00
1.5e+00
cases:0.07%
controls:0.06%
cases:0.08%
controls:0.05%
cases:0.07%
controls:0.02%
—
—
cases:0.48%
controls:0.03%
cases:0.89%
controls:0.05%
cases:0.52%
controls:0.11%
5
45
7357
73089
6
34
7356
73105
5
15
7357
73124
—
35
19
7326
73087
65
39
7275
72709
36
78
6876
67894
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
16933-4 [3021879]
-1.6e-01
9.9e-02
1.7e+00
—
2.8e+00
1.6e+00
1.1e+00
cases:0.91%
controls:1.07%
cases:0.52%
controls:0.47%
cases:0.31%
controls:0.05%
—
—
cases:0.79%
controls:0.05%
cases:1.87%
controls:0.38%
cases:4.01%
controls:1.42%
67
779
7295
72355
38
342
7324
72797
23
40
7339
73099
—
58
34
7303
73072
137
280
7203
72468
277
967
6635
67005
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
-1.2e-02
3.2e-01
1.5e+00
3.5e+00
1.2e+00
3.9e-01
3.1e-01
cases:15.44%
controls:15.60%
cases:15.24%
controls:11.59%
cases:8.68%
controls:2.00%
cases:3.31%
controls:0.11%
cases:6.48%
controls:2.04%
cases:17.57%
controls:12.59%
cases:34.20%
controls:27.69%
1137
11411
6225
61723
1122
8480
6240
64659
639
1464
6723
71675
244
78
7118
73061
477
1488
6884
71618
1290
9157
6050
63591
2364
18820
4548
49152
Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
92694-9 [37020957]
92694-9 [37020957]
1.6e+00
2.4e+00
—
—
—
2.7e+00
2.0e+00
cases:0.07%
controls:0.01%
cases:0.11%
controls:0.01%
—
—
—
—
—
—
cases:0.19%
controls:0.01%
cases:0.26%
controls:0.03%
5
10
7357
73124
8
7
7354
73132
—
—
—
14
9
7326
72739
18
23
6894
67949
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
1.4e-01
4.1e-01
1.5e+00
3.2e+00
1.1e+00
6.2e-01
4.1e-01
cases:5.24%
controls:4.58%
cases:3.76%
controls:2.54%
cases:1.62%
controls:0.35%
cases:0.35%
controls:0.02%
cases:1.06%
controls:0.37%
cases:5.56%
controls:3.07%
cases:14.31%
controls:9.98%
386
3353
6976
69781
277
1856
7085
71283
119
255
7243
72884
26
11
7336
73128
78
270
7283
72836
408
2232
6932
70516
989
6783
5923
61189
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
-5.2e-02
3.0e-01
1.0e+00
3.3e+00
9.6e-01
8.5e-01
7.6e-01
cases:3.50%
controls:3.68%
cases:3.07%
controls:2.29%
cases:1.68%
controls:0.61%
cases:1.02%
controls:0.04%
cases:1.64%
controls:0.64%
cases:5.07%
controls:2.23%
cases:12.40%
controls:6.20%
258
2694
7104
70440
226
1672
7136
71467
124
447
7238
72692
75
28
7287
73111
121
466
7240
72640
372
1624
6968
71124
857
4216
6055
63756
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
-4.7e-02
3.5e-01
1.8e+00
3.0e+00
1.3e+00
5.4e-01
1.8e-01
cases:15.44%
controls:16.07%
cases:16.34%
controls:12.09%
cases:12.63%
controls:2.43%
cases:2.77%
controls:0.14%
cases:8.25%
controls:2.41%
cases:20.42%
controls:13.03%
cases:32.09%
controls:28.22%
1137
11752
6225
61382
1203
8840
6159
64299
930
1776
6432
71363
204
99
7158
73040
607
1762
6754
71344
1499
9476
5841
63272
2218
19180
4694
48792
clidinium and psycholeptics
A03CA02 [21600204]
A03CA02 [21600204]
9.0e-01
1.6e+00
2.5e+00
—
—
1.1e+00
1.0e+00
cases:1.45%
controls:0.59%
cases:1.02%
controls:0.20%
cases:0.26%
controls:0.02%
—
—
—
—
cases:0.61%
controls:0.21%
cases:1.74%
controls:0.64%
107
434
7255
72700
75
145
7287
72994
19
15
7343
73124
—
—
45
152
7295
72596
120
438
6792
67534
Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
92695-6 [37019628]
92695-6 [37019628]
8.1e-01
2.6e+00
—
1.0e+50
—
2.6e+00
2.0e+00
cases:0.26%
controls:0.11%
cases:0.90%
controls:0.07%
—
—
cases:0.20%
controls:0.00%
—
—
cases:1.10%
controls:0.09%
cases:2.26%
controls:0.31%
19
84
7343
73050
66
50
7296
73089
—
15
0
7347
73139
—
81
62
7259
72686
156
209
6756
67763
other preparations, combinations; ointment
C05AX03 [21601631]
C05AX03 [21601631]
7.0e-01
1.6e+00
2.2e+00
—
1.2e+00
7.7e-01
5.9e-01
cases:4.17%
controls:2.11%
cases:3.57%
controls:0.72%
cases:0.87%
controls:0.09%
—
—
cases:0.29%
controls:0.08%
cases:1.49%
controls:0.69%
cases:3.75%
controls:2.12%
307
1546
7055
71588
263
527
7099
72612
64
69
7298
73070
—
21
61
7340
73045
109
503
7231
72245
259
1441
6653
66531
Examination and observation for other specified reasons
Z04.8 [45552063]
Z04.8 [45552063]
1.7e-01
8.1e-01
1.8e+00
1.0e+50
2.2e+00
1.5e+00
8.3e-01
cases:1.17%
controls:0.99%
cases:0.62%
controls:0.28%
cases:0.19%
controls:0.03%
cases:0.10%
controls:0.00%
cases:0.24%
controls:0.03%
cases:1.44%
controls:0.32%
cases:2.78%
controls:1.23%
86
721
7276
72413
46
205
7316
72934
14
24
7348
73115
7
0
7355
73139
18
19
7343
73087
106
235
7234
72513
192
835
6720
67137
Biopsy of liver with ultrasound guidance
JJ2AT [2001305254]
JJ2AT [2001305254]
6.5e-01
1.8e+00
—
—
1.0e+50
3.2e+00
2.2e+00
cases:0.19%
controls:0.10%
cases:0.15%
controls:0.03%
—
—
—
—
cases:0.08%
controls:0.00%
cases:0.45%
controls:0.02%
cases:0.72%
controls:0.08%
14
73
7348
73061
11
19
7351
73120
—
—
6
0
7355
73106
33
14
7307
72734
50
53
6862
67919
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
4.9e-02
2.3e-01
1.8e+00
—
2.0e+00
1.9e+00
1.5e+00
cases:1.40%
controls:1.33%
cases:0.50%
controls:0.40%
cases:0.19%
controls:0.03%
—
—
cases:0.29%
controls:0.04%
cases:2.07%
controls:0.33%
cases:4.98%
controls:1.17%
103
975
7259
72159
37
292
7325
72847
14
23
7348
73116
—
21
29
7340
73077
152
237
7188
72511
344
793
6568
67179
Rotavirus RNA [Identifier] in Stool by NAA with probe detection
71700-9 [42869457]
71700-9 [42869457]
1.6e+00
2.4e+00
—
—
—
2.6e+00
2.0e+00
cases:0.07%
controls:0.01%
cases:0.11%
controls:0.01%
—
—
—
—
—
—
cases:0.19%
controls:0.01%
cases:0.26%
controls:0.03%
5
10
7357
73124
8
7
7354
73132
—
—
—
14
10
7326
72738
18
23
6894
67949
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
3.2e-01
3.8e-01
8.6e-01
3.3e+00
1.3e+00
7.2e-01
2.4e-01
cases:52.69%
controls:44.79%
cases:47.24%
controls:37.98%
cases:27.97%
controls:14.17%
cases:18.43%
controls:0.83%
cases:37.85%
controls:14.44%
cases:59.05%
controls:41.16%
cases:66.32%
controls:60.74%
3879
32760
3483
40374
3478
27776
3884
45363
2059
10363
5303
62776
1357
607
6005
72532
2786
10555
4575
62551
4334
29944
3006
42804
4584
41288
2328
26684
Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9838-4 [3003265]
9838-4 [3003265]
8.8e-01
1.9e+00
—
—
—
2.6e+00
2.6e+00
cases:0.22%
controls:0.09%
cases:0.24%
controls:0.04%
—
—
—
—
—
—
cases:0.57%
controls:0.04%
cases:1.63%
controls:0.13%
16
66
7346
73068
18
27
7344
73112
—
—
—
42
30
7298
72718
113
87
6799
67885
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
-4.3e-02
1.8e-01
1.1e+00
4.2e+00
1.1e+00
4.0e-01
3.2e-01
cases:2.77%
controls:2.89%
cases:1.75%
controls:1.47%
cases:0.50%
controls:0.16%
cases:0.45%
controls:0.01%
cases:0.50%
controls:0.18%
cases:2.26%
controls:1.53%
cases:7.19%
controls:5.34%
204
2113
7158
71021
129
1075
7233
72064
37
120
7325
73019
33
5
7329
73134
37
128
7324
72978
166
1114
7174
71634
497
3627
6415
64345
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
-1.1e-01
1.8e-01
1.4e+00
3.0e+00
1.4e+00
6.6e-01
6.6e-01
cases:3.69%
controls:4.11%
cases:2.87%
controls:2.40%
cases:1.33%
controls:0.33%
cases:0.34%
controls:0.02%
cases:1.40%
controls:0.36%
cases:4.69%
controls:2.47%
cases:12.76%
controls:7.02%
272
3005
7090
70129
211
1752
7151
71387
98
240
7264
72899
25
13
7337
73126
103
262
7258
72844
344
1798
6996
70950
882
4773
6030
63199
esomeprazole; oral, parenteral
A02BC05 [21600100]
A02BC05 [21600100]
4.4e-01
6.4e-01
1.1e+00
2.4e+00
1.4e+00
6.6e-01
5.1e-01
cases:7.88%
controls:5.21%
cases:4.88%
controls:2.63%
cases:1.51%
controls:0.53%
cases:0.23%
controls:0.02%
cases:2.04%
controls:0.52%
cases:5.18%
controls:2.75%
cases:10.05%
controls:6.26%
580
3810
6782
69324
359
1924
7003
71215
111
388
7251
72751
17
16
7345
73123
150
377
7211
72729
380
1998
6960
70750
695
4256
6217
63716
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
-2.5e-01
9.4e-02
1.1e+00
3.6e+00
1.2e+00
6.1e-01
5.2e-01
cases:2.16%
controls:2.76%
cases:1.67%
controls:1.52%
cases:0.60%
controls:0.19%
cases:0.39%
controls:0.01%
cases:0.67%
controls:0.21%
cases:2.68%
controls:1.47%
cases:7.58%
controls:4.66%
159
2016
7203
71118
123
1114
7239
72025
44
141
7318
72998
29
8
7333
73131
49
153
7312
72953
197
1070
7143
71678
524
3169
6388
64803
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
1.2e-01
4.0e-01
1.5e+00
3.0e+00
1.0e+00
6.1e-01
4.1e-01
cases:5.31%
controls:4.75%
cases:3.87%
controls:2.62%
cases:1.59%
controls:0.36%
cases:0.34%
controls:0.02%
cases:1.06%
controls:0.37%
cases:5.61%
controls:3.12%
cases:14.53%
controls:10.18%
391
3471
6971
69663
285
1918
7077
71221
117
264
7245
72875
25
12
7337
73127
78
274
7283
72832
412
2273
6928
70475
1004
6918
5908
61054
Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
70295-1 [42868766]
70295-1 [42868766]
—
2.5e+00
—
—
1.0e+50
2.7e+00
1.7e+00
—
—
cases:0.14%
controls:0.01%
—
—
—
—
cases:0.15%
controls:0.00%
cases:0.16%
controls:0.01%
cases:0.30%
controls:0.05%
—
10
8
7352
73131
—
—
11
0
7350
73106
12
8
7328
72740
21
36
6891
67936
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
1.3e-01
4.0e-01
1.5e+00
3.0e+00
1.0e+00
6.1e-01
4.0e-01
cases:5.31%
controls:4.68%
cases:3.79%
controls:2.58%
cases:1.60%
controls:0.36%
cases:0.34%
controls:0.02%
cases:1.06%
controls:0.38%
cases:5.60%
controls:3.13%
cases:14.44%
controls:10.19%
391
3422
6971
69712
279
1890
7083
71249
118
261
7244
72878
25
13
7337
73126
78
276
7283
72830
411
2274
6929
70474
998
6926
5914
61046
fluocortolone
D07AC05 [21602124]
D07AC05 [21602124]
7.5e-01
1.6e+00
2.2e+00
—
1.8e+00
1.4e+00
9.0e-01
cases:0.94%
controls:0.44%
cases:0.80%
controls:0.16%
cases:0.14%
controls:0.02%
—
—
cases:0.08%
controls:0.01%
cases:0.64%
controls:0.16%
cases:1.45%
controls:0.59%
69
325
7293
72809
59
116
7303
73023
10
11
7352
73128
—
6
10
7355
73096
47
113
7293
72635
100
403
6812
67569
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
1.9e-02
2.3e-01
1.4e+00
3.1e+00
9.6e-01
6.2e-01
5.3e-01
cases:8.52%
controls:8.37%
cases:5.56%
controls:4.48%
cases:2.50%
controls:0.60%
cases:0.50%
controls:0.02%
cases:1.62%
controls:0.63%
cases:8.34%
controls:4.68%
cases:20.25%
controls:13.02%
627
6120
6735
67014
409
3274
6953
69865
184
441
7178
72698
37
17
7325
73122
119
457
7242
72649
612
3406
6728
69342
1400
8849
5512
59123
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
83084-4 [42529201]
3.7e-01
1.0e+00
2.8e+00
—
—
1.9e+00
2.2e+00
cases:0.11%
controls:0.08%
cases:0.16%
controls:0.06%
cases:0.11%
controls:0.01%
—
—
—
—
cases:0.37%
controls:0.06%
cases:0.90%
controls:0.10%
8
55
7354
73079
12
43
7350
73096
8
5
7354
73134
—
—
27
42
7313
72706
62
69
6850
67903
General Practice
1 [38004446]
1 [38004446]
2.3e-02
1.4e-01
1.1e+00
4.4e+00
6.5e-01
2.9e-01
2.9e-01
cases:8.39%
controls:8.22%
cases:3.45%
controls:3.02%
cases:1.24%
controls:0.41%
cases:0.92%
controls:0.01%
cases:0.72%
controls:0.38%
cases:3.98%
controls:3.01%
cases:12.21%
controls:9.43%
618
6012
6744
67122
254
2206
7108
70933
91
298
7271
72841
68
8
7294
73131
53
276
7308
72830
292
2192
7048
70556
844
6409
6068
61563
Neutrophil cytoplasmic Ab.classic [Titer] in Serum
32708-0 [3046294]
32708-0 [3046294]
5.6e-01
1.3e+00
1.0e+50
—
—
3.4e+00
3.4e+00
cases:0.20%
controls:0.12%
cases:0.14%
controls:0.04%
cases:0.12%
controls:0.00%
—
—
—
—
cases:0.50%
controls:0.02%
cases:1.42%
controls:0.05%
15
85
7347
73049
10
28
7352
73111
9
0
7353
73139
—
—
37
12
7303
72736
98
34
6814
67938
Acute and subacute iridocyclitis
H20.0 [45542994]
H20.0 [45542994]
9.1e-01
1.3e+00
1.4e+00
—
1.9e+00
1.3e+00
1.3e+00
cases:0.80%
controls:0.33%
cases:0.49%
controls:0.13%
cases:0.12%
controls:0.03%
—
—
cases:0.16%
controls:0.02%
cases:0.49%
controls:0.13%
cases:1.45%
controls:0.39%
59
238
7303
72896
36
94
7326
73045
9
22
7353
73117
—
12
18
7349
73088
36
97
7304
72651
100
263
6812
67709
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
-1.5e-01
1.7e-01
1.1e+00
3.5e+00
1.1e+00
5.5e-01
4.4e-01
cases:2.65%
controls:3.07%
cases:2.12%
controls:1.79%
cases:0.72%
controls:0.24%
cases:0.42%
controls:0.01%
cases:0.79%
controls:0.25%
cases:3.19%
controls:1.87%
cases:8.83%
controls:5.87%
195
2243
7167
70891
156
1310
7206
71829
53
176
7309
72963
31
9
7331
73130
58
185
7303
72921
234
1363
7106
71385
610
3990
6302
63982
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
32787-4 [3043453]
32787-4 [3043453]
5.6e-01
1.3e+00
1.0e+50
—
—
3.4e+00
3.3e+00
cases:0.20%
controls:0.12%
cases:0.14%
controls:0.04%
cases:0.12%
controls:0.00%
—
—
—
—
cases:0.50%
controls:0.02%
cases:1.42%
controls:0.05%
15
85
7347
73049
10
28
7352
73111
9
0
7353
73139
—
—
37
12
7303
72736
98
35
6814
67937
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
-1.7e-01
5.4e-01
2.2e+00
—
1.9e+00
1.3e+00
7.3e-01
cases:0.65%
controls:0.77%
cases:0.65%
controls:0.38%
cases:0.50%
controls:0.05%
—
—
cases:0.42%
controls:0.06%
cases:1.38%
controls:0.36%
cases:2.65%
controls:1.29%
48
563
7314
72571
48
280
7314
72859
37
40
7325
73099
—
31
46
7330
73060
101
265
7239
72483
183
877
6729
67095
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
-2.4e-02
5.4e-01
2.1e+00
—
1.8e+00
1.3e+00
9.1e-01
cases:1.05%
controls:1.07%
cases:0.67%
controls:0.39%
cases:0.31%
controls:0.04%
—
—
cases:0.29%
controls:0.05%
cases:1.25%
controls:0.34%
cases:3.24%
controls:1.33%
77
783
7285
72351
49
284
7313
72855
23
28
7339
73111
—
21
33
7340
73073
92
244
7248
72504
224
902
6688
67070
Abdominal X-ray examination without contrast
JN3AA [2001305553]
JN3AA [2001305553]
2.1e-01
1.2e+00
2.4e+00
1.0e+50
2.3e+00
2.3e+00
2.0e+00
cases:0.24%
controls:0.20%
cases:0.16%
controls:0.05%
cases:0.11%
controls:0.01%
cases:0.33%
controls:0.00%
cases:0.07%
controls:0.01%
cases:0.44%
controls:0.04%
cases:1.23%
controls:0.17%
18
145
7344
72989
12
37
7350
73102
8
7
7354
73132
24
0
7338
73139
5
5
7356
73101
32
31
7308
72717
85
118
6827
67854
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-1.5e+00
-1.3e+00
-2.0e-01
—
3.0e+00
3.1e+00
3.4e+00
cases:7.81%
controls:26.91%
cases:2.88%
controls:10.05%
cases:0.80%
controls:0.98%
—
—
cases:0.83%
controls:0.04%
cases:4.96%
controls:0.24%
cases:14.44%
controls:0.57%
575
19681
6787
53453
212
7352
7150
65787
59
717
7303
72422
—
61
29
7300
73077
364
177
6976
72571
998
385
5914
67587
Ulcerative (chronic) pancolitis
K51.0 [45557656]
K51.0 [45557656]
—
—
—
1.0e+50
1.0e+50
—
6.7e+00
—
—
—
—
—
—
cases:2.57%
controls:0.00%
cases:1.20%
controls:0.00%
—
—
cases:5.58%
controls:0.01%
—
—
—
189
0
7173
73139
88
0
7273
73106
—
386
5
6526
67967
Extensive MRI examination of upper part of abdomen with high intensity magnet
JN1CG [2001305527]
JN1CG [2001305527]
3.2e-01
1.8e+00
—
—
—
2.6e+00
2.3e+00
cases:0.14%
controls:0.10%
cases:0.15%
controls:0.03%
—
—
—
—
—
—
cases:0.30%
controls:0.02%
cases:0.75%
controls:0.08%
10
72
7352
73062
11
19
7351
73120
—
—
—
22
16
7318
72732
52
51
6860
67921
Band form neutrophils/Leukocytes in Blood
26508-2 [3004809]
26508-2 [3004809]
—
8.6e-01
—
—
2.9e+00
2.1e+00
1.7e+00
—
—
cases:0.12%
controls:0.05%
—
—
—
—
cases:0.15%
controls:0.01%
cases:0.52%
controls:0.06%
cases:0.94%
controls:0.18%
—
9
38
7353
73101
—
—
11
6
7350
73100
38
47
7302
72701
65
120
6847
67852
Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
92689-9 [37020300]
92689-9 [37020300]
—
2.4e+00
—
—
1.0e+50
2.6e+00
1.7e+00
—
—
cases:0.16%
controls:0.02%
—
—
—
—
cases:0.15%
controls:0.00%
cases:0.20%
controls:0.02%
cases:0.36%
controls:0.07%
—
12
11
7350
73128
—
—
11
0
7350
73106
15
11
7325
72737
25
47
6887
67925
Internal hemorrhoids without complication
I84.2 [45596267]
I84.2 [45596267]
7.4e-01
1.7e+00
2.1e+00
1.0e+50
—
1.3e+00
7.5e-01
cases:0.81%
controls:0.39%
cases:0.65%
controls:0.12%
cases:0.08%
controls:0.01%
cases:0.27%
controls:0.00%
—
—
cases:0.40%
controls:0.11%
cases:0.87%
controls:0.41%
60
287
7302
72847
48
90
7314
73049
6
7
7356
73132
20
0
7342
73139
—
29
77
7311
72671
60
281
6852
67691
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
-1.4e-01
1.5e-01
1.2e+00
3.1e+00
1.4e+00
5.5e-01
3.9e-01
cases:0.81%
controls:0.94%
cases:0.69%
controls:0.59%
cases:0.27%
controls:0.08%
cases:0.19%
controls:0.01%
cases:0.34%
controls:0.09%
cases:1.24%
controls:0.72%
cases:3.41%
controls:2.34%
60
686
7302
72448
51
435
7311
72704
20
62
7342
73077
14
6
7348
73133
25
64
7336
73042
91
521
7249
72227
236
1593
6676
66379
Neutrophils [#/volume] in Blood
26499-4 [3017732]
26499-4 [3017732]
4.9e-02
6.5e-01
2.4e+00
—
1.4e+00
1.1e+00
9.9e-01
cases:0.56%
controls:0.53%
cases:0.61%
controls:0.32%
cases:0.49%
controls:0.05%
—
—
cases:0.19%
controls:0.05%
cases:1.29%
controls:0.43%
cases:4.20%
controls:1.61%
41
388
7321
72746
45
234
7317
72905
36
34
7326
73105
—
14
33
7347
73073
95
313
7245
72435
290
1092
6622
66880
Coeliac disease
K90.0 [45586745]
K90.0 [45586745]
4.5e-01
8.9e-01
1.7e+00
—
1.8e+00
1.4e+00
7.6e-01
cases:0.61%
controls:0.39%
cases:0.43%
controls:0.18%
cases:0.20%
controls:0.04%
—
—
cases:0.22%
controls:0.04%
cases:0.72%
controls:0.19%
cases:0.97%
controls:0.45%
45
286
7317
72848
32
131
7330
73008
15
26
7347
73113
—
16
27
7345
73079
53
136
7287
72612
67
309
6845
67663
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
2039-6 [3003785]
2.7e-01
8.3e-01
1.7e+00
—
1.7e+00
1.1e+00
1.2e+00
cases:0.67%
controls:0.51%
cases:0.77%
controls:0.34%
cases:0.39%
controls:0.07%
—
—
cases:0.27%
controls:0.05%
cases:1.05%
controls:0.35%
cases:2.49%
controls:0.77%
49
371
7313
72763
57
248
7305
72891
29
52
7333
73087
—
20
37
7341
73069
77
255
7263
72493
172
523
6740
67449
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
-7.2e-02
6.1e-02
1.0e+00
3.1e+00
1.2e+00
6.2e-01
5.2e-01
cases:4.05%
controls:4.34%
cases:2.35%
controls:2.21%
cases:0.73%
controls:0.27%
cases:0.31%
controls:0.01%
cases:0.80%
controls:0.24%
cases:3.43%
controls:1.87%
cases:10.43%
controls:6.47%
298
3173
7064
69961
173
1619
7189
71520
54
197
7308
72942
23
10
7339
73129
59
175
7302
72931
252
1359
7088
71389
721
4401
6191
63571
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
-1.6e-01
2.0e-01
1.1e+00
3.3e+00
1.2e+00
5.6e-01
3.4e-01
cases:0.71%
controls:0.83%
cases:0.71%
controls:0.58%
cases:0.24%
controls:0.08%
cases:0.18%
controls:0.01%
cases:0.30%
controls:0.09%
cases:1.27%
controls:0.73%
cases:3.44%
controls:2.48%
52
607
7310
72527
52
424
7310
72715
18
59
7344
73080
13
5
7349
73134
22
67
7339
73039
93
529
7247
72219
238
1688
6674
66284
Ostomy education
TJF80 [2001305042]
TJF80 [2001305042]
—
—
—
—
—
3.0e+00
3.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.14%
controls:0.01%
cases:0.51%
controls:0.02%
—
—
—
—
—
10
5
7330
72743
35
11
6877
67961
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
4.7e-02
5.9e-01
1.2e+00
—
1.7e+00
1.6e+00
1.2e+00
cases:3.90%
controls:3.72%
cases:2.05%
controls:1.15%
cases:0.52%
controls:0.16%
—
—
cases:0.72%
controls:0.14%
cases:4.51%
controls:0.92%
cases:8.15%
controls:2.48%
287
2724
7075
70410
151
840
7211
72299
38
116
7324
73023
—
53
100
7308
73006
331
669
7009
72079
563
1689
6349
66283
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
1.3e-01
4.1e-01
1.3e+00
2.7e+00
9.5e-01
5.3e-01
3.2e-01
cases:4.51%
controls:4.00%
cases:2.95%
controls:1.97%
cases:1.11%
controls:0.30%
cases:0.15%
controls:0.01%
cases:0.72%
controls:0.28%
cases:3.91%
controls:2.34%
cases:10.78%
controls:8.05%
332
2923
7030
70211
217
1438
7145
71701
82
218
7280
72921
11
7
7351
73132
53
205
7308
72901
287
1704
7053
71044
745
5471
6167
62501
Capsular endoscopy
UJF92 [2001305032]
UJF92 [2001305032]
5.9e-01
9.7e-01
—
—
—
3.7e+00
2.5e+00
cases:0.18%
controls:0.10%
cases:0.11%
controls:0.04%
—
—
—
—
—
—
cases:0.90%
controls:0.02%
cases:1.33%
controls:0.11%
13
72
7349
73062
8
30
7354
73109
—
—
—
66
16
7274
72732
92
72
6820
67900
Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
92687-3 [37020937]
92687-3 [37020937]
1.7e-01
2.2e+00
—
—
—
2.3e+00
1.7e+00
cases:0.07%
controls:0.06%
cases:0.27%
controls:0.03%
—
—
—
—
—
—
cases:0.31%
controls:0.03%
cases:0.54%
controls:0.10%
5
42
7357
73092
20
21
7342
73118
—
—
—
23
23
7317
72725
37
67
6875
67905
Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
88928-7 [36305771]
88928-7 [36305771]
1.4e-01
2.2e+00
—
—
—
2.3e+00
1.7e+00
cases:0.07%
controls:0.06%
cases:0.27%
controls:0.03%
—
—
—
—
—
—
cases:0.31%
controls:0.03%
cases:0.54%
controls:0.10%
5
43
7357
73091
20
21
7342
73118
—
—
—
23
23
7317
72725
37
67
6875
67905
Irritable bowel syndrome with diarrhoea
K58.0 [45596336]
K58.0 [45596336]
6.3e-01
1.8e+00
3.0e+00
—
—
8.0e-01
3.4e-01
cases:0.71%
controls:0.38%
cases:1.03%
controls:0.16%
cases:0.34%
controls:0.02%
—
—
—
—
cases:0.34%
controls:0.15%
cases:0.67%
controls:0.47%
52
276
7310
72858
76
120
7286
73019
25
13
7337
73126
—
—
25
111
7315
72637
46
322
6866
67650
Tissue Pathology biopsy report
66121-5 [40768804]
66121-5 [40768804]
9.8e-02
3.1e-01
1.4e+00
—
2.4e+00
1.2e+00
9.6e-01
cases:4.17%
controls:3.80%
cases:2.09%
controls:1.55%
cases:0.67%
controls:0.17%
—
—
cases:1.30%
controls:0.12%
cases:4.43%
controls:1.43%
cases:12.41%
controls:5.13%
307
2777
7055
70357
154
1132
7208
72007
49
123
7313
73016
—
96
87
7265
73019
325
1042
7015
71706
858
3490
6054
64482
MRI examination of bile and pancreas ducts with high intesity magnet
JL5BG [2001305383]
JL5BG [2001305383]
1.1e-01
1.5e+00
—
—
—
2.7e+00
1.9e+00
cases:0.10%
controls:0.08%
cases:0.12%
controls:0.03%
—
—
—
—
—
—
cases:0.35%
controls:0.02%
cases:0.75%
controls:0.11%
7
62
7355
73072
9
19
7353
73120
—
—
—
26
17
7314
72731
52
75
6860
67897
tofacitinib; oral
L04AF01 [955219]
L04AF01 [955219]
—
—
—
—
—
2.4e+00
3.7e+00
—
—
—
—
—
—
—
—
—
—
cases:0.19%
controls:0.02%
cases:0.78%
controls:0.02%
—
—
—
—
—
14
12
7326
72736
54
13
6858
67959
Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
63459-2 [40766189]
63459-2 [40766189]
5.8e-01
2.2e+00
3.4e+00
—
—
2.6e-01
3.4e-01
cases:0.65%
controls:0.37%
cases:0.88%
controls:0.10%
cases:0.33%
controls:0.01%
—
—
—
—
cases:0.16%
controls:0.13%
cases:0.62%
controls:0.45%
48
267
7314
72867
65
74
7297
73065
24
8
7338
73131
—
—
12
92
7328
72656
43
303
6869
67669
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
2.1e-01
3.9e-01
1.6e+00
—
1.7e+00
1.2e+00
1.0e+00
cases:5.03%
controls:4.09%
cases:1.82%
controls:1.23%
cases:0.49%
controls:0.10%
—
—
cases:0.48%
controls:0.09%
cases:2.94%
controls:0.91%
cases:8.64%
controls:3.27%
370
2994
6992
70140
134
903
7228
72236
36
71
7326
73068
—
35
65
7326
73041
216
661
7124
72087
597
2224
6315
65748
Immunohistochemistry procedure
117617002 [4035726]
117617002 [4035726]
-8.6e-02
3.8e-01
1.5e+00
1.0e+50
2.8e+00
1.8e+00
1.5e+00
cases:0.53%
controls:0.58%
cases:0.37%
controls:0.25%
cases:0.10%
controls:0.02%
cases:0.18%
controls:0.00%
cases:0.26%
controls:0.02%
cases:1.02%
controls:0.17%
cases:2.36%
controls:0.51%
39
422
7323
72712
27
184
7335
72955
7
15
7355
73124
13
0
7349
73139
19
12
7342
73094
75
121
7265
72627
163
349
6749
67623
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
14685-2 [3009035]
2.1e-01
3.1e-01
2.6e+00
—
1.5e+00
1.2e+00
8.7e-01
cases:2.06%
controls:1.68%
cases:0.95%
controls:0.70%
cases:1.25%
controls:0.10%
—
—
cases:0.31%
controls:0.07%
cases:2.36%
controls:0.75%
cases:6.55%
controls:2.86%
152
1227
7210
71907
70
511
7292
72628
92
71
7270
73068
—
23
50
7338
73056
173
544
7167
72204
453
1945
6459
66027
Acute pancreatitis, unspecified
K85.9 [45591611]
K85.9 [45591611]
—
1.8e+00
1.0e+50
—
—
2.5e+00
1.8e+00
—
—
cases:0.12%
controls:0.02%
cases:0.07%
controls:0.00%
—
—
—
—
cases:0.23%
controls:0.02%
cases:0.46%
controls:0.07%
—
9
15
7353
73124
5
0
7357
73139
—
—
17
14
7323
72734
32
50
6880
67922
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
-2.2e-02
1.9e-01
1.1e+00
3.4e+00
8.4e-01
3.9e-01
3.3e-01
cases:7.65%
controls:7.80%
cases:4.79%
controls:4.01%
cases:1.66%
controls:0.54%
cases:0.71%
controls:0.02%
cases:1.28%
controls:0.55%
cases:6.02%
controls:4.16%
cases:16.03%
controls:12.05%
563
5708
6799
67426
353
2933
7009
70206
122
397
7240
72742
52
17
7310
73122
94
404
7267
72702
442
3023
6898
69725
1108
8189
5804
59783
Adalimumab Ab [Units/volume] in Serum or Plasma
87742-3 [36304052]
87742-3 [36304052]
—
—
—
—
—
2.9e+00
3.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.19%
controls:0.01%
cases:1.16%
controls:0.05%
—
—
—
—
—
14
8
7326
72740
80
31
6832
67941
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
-1.3e-01
2.7e-01
1.8e+00
—
2.1e+00
1.2e+00
9.9e-01
cases:2.15%
controls:2.43%
cases:1.75%
controls:1.34%
cases:0.99%
controls:0.17%
—
—
cases:1.25%
controls:0.15%
cases:3.65%
controls:1.12%
cases:8.32%
controls:3.27%
158
1778
7204
71356
129
980
7233
72159
73
125
7289
73014
—
92
109
7269
72997
268
817
7072
71931
575
2224
6337
65748
ofloxacin; oral, parenteral
J01MA01 [21603008]
J01MA01 [21603008]
4.4e-01
7.8e-01
2.0e+00
—
2.3e+00
1.0e+00
7.7e-01
cases:0.76%
controls:0.49%
cases:0.29%
controls:0.13%
cases:0.11%
controls:0.02%
—
—
cases:0.08%
controls:0.01%
cases:0.35%
controls:0.13%
cases:0.95%
controls:0.45%
56
359
7306
72775
21
96
7341
73043
8
11
7354
73128
—
6
6
7355
73100
26
92
7314
72656
66
303
6846
67669
Varicella zoster virus IgG Ab [Units/volume] in Serum
8047-3 [3022575]
8047-3 [3022575]
—
9.1e-01
—
—
—
4.0e+00
2.0e+00
—
—
cases:0.07%
controls:0.03%
—
—
—
—
—
—
cases:0.46%
controls:0.01%
cases:0.69%
controls:0.09%
—
5
20
7357
73119
—
—
—
34
6
7306
72742
48
62
6864
67910
nizatidine; oral, parenteral
A02BA04 [21600085]
A02BA04 [21600085]
1.6e-01
1.1e+00
2.0e+00
—
2.0e+00
9.5e-01
5.9e-01
cases:0.49%
controls:0.42%
cases:0.27%
controls:0.09%
cases:0.12%
controls:0.02%
—
—
cases:0.10%
controls:0.01%
cases:0.26%
controls:0.10%
cases:0.42%
controls:0.23%
36
305
7326
72829
20
69
7342
73070
9
12
7353
73127
—
7
9
7354
73097
19
73
7321
72675
29
158
6883
67814
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
19231-0 [3004490]
-9.3e-01
-5.9e-02
1.8e+00
—
2.9e+00
8.3e-01
5.8e-01
cases:0.14%
controls:0.34%
cases:0.18%
controls:0.19%
cases:0.10%
controls:0.02%
—
—
cases:0.12%
controls:0.01%
cases:0.40%
controls:0.17%
cases:0.72%
controls:0.41%
10
252
7352
72882
13
137
7349
73002
7
12
7355
73127
—
9
5
7352
73101
29
126
7311
72622
50
276
6862
67696
adalimumab; parenteral
L04AB04 [21603911]
L04AB04 [21603911]
3.4e-01
6.1e-01
8.6e-01
—
1.1e+00
2.1e+00
2.7e+00
cases:0.26%
controls:0.18%
cases:0.26%
controls:0.14%
cases:0.12%
controls:0.05%
—
—
cases:0.22%
controls:0.07%
cases:1.21%
controls:0.15%
cases:3.60%
controls:0.24%
19
135
7343
72999
19
103
7343
73036
9
38
7353
73101
—
16
51
7345
73055
89
106
7251
72642
249
162
6663
67810
Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
1778-0 [3020013]
1778-0 [3020013]
1.3e+00
—
—
—
—
2.4e+00
2.3e+00
cases:0.16%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.18%
controls:0.02%
cases:0.52%
controls:0.05%
12
31
7350
73103
—
—
—
—
13
12
7327
72736
36
36
6876
67936
hyoscyamine; oral
A03BA03 [21600193]
A03BA03 [21600193]
1.4e+00
2.2e+00
—
—
—
—
2.5e+00
cases:0.14%
controls:0.03%
cases:0.10%
controls:0.01%
—
—
—
—
—
—
—
—
cases:0.17%
controls:0.01%
10
25
7352
73109
7
8
7355
73131
—
—
—
—
12
10
6900
67962
Adalimumab [Mass/volume] in Serum or Plasma
74117-3 [44786774]
74117-3 [44786774]
—
—
—
—
—
2.5e+00
3.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.03%
cases:1.82%
controls:0.06%
—
—
—
—
—
24
19
7316
72729
126
40
6786
67932
Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
34720-3 [3030558]
34720-3 [3030558]
—
—
—
1.0e+50
—
3.0e+00
2.9e+00
—
—
—
—
—
—
cases:0.07%
controls:0.00%
—
—
cases:0.31%
controls:0.02%
cases:0.67%
controls:0.04%
—
—
—
5
0
7357
73139
—
23
11
7317
72737
46
24
6866
67948
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
-1.4e-01
3.0e-01
2.0e+00
—
2.2e+00
1.0e+00
7.0e-01
cases:1.60%
controls:1.83%
cases:1.25%
controls:0.93%
cases:0.71%
controls:0.09%
—
—
cases:0.95%
controls:0.11%
cases:2.53%
controls:0.90%
cases:6.22%
controls:3.18%
118
1342
7244
71792
92
680
7270
72459
52
68
7310
73071
—
70
81
7291
73025
186
657
7154
72091
430
2162
6482
65810
saccharomyces boulardii; oral
A07FA02 [21600670]
A07FA02 [21600670]
4.1e-01
1.5e+00
2.6e+00
—
—
9.7e-01
8.6e-01
cases:0.84%
controls:0.56%
cases:0.72%
controls:0.17%
cases:0.20%
controls:0.02%
—
—
—
—
cases:0.45%
controls:0.17%
cases:1.62%
controls:0.69%
62
410
7300
72724
53
122
7309
73017
15
11
7347
73128
—
—
33
124
7307
72624
112
471
6800
67501
Abdominal CT examination
JN3AD [2001305554]
JN3AD [2001305554]
4.7e-02
1.2e+00
2.4e+00
—
1.4e+00
1.4e+00
9.5e-01
cases:0.31%
controls:0.30%
cases:0.54%
controls:0.17%
cases:0.20%
controls:0.02%
—
—
cases:0.11%
controls:0.03%
cases:0.76%
controls:0.19%
cases:2.23%
controls:0.87%
23
218
7339
72916
40
123
7322
73016
15
14
7347
73125
—
8
19
7353
73087
56
136
7284
72612
154
593
6758
67379
Simple MRI examination of bile and pancreas ducts with high intesity magnet
JL5AG [2001305380]
JL5AG [2001305380]
8.6e-01
—
—
—
—
2.7e+00
3.1e+00
cases:0.07%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.15%
controls:0.01%
cases:0.41%
controls:0.02%
5
21
7357
73113
—
—
—
—
11
7
7329
72741
28
12
6884
67960
Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
1777-2 [3001467]
1777-2 [3001467]
1.2e+00
—
—
—
—
2.4e+00
2.2e+00
cases:0.22%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.03%
cases:0.85%
controls:0.10%
16
47
7346
73087
—
—
—
—
26
23
7314
72725
59
68
6853
67904
Elastase.pancreatic [Mass/mass] in Stool
25907-7 [3000570]
25907-7 [3000570]
3.6e-01
1.6e+00
—
—
2.3e+00
1.1e+00
7.5e-01
cases:0.29%
controls:0.20%
cases:0.54%
controls:0.11%
—
—
—
—
cases:0.08%
controls:0.01%
cases:0.27%
controls:0.09%
cases:0.65%
controls:0.31%
21
146
7341
72988
40
78
7322
73061
—
—
6
6
7355
73100
20
66
7320
72682
45
210
6867
67762
Very extensive MRI examination of upper part of abdomen with high intensity magnet
JN1DG [2001305530]
JN1DG [2001305530]
-4.6e-02
1.0e+00
—
—
—
3.2e+00
2.6e+00
cases:0.07%
controls:0.07%
cases:0.08%
controls:0.03%
—
—
—
—
—
—
cases:0.44%
controls:0.02%
cases:0.77%
controls:0.06%
5
52
7357
73082
6
22
7356
73117
—
—
—
32
13
7308
72735
53
40
6859
67932
Ceruloplasmin [Mass/volume] in Serum or Plasma
2064-4 [3022756]
2064-4 [3022756]
—
1.6e+00
1.0e+50
—
1.0e+50
2.2e+00
2.0e+00
—
—
cases:0.14%
controls:0.03%
cases:0.07%
controls:0.00%
—
—
cases:0.07%
controls:0.00%
cases:0.27%
controls:0.03%
cases:0.62%
controls:0.08%
—
10
21
7352
73118
5
0
7357
73139
—
5
0
7356
73106
20
22
7320
72726
43
57
6869
67915
ustekinumab; parenteral
L04AC05 [21603919]
L04AC05 [21603919]
—
—
—
—
—
2.0e+00
3.7e+00
—
—
—
—
—
—
—
—
—
—
cases:0.23%
controls:0.03%
cases:1.48%
controls:0.04%
—
—
—
—
—
17
23
7323
72725
102
24
6810
67948
Percutaneous needle biopsy of liver
TJJ00 [2001305268]
TJJ00 [2001305268]
2.5e+00
1.0e+50
—
—
—
—
3.2e+00
cases:0.08%
controls:0.01%
cases:0.07%
controls:0.00%
—
—
—
—
—
—
—
—
cases:0.22%
controls:0.01%
6
5
7356
73129
5
0
7357
73139
—
—
—
—
15
6
6897
67966
Hemoglobin.gastrointestinal [Presence] in Stool
2335-8 [3016251]
2335-8 [3016251]
3.7e-01
2.2e+00
3.5e+00
—
—
—
-3.9e-01
cases:0.53%
controls:0.37%
cases:1.05%
controls:0.12%
cases:0.49%
controls:0.02%
—
—
—
—
—
—
cases:0.33%
controls:0.49%
39
268
7323
72866
77
87
7285
73052
36
11
7326
73128
—
—
—
23
334
6889
67638
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
K21.9 [45538509]
4.2e-01
5.7e-01
2.0e+00
—
1.6e+00
1.1e+00
9.9e-01
cases:0.79%
controls:0.52%
cases:0.37%
controls:0.21%
cases:0.11%
controls:0.02%
—
—
cases:0.11%
controls:0.02%
cases:0.68%
controls:0.23%
cases:1.81%
controls:0.68%
58
381
7304
72753
27
152
7335
72987
8
11
7354
73128
—
8
16
7353
73090
50
167
7290
72581
125
463
6787
67509
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
14731-4 [3019309]
-8.2e-02
4.0e-01
2.4e+00
—
1.5e+00
9.7e-01
8.4e-01
cases:1.51%
controls:1.63%
cases:0.79%
controls:0.53%
cases:0.57%
controls:0.05%
—
—
cases:0.27%
controls:0.06%
cases:1.23%
controls:0.47%
cases:3.50%
controls:1.55%
111
1195
7251
71939
58
388
7304
72751
42
39
7320
73100
—
20
46
7341
73060
90
340
7250
72408
242
1051
6670
66921
Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
87406-5 [36304617]
87406-5 [36304617]
—
—
—
—
—
2.5e+00
3.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.08%
controls:0.01%
cases:0.35%
controls:0.01%
—
—
—
—
—
6
5
7334
72743
24
10
6888
67962
Anoscopy
UJH02 [2001305182]
UJH02 [2001305182]
6.3e-01
1.5e+00
1.8e+00
1.0e+50
—
1.1e+00
1.2e+00
cases:0.38%
controls:0.20%
cases:0.27%
controls:0.06%
cases:0.10%
controls:0.02%
cases:0.10%
controls:0.00%
—
—
cases:0.19%
controls:0.07%
cases:0.68%
controls:0.21%
28
149
7334
72985
20
43
7342
73096
7
11
7355
73128
7
0
7355
73139
—
14
48
7326
72700
47
140
6865
67832
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
4071
24012
2.44
320.35
5.1
3.3
30.59
34.00
u/l
2.15
3774
22838
5012
30557
2.76
307.65
20.4
10.6
0.00
0.00
e9/l
2.82
4400
24931
6091
32529
4.84
307.65
15.1
6.4
56.91
56.78
%
0.44
5969
31254
347
21
172.80
307.65
3.1
2.8
—
—
—
0
0
6524
34965
6.03
307.65
15.7
6.4
0.56
0.57
e9/l
2.24
6058
30395
6961
49076
4.58
307.65
8.1
4.1
11.35
10.23
mm/h
10.95
6718
46458
5114
22620
4.59
307.65
13.4
6.5
—
3.66
—
0
5
1000
2073
5.38
307.65
1.8
1.2
69.66
135.05
titre
1.60
116
204
5988
29634
5.25
307.65
4.4
2.4
74.90
74.66
nmol/l
0.28
5848
27491
1812
5542
3.95
307.65
6.9
4.4
0.41
0.75
%
8.16
534
1611
6475
27566
8.56
307.65
10.6
5.1
37.10
36.42
g/l
26.07
6348
25999
6052
31942
4.85
307.65
15.8
6.6
0.76
0.68
%
29.60
5893
30113
6592
36206
6.01
307.65
15.9
6.7
0.19
0.19
e9/l
2.03
6145
32015
2772
4133
9.80
307.65
2.2
1.6
—
—
—
0
0
6522
9270
35.98
307.65
8.7
1.8
232.64
108.02
ug/g
83.88
6322
7323
2134
8635
3.02
307.65
3.6
3.2
4.23
4.50
e9/l
0.70
1905
7659
928
175
59.97
307.65
3.5
4.2
9.52
7.59
mg/l
3.71
782
127
942
1495
7.02
307.65
3.6
6.5
780.65
713.86
iu/ml
0.11
102
210
388
232
17.54
307.65
2.5
2.1
9.48
9.12
mg/l
0.38
337
195
6670
38838
5.67
307.65
17.1
9.8
3.89
4.07
e9/l
11.82
6190
33800
6118
33080
4.80
307.65
15.6
6.5
28.81
28.57
%
1.09
5991
31563
6070
31958
4.91
307.65
15.6
6.6
2.84
2.84
%
0.08
5912
30162
834
1818
5.01
307.65
1.2
1.3
27.97
61.44
u/ml
1.04
13
28
492
694
7.49
307.65
2.1
1.2
—
—
—
0
0
4036
16454
3.98
307.65
4.1
2.2
2.67
2.69
mg/l
0.25
3763
14361
939
1789
5.82
307.65
1.5
1.3
—
—
—
0
0
2011
2253
11.64
307.65
1.7
1.5
3.71
4.03
iu/ml
0.03
360
395
380
24
166.30
307.65
3.1
2.8
24.60
18.63
mg/l
1.79
365
24
6556
35876
5.92
307.65
15.7
6.4
1.86
1.95
e9/l
8.89
6140
31957
806
1691
5.20
307.65
1.3
1.3
261.54
251.41
u/ml
0.39
476
1085
767
166
51.08
307.65
2.8
3.1
119.71
152.75
au/ml
0.33
126
25
7480
49933
10.76
307.65
20.4
7.8
75.51
76.87
u/l
2.37
7405
47725
6527
35035
6.02
307.65
15.7
6.4
0.04
0.04
e9/l
3.67
6055
30439
2143
9280
2.80
307.65
2.8
2.7
22.60
23.74
%
3.37
2055
8711
2232
10106
2.69
307.52
2.8
2.6
2.42
2.36
g/l
5.88
2135
9424
2341
10924
2.63
302.71
2.9
2.6
13.59
13.86
umol/l
0.93
2250
10290
5156
34374
2.45
299.69
4.5
3.1
94.42
113.45
ug/l
7.64
4985
32611
1277
4314
3.34
298.13
2.1
1.9
1.26
1.29
g/l
0.31
1215
4015
261
176
15.30
296.20
2.0
1.7
82.20
152.75
au/ml
0.78
46
18
5031
33838
2.35
276.22
8.5
6.5
10.72
11.26
umol/l
2.86
4861
32300
1460
5573
2.99
275.12
2.9
2.8
11.61
10.52
g/l
22.16
1382
5171
385
554
7.25
254.76
1.5
1.2
283.50
205.78
titre
0.84
143
83
384
554
7.24
253.49
1.5
1.2
366.50
178.18
titre
0.58
20
11
1482
6064
2.78
242.97
3.6
2.4
0.23
0.22
g/l
9.93
1409
5690
159
64
25.33
227.31
1.0
1.0
—
—
—
0
0
2069
10257
2.38
224.90
1.7
1.4
553.25
515.01
titre
0.43
563
1986
3383
20880
2.09
209.82
4.2
2.7
60.40
62.69
u/l
0.25
3207
19502
533
1263
4.45
205.25
2.3
1.6
0.77
0.78
g/l
0.05
452
983
842
2803
3.24
197.40
1.8
1.7
—
—
—
0
0
619
1777
3.70
182.62
1.8
1.4
5.37
14.26
iu/ml
1.48
15
34
7652
67552
5.55
176.45
29.4
14.0
15.60
23.17
mg/l
143.31
7013
54803
305
512
6.16
173.63
2.7
1.4
—
—
—
0
0
379
779
5.06
173.23
1.7
1.4
—
—
—
0
0
375
768
5.08
172.11
1.7
1.4
—
—
—
0
0
374
766
5.08
171.63
1.7
1.4
—
—
—
0
0
2597
15406
2.02
171.25
1.8
1.5
2.46
2.32
g/l
3.23
1901
10031
411
935
4.58
166.16
1.4
1.2
—
—
—
0
0
574
1693
3.58
162.19
1.4
1.3
—
—
—
0
0
823
3019
2.93
161.79
1.3
1.4
—
—
—
0
0
3974
27583
1.89
161.28
12.7
12.4
1.15
1.20
inr
11.18
3438
22947
767
2765
2.97
155.37
1.9
1.6
5.75
17.64
iu/ml
2.31
100
60
344
729
4.89
151.51
1.7
1.4
—
—
—
0
0
345
733
4.88
151.48
1.7
1.4
—
—
—
0
0
344
735
4.85
150.02
1.7
1.4
—
—
—
0
0
7342
64292
3.07
146.67
23.7
13.1
89.72
87.76
ml/min/173m2
13.80
7035
58867
562
1775
3.33
142.28
1.3
1.1
—
—
—
0
0
562
1781
3.32
141.48
1.3
1.1
—
—
—
0
0
4213
30623
1.81
139.34
7.6
7.5
1.21
1.21
mmol/l
1.84
3669
26663
294
602
5.03
134.72
1.4
1.2
55.58
63.80
u/l
1.27
261
532
3795
27367
1.75
123.18
6.8
6.9
1.21
1.21
mmol/l
3.22
3572
25582
570
1976
3.03
122.97
6.2
3.7
166.80
2790.46
u/ml
1.18
523
1715
113
85
13.47
120.24
2.5
1.9
2.25
1.46
mg/l
3.25
100
73
372
1039
3.71
113.44
1.1
1.1
1.46
1.49
g/l
0.84
353
945
1255
6562
2.09
110.72
3.7
2.6
43.19
48.37
u/l
0.26
1131
5596
1439
7937
1.99
109.40
4.3
2.8
6.42
7.73
umol/l
2.41
1283
6946
2033
12570
1.83
108.97
2.5
1.7
35418223.52
31246945.81
pmol/l
0.12
1855
10782
88
50
17.79
108.58
1.1
1.1
20.38
27.45
u/ml
0.55
13
11
88
50
17.79
108.58
1.1
1.1
25.25
36.33
u/ml
0.40
19
16
160
239
6.81
101.89
1.8
1.9
10357.21
16618.92
u/ml
0.19
19
37
2603
17583
1.72
101.35
1.4
1.3
1.39
1.78
u/ml
0.92
679
5058
183
324
5.76
98.42
18.5
27.9
132.66
116.40
ug/l
1.99
165
251
185
331
5.70
98.40
1.8
1.5
5.87
6.10
u/l
0.08
155
271
220
477
4.72
94.06
1.1
1.1
1568.80
1473.65
miu/ml
0.58
220
477
189
361
5.34
93.64
1.5
1.2
83.67
91.81
u/l
0.39
158
303
185
347
5.44
93.51
1.5
1.2
21.57
23.57
u/l
0.13
156
288
2511
17113
1.69
92.75
6.3
4.2
93.64
91.68
%
4.28
2445
16751
3615
27091
1.62
91.16
2.2
2.0
96.20
96.64
pmol/l
0.23
2171
14854
1530
9139
1.84
89.34
2.1
1.7
1161.90
1156.07
nmol/l
0.08
1029
7143
6641
58339
1.88
88.17
31.3
17.1
13.64
13.44
%
34.16
6618
57597
7687
71741
3.89
86.94
33.1
17.2
76.22
76.08
umol/l
0.17
7661
70994
7667
71577
3.61
83.84
26.3
10.9
27.25
27.98
u/l
3.31
7629
69954
213
499
4.36
82.64
1.2
1.2
—
—
—
0
0
213
507
4.29
80.95
1.2
1.2
—
—
—
0
0
7314
66884
2.30
80.66
21.5
15.9
139.50
139.69
mmol/l
11.86
7202
65573
7327
67078
2.31
80.13
21.7
16.0
3.91
3.96
mmol/l
44.55
7202
65623
83
76
11.03
78.03
2.1
1.7
—
—
—
0
0
1008
5504
1.95
76.68
5.6
4.4
8.48
31.50
ug/l
2.58
782
4384
4486
36209
1.55
76.53
4.1
3.6
0.80
0.06
estimate
0.45
1258
6992
762
3767
2.13
76.26
1.5
1.4
—
—
—
0
0
4462
36013
1.55
75.81
4.1
3.6
6.03
4.56
estimate
0.24
1302
7367
4417
35650
1.54
74.41
4.1
3.5
0.00
0.00
estimate
2.33
1288
7311
305
990
3.16
73.21
3.3
3.4
0.87
1.62
%
4.40
279
894
213
549
3.96
72.72
1.1
1.1
—
0.60
—
0
6
2381
16866
1.59
71.17
1.7
1.6
20.07
19.80
nmol/l
0.39
2139
14686
119
199
6.06
67.91
1.2
1.3
—
—
—
0
0
2602
19067
1.54
65.82
4.3
3.7
0.00
0.00
estimate
0.63
1236
6783
4624
38220
1.51
65.69
5.8
5.2
6.56
6.59
mmol/l
0.58
4389
35913
415
1701
2.52
64.14
1.3
1.5
14.30
20.89
u/ml
—
5
36
325
1192
2.80
62.70
6.0
3.7
132.68
727.68
u/ml
1.69
297
1095
386
1568
2.54
60.76
1.4
1.5
140.62
147.71
au/ml
0.40
75
459
1110
6829
1.73
56.08
2.4
2.3
336.10
375.66
nmol/l
10.17
1040
6342
3453
27446
1.46
56.01
4.1
3.4
0.03
0.13
estimate
0.57
1155
6114
321
1261
2.61
54.10
2.7
3.1
962.68
1038.73
u/ml
0.05
22
62
80
114
7.08
53.24
1.4
1.2
—
—
—
0
0
2665
20298
1.47
53.10
3.7
2.9
0.01
0.10
estimate
1.33
1149
5883
1078
6675
1.71
52.98
3.6
2.8
1.83
1.77
%
1.10
992
6017
134
314
4.32
52.02
1.2
1.1
13.63
24.28
u/l
2.73
123
289
134
315
4.31
51.81
1.2
1.1
67.09
84.68
u/l
2.04
125
289
200
634
3.21
49.94
1.1
1.1
278.99
284.95
mg/l
0.53
182
584
831
4972
1.75
45.79
2.8
2.7
73.13
70.92
e9/l
0.78
616
3594
192
631
3.09
45.14
3.2
3.4
55.37
57.01
%
0.56
170
549
377
1742
2.22
44.22
3.3
3.0
1.36
2.28
index
2.31
214
918
104
237
4.43
41.90
1.5
1.4
—
—
—
0
0
104
237
4.43
41.90
1.5
1.4
—
—
—
0
0
127
336
3.83
41.89
1.4
1.4
—
—
—
0
0
127
345
3.73
40.34
1.4
1.4
—
—
—
0
0
436
2225
2.02
39.40
3.9
4.1
1.35
1.42
mg/l
1.26
407
2077
644
3734
1.79
39.32
1.1
1.1
171.00
170.90
titre
—
10
122
2878
23159
1.38
38.81
3.6
3.3
—
1.99
—
0
15
4873
42632
1.37
38.75
4.7
4.2
1186.47
1194.04
e6/l
0.00
60
551
271
1169
2.37
37.37
1.3
1.3
134.00
206.40
titre
—
10
25
268
1158
2.36
36.81
1.3
1.3
403.94
459.73
titre
0.18
52
73
1232
8582
1.52
35.96
8.9
8.0
104.65
104.45
mmol/l
0.94
1232
8576
110
296
3.75
35.46
1.3
1.2
—
—
—
0
0
113
313
3.65
34.93
1.6
1.7
3210.59
3160.89
titre
0.02
34
45
1202
8378
1.51
34.89
6.5
6.9
1.02
1.04
mmol/l
1.87
1145
7874
93
228
4.12
34.13
1.2
1.2
—
—
—
0
0
1630
12120
1.43
33.90
1.3
1.3
6.28
9.98
u/ml
2.17
596
5000
3690
31344
1.33
33.23
3.3
2.8
—
—
estimate
—
0
0
1873
14325
1.40
33.09
2.9
2.7
5.50
5.58
e6/l
0.08
1749
13065
2292
18150
1.37
32.74
3.4
3.2
0.41
0.34
e6/l
0.83
1776
13101
2598
21024
1.35
32.14
3.6
3.3
67.96
80.63
e6/l
0.25
2096
15878
2973
24590
1.34
31.62
4.1
3.8
71.81
76.61
e6/l
0.10
2224
17015
167
626
2.70
30.97
1.2
1.3
78.79
81.21
0.19
21
33
7699
74670
2.34
29.42
40.5
21.3
271.33
253.71
e9/l
91.15
7664
73387
7700
74693
2.34
29.25
40.2
21.2
91.39
90.46
fl
60.91
7683
74087
7700
74700
2.33
29.12
40.9
21.7
40.91
41.71
%
3.85
7680
74058
7700
74705
2.33
29.03
40.4
21.2
4.52
4.58
e12/l
29.88
7654
73271
7701
74719
2.34
29.02
40.5
21.3
6.79
6.69
e9/l
4.05
7654
73262
511
3030
1.73
28.67
1.8
1.9
6.47
6.60
iu/ml
0.04
120
735
7700
74728
2.32
28.61
40.6
21.4
136.23
137.76
g/l
19.11
7683
74128
1434
10719
1.41
28.31
4.3
3.8
0.81
0.82
mmol/l
3.69
1354
10190
1359
10063
1.42
28.30
2.1
1.9
—
—
—
0
0
1595
12159
1.39
28.04
3.0
2.8
543.66
541.99
mosm/kgh2o
0.10
1454
10693
1707
13170
1.38
27.87
1.3
1.3
25.01
29.97
iu/ml
0.62
506
3895
5550
50715
1.32
26.25
4.9
3.3
52.73
44.17
u/l
9.70
5306
48500
1927
15306
1.34
25.77
2.0
1.9
1.15
1.09
mg/l
0.42
1517
11605
187
814
2.33
25.34
1.3
1.4
0.39
0.38
g/l
0.04
122
588
187
814
2.33
25.34
1.3
1.4
7.92
6.57
g/l
4.29
124
587
187
815
2.33
25.27
1.3
1.4
2.88
2.98
g/l
0.31
122
590
349
1926
1.85
24.93
1.6
1.4
281.72
284.77
ug/g
0.10
209
1088
830
5726
1.50
24.76
9.5
8.7
8.74
9.09
mmol/l
0.80
793
5526
2024
16286
1.33
24.56
2.9
2.3
—
—
—
0
0
696
4703
1.53
22.84
4.1
4.0
1.22
1.23
mmol/l
0.37
622
4121
2538
21272
1.28
22.26
3.5
3.5
2.35
2.35
mmol/l
1.24
2335
19614
856
6105
1.45
21.44
3.3
3.2
—
—
—
0
0
973
7114
1.42
21.27
4.0
4.7
223.37
237.69
u/l
3.93
929
6779
2733
23268
1.27
20.71
3.6
3.4
41.85
59.78
ng/l
0.86
1715
14209
102
375
2.74
19.79
2.1
1.9
2.13
1.92
umol/l
1.22
96
343
429
2688
1.63
19.49
1.9
1.8
1.44
1.47
g/l
0.23
378
2338
847
6162
1.42
18.93
4.9
4.2
1.63
1.73
mmol/l
0.31
731
5412
989
7403
1.38
18.70
1.9
1.8
—
—
—
0
0
75
243
3.11
18.29
3.7
2.8
0.61
0.61
mmol/l
0.17
75
243
939
7038
1.38
17.55
2.0
1.8
—
—
—
0
0
331
2019
1.67
16.73
1.1
1.1
2.73
5.95
eliau/ml
1.50
34
296
847
6306
1.38
16.45
5.0
4.2
5.82
5.83
kpa
0.09
823
6144
430
2816
1.56
16.22
1.3
1.3
0.26
1.05
u/ml
2.97
20
219
362
2307
1.60
15.37
1.6
1.8
1.19
1.19
g/l
0.11
341
2208
352
2233
1.60
15.23
1.6
1.8
0.22
0.23
g/l
1.09
330
2131
545
3815
1.46
14.93
1.5
1.8
0.23
0.31
mg/l
3.31
243
1877
448
3036
1.50
14.44
1.8
2.0
39.11
39.88
u/l
0.36
394
2769
105
462
2.29
14.08
2.8
2.6
91.70
96.85
%
0.84
99
437
2340
20233
1.22
13.99
2.9
2.7
0.16
0.06
0.62
31
332
702
5221
1.38
13.65
2.9
2.7
71.95
71.96
ml/min/173m2
0.00
305
2130
269
1642
1.66
13.62
1.2
1.3
4.34
5.66
u/ml
0.17
19
101
102
458
2.24
13.07
1.5
1.6
24.86
23.12
umol/l
0.23
97
424
1381
11370
1.26
12.81
3.1
2.8
0.92
1.02
e6/l
0.38
766
5866
270
1682
1.63
12.64
1.7
1.6
—
—
—
0
0
1277
10435
1.27
12.60
3.2
3.0
2.34
2.44
e6/l
0.15
659
4902
134
680
1.99
12.50
1.0
1.1
—
—
—
0
0
602
4446
1.38
12.20
4.1
4.3
87.03
89.77
ng/l
0.26
535
3941
635
4736
1.37
12.11
2.5
2.6
67.38
66.81
g/l
1.09
608
4415
330
2177
1.54
12.10
1.2
1.3
25.92
31.20
u/ml
0.13
12
117
217
1300
1.69
11.84
2.5
2.6
16.81
16.90
%
0.15
212
1276
1933
16636
1.21
11.71
1.7
1.7
—
—
—
0
0
308
2025
1.54
11.48
1.2
1.3
7.17
4.74
u/ml
0.34
31
184
760
5875
1.32
11.43
9.0
9.7
121.24
123.27
g/l
1.95
741
5742
208
1245
1.69
11.41
2.4
2.4
13.55
6.63
umol/l
2.33
162
915
588
4378
1.37
11.33
9.0
9.0
24.68
24.78
mmol/l
0.29
581
4358
306
2025
1.53
11.09
1.2
1.3
11.42
9.40
u/ml
0.26
46
287
796
6249
1.30
10.69
8.6
9.2
96.57
95.86
%
3.39
761
6041
98
477
2.07
10.34
1.5
1.7
—
—
—
0
0
186
1116
1.68
10.16
1.9
1.7
—
—
—
0
0
269
1769
1.54
10.07
1.8
1.6
—
—
—
0
0
493
3639
1.38
10.04
1.1
1.1
1.19
11.64
u/ml
—
8
35
1845
16005
1.20
10.04
3.7
3.5
0.38
0.17
0.39
13
135
173
1024
1.70
9.94
1.5
1.4
—
—
—
0
0
1847
16036
1.20
9.94
3.9
3.6
1.02
1.21
kg/l
0.80
1242
10437
6470
62285
1.22
9.77
5.0
5.1
1.69
1.82
mu/l
17.71
6136
58719
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
279
1868
1.51
9.62
3.6
3.6
0.34
0.33
iu/ml
0.09
153
1004
40
133
3.02
9.51
3.5
3.4
4.63
252.59
ug/l
0.61
40
133
290
1963
1.50
9.49
2.5
2.6
—
—
—
0
0
283
1907
1.50
9.47
2.0
2.1
11.46
11.23
mg/l
0.19
263
1802
1990
17460
1.19
9.44
2.8
2.6
335.34
339.08
umol/l
0.89
1817
15806
332
2312
1.46
9.42
1.9
2.0
6.60
2.13
ug/l
0.51
297
2089
153
894
1.73
9.25
1.2
1.3
6.25
58.79
u/ml
—
6
49
323
2248
1.46
9.20
2.3
2.3
3.90
3.72
g/l
1.47
305
2096
323
2250
1.45
9.16
2.3
2.3
4.31
4.23
g/l
0.92
305
2097
323
2251
1.45
9.14
2.3
2.3
7.24
7.27
g/l
0.09
305
2096
259
1732
1.51
9.01
3.3
3.5
37.35
56.66
mg/l
1.23
217
1472
259
1733
1.51
8.98
3.3
3.5
43.44
51.91
mg/l
0.84
218
1472
476
3560
1.36
8.95
11.3
11.4
16.22
16.19
%
0.06
464
3435
58
242
2.41
8.92
2.8
3.4
0.94
1.30
%
1.11
58
242
554
4252
1.33
8.76
1.0
1.1
—
—
—
0
0
536
4096
1.33
8.73
4.8
3.7
5.03
5.14
kpa
3.29
513
3938
202
1291
1.58
8.63
1.5
1.4
—
—
—
0
0
209
1348
1.57
8.59
1.5
1.4
—
—
—
0
0
105
561
1.88
8.56
4.4
3.3
13.32
13.80
index
0.22
77
364
77
369
2.10
8.54
4.6
3.5
0.79
0.88
index
0.24
77
364
162
985
1.66
8.48
1.3
1.3
—
—
—
0
0
176
1093
1.62
8.48
1.4
1.4
11.47
10.99
u/ml
—
6
21
321
2268
1.43
8.46
3.0
2.9
3.46
3.53
g/l
0.40
299
2162
663
5239
1.29
8.46
4.4
3.6
4.56
4.69
kpa
0.74
641
5093
239
1597
1.51
8.37
1.5
1.4
—
—
—
0
0
861
7034
1.25
8.34
8.4
8.7
5.02
5.10
kpa
1.68
827
6777
861
7034
1.25
8.34
8.4
8.7
13.16
12.79
kpa
1.29
827
6779
1346
11515
1.20
8.34
3.0
2.9
2.44
2.43
mmol/l
1.13
1201
10317
67
307
2.19
8.33
1.6
1.9
—
—
—
0
0
67
307
2.19
8.33
1.6
1.9
—
—
—
0
0
67
307
2.19
8.33
1.6
1.9
—
—
—
0
0
67
307
2.19
8.33
1.6
1.9
—
—
—
0
0
339
2427
1.41
8.31
2.3
2.5
96.42
94.03
%
1.08
323
2346
5547
52914
1.16
8.29
4.1
4.3
14.73
14.59
pmol/l
4.29
5183
49395
854
6979
1.25
8.25
8.3
8.7
0.68
0.83
mmol/l
0.51
708
5728
222
1468
1.53
8.18
3.5
3.0
29.68
35.29
umol/l
4.84
204
1352
205
1335
1.55
8.10
3.2
4.1
2.40
2.38
mmol/l
0.04
133
888
205
1336
1.55
8.07
3.2
4.1
4.95
5.01
kpa
0.71
199
1316
719
5778
1.27
8.02
8.8
8.6
1.32
1.33
mmol/l
0.17
707
5666
139
826
1.70
7.97
1.8
1.5
—
—
—
0
0
328
2353
1.41
7.96
2.2
2.0
—
—
—
0
0
1145
9690
1.21
7.92
2.5
2.3
29.64
29.56
s
0.19
1109
9444
302
2139
1.43
7.88
2.4
2.3
2.98
2.88
g/l
0.89
284
1986
99
534
1.86
7.88
2.1
2.6
180.67
225.29
e6/l
1.14
82
444
314
2242
1.42
7.84
2.6
2.8
187.88
183.05
%
0.44
292
2141
53
226
2.35
7.82
1.3
1.3
16.50
16.65
umol/l
0.08
48
192
332
2396
1.40
7.80
5.2
5.8
0.93
0.88
%
1.38
315
2255
192
1244
1.56
7.77
1.5
1.5
—
—
—
0
0
357
2614
1.38
7.70
5.0
5.5
1.62
1.68
%
0.46
340
2463
643
5123
1.28
7.69
2.7
2.4
0.37
0.40
e6/l
0.15
623
4864
96
518
1.86
7.64
2.0
2.5
457.20
531.12
e6/l
0.81
75
411
236
1607
1.48
7.58
6.0
3.5
8.72
8.56
kpa
0.85
229
1568
243
1665
1.47
7.57
1.2
1.3
32.80
40.89
u/ml
0.29
19
144
475
3644
1.32
7.56
6.1
7.4
24.24
24.41
mmol/l
0.49
454
3483
273
1919
1.44
7.45
2.4
2.3
10.67
10.24
g/l
0.74
253
1753
228
1548
1.49
7.44
3.4
3.3
3.41
2.73
ratio
0.15
134
865
454
3471
1.33
7.41
4.8
3.6
1.44
1.58
mmol/l
0.36
329
2556
95
523
1.83
7.13
1.6
1.6
—
—
—
0
0
95
523
1.83
7.13
1.6
1.6
—
—
—
0
0
95
523
1.83
7.13
1.6
1.6
—
—
—
0
0
234
1616
1.46
7.03
2.5
2.2
0.00
0.00
g/l
0.50
205
1436
298
2157
1.40
6.92
4.2
3.0
23.99
24.57
mmol/l
1.95
293
2125
644
5200
1.26
6.91
1.3
1.3
252.53
243.10
u/ml
0.06
608
4861
738
6052
1.24
6.90
2.1
2.0
0.04
0.02
estimate
0.32
155
1364
175
1153
1.53
6.64
1.1
1.1
2.19
3.52
eliau/ml
1.89
71
593
294
2148
1.38
6.48
2.1
1.9
—
—
—
0
0
411
3163
1.32
6.44
2.1
2.1
0.02
0.25
estimate
0.49
132
1073
271
1956
1.40
6.43
2.6
2.4
0.76
0.82
g/l
0.10
239
1720
239
1691
1.43
6.35
2.5
2.2
0.01
0.02
g/l
0.12
216
1544
133
833
1.61
6.31
1.9
1.6
—
—
—
0
0
25
672
0.37
6.26
11.3
22.6
1262.20
2804.45
nmol/l
0.56
25
650
347
2623
1.34
6.17
4.4
3.6
24.90
25.24
mmol/l
0.89
333
2525
184
1246
1.49
6.16
4.4
3.0
91.58
90.69
%
1.46
178
1215
181
1230
1.48
5.97
6.3
7.8
11.48
11.42
mmol/l
0.08
166
1104
181
1231
1.48
5.94
6.4
7.8
104.93
105.14
mmol/l
0.25
166
1105
184
1260
1.47
5.85
1.3
1.3
4.64
3.97
u/ml
0.39
90
596
214
1509
1.43
5.83
2.6
2.3
0.00
0.00
g/l
-0.00
203
1434
44
202
2.18
5.57
1.4
1.5
—
—
—
0
0
82
469
1.76
5.52
2.0
1.5
—
—
—
0
0
186
1292
1.45
5.51
1.3
1.3
5.30
3.24
u/ml
0.93
92
471
33
134
2.47
5.51
1.6
1.5
0.45
0.35
ug/l
0.50
28
99
2123
19352
1.13
5.50
2.3
2.2
216.58
217.57
u/l
0.01
2022
18458
507
4099
1.25
5.42
10.5
11.0
95.14
94.02
%
8.70
499
4087
204
1452
1.42
5.31
2.6
2.3
130.60
132.69
g/l
0.63
167
1146
6176
59945
1.14
5.31
31.1
17.5
332.23
333.55
g/l
25.13
6165
59628
1752
15806
1.14
5.30
3.2
3.1
1376.68
1132.36
ng/l
1.16
1449
13315
324
2486
1.32
5.25
1.3
1.3
—
—
—
0
0
12
18
6.67
5.24
1.0
1.1
269.67
290.39
u/ml
0.14
12
18
70
390
1.80
5.17
1.2
1.2
—
—
—
0
0
1266
11192
1.16
5.12
1.6
1.5
—
—
—
0
0
15
31
4.85
5.11
1.0
1.1
—
—
—
0
0
476
3851
1.25
5.08
4.2
3.5
130.64
131.55
g/l
0.35
458
3750
29
116
2.51
5.02
3.0
3.1
25.23
35.25
mg/l
—
10
28
152
1038
1.47
4.96
2.5
2.5
22.49
30.31
iu/ml
0.33
13
80
1343
11949
1.15
4.96
3.5
3.7
525.81
536.56
ng/l
0.02
918
8408
488
3971
1.24
4.95
10.7
11.1
0.65
0.64
%
0.25
483
3946
165
1159
1.43
4.67
1.9
2.0
5.36
5.21
mmol/24h
0.24
151
1054
40
191
2.10
4.65
1.4
1.6
10.87
8.58
ug/l
1.53
40
191
435
3522
1.25
4.64
1.8
1.7
—
—
—
0
0
48
246
1.96
4.61
5.3
4.0
—
—
—
0
0
404
3248
1.26
4.58
1.5
1.5
—
—
—
0
0
497
4089
1.23
4.58
10.4
10.8
1.21
1.36
%
4.46
490
4063
111
723
1.54
4.57
1.7
1.7
—
—
—
0
0
94
589
1.60
4.57
1.3
1.2
—
—
—
0
0
70
411
1.71
4.38
1.1
1.2
8.86
8.50
mm/h
0.11
70
411
31
137
2.27
4.37
1.3
1.2
10.24
12.25
pmol/l
0.18
14
54
69
405
1.71
4.33
1.9
1.5
—
—
—
0
0
66
384
1.72
4.28
1.9
1.5
—
—
—
0
0
98
633
1.56
4.22
1.3
1.2
—
—
—
0
0
95
612
1.56
4.14
1.3
1.2
—
—
—
0
0
95
613
1.56
4.12
1.3
1.2
—
—
—
0
0
2096
19382
1.11
4.04
3.7
3.6
43.74
52.74
mg/l
1.38
1414
12761
86
546
1.58
4.01
2.2
1.8
—
—
—
0
0
135
950
1.43
3.86
1.1
1.2
—
—
—
0
0
62
367
1.69
3.82
1.9
1.5
—
—
—
0
0
15
49
3.07
3.80
1.3
3.5
—
—
—
0
0
242
1873
1.30
3.79
1.6
1.8
—
—
—
0
0
104
699
1.49
3.77
1.3
1.2
—
—
—
0
0
164
1199
1.38
3.77
1.1
1.1
125.36
114.48
%
4.58
151
1104
311
2486
1.26
3.77
1.6
1.5
—
—
—
0
0
131
922
1.43
3.75
1.1
1.1
99.46
97.69
%
0.32
125
868
22
90
2.45
3.71
2.0
1.7
—
—
—
0
0
248
1932
1.29
3.70
3.2
4.1
1.37
1.41
mmol/l
0.21
236
1900
2116
19667
1.10
3.64
4.5
4.3
7.21
9.26
mg/mmol
1.58
1394
12752
163
1199
1.37
3.62
1.6
1.3
—
—
—
0
0
163
1199
1.37
3.62
1.6
1.3
—
—
—
0
0
84
547
1.54
3.55
2.7
2.2
1.19
1.19
mmol/l
0.47
84
537
75
476
1.58
3.55
1.1
1.2
1.05
1.06
ratio
0.44
60
395
348
2843
1.23
3.50
3.7
3.0
1.02
1.02
ratio
0.06
324
2546
86
566
1.53
3.47
2.7
2.2
3.99
4.05
mmol/l
0.62
86
556
86
566
1.53
3.47
2.7
2.2
106.02
105.49
mmol/l
0.51
86
556
96
651
1.48
3.38
1.8
1.8
—
—
—
0
0
911
10187
0.88
3.24
1.8
1.9
3.56
3.57
ratio
0.11
665
7694
674
7689
0.87
3.22
1.5
1.6
3.48
3.49
mmol/l
0.15
427
5169
88
593
1.49
3.21
1.3
1.2
—
—
—
0
0
239
2997
0.79
3.18
1.7
1.8
4.18
4.25
mg/l
0.04
185
2170
56
343
1.64
3.10
1.3
1.2
1220.00
1037.88
titre
—
10
66
43
247
1.74
3.02
1.1
1.1
7.00
4.36
u/ml
—
5
11
212
1671
1.28
2.96
1.5
1.4
—
—
—
0
0
50
302
1.66
2.94
1.7
1.5
4.50
3.50
%
0.18
12
70
57
361
1.58
2.79
1.5
1.3
227.41
379.01
u/l
1.30
51
334
164
1264
1.30
2.75
1.1
1.1
—
—
—
0
0
50
310
1.62
2.69
6.1
6.1
4235.53
693.89
mg/l
0.39
40
226
9
24
3.75
2.67
1.1
1.1
—
—
—
0
0
183
1440
1.28
2.64
1.1
1.1
21.55
14.90
au/ml
0.50
60
402
59
385
1.54
2.57
1.2
1.1
—
—
—
0
0
38
222
1.72
2.56
1.7
2.1
—
—
—
0
0
38
222
1.72
2.56
1.7
2.1
—
—
—
0
0
38
223
1.71
2.53
1.7
2.1
—
—
—
0
0
57
371
1.54
2.52
2.1
1.4
16.89
20.81
u/ml
—
9
63
60
397
1.52
2.47
1.2
1.2
—
—
—
0
0
2363
22399
1.08
2.45
3.5
3.6
8.51
8.22
mmol/l
1.94
2063
19492
79
555
1.43
2.42
1.8
1.5
30.67
31.71
%
0.09
46
346
56
369
1.52
2.36
1.1
1.1
9.56
16.03
u/ml
—
9
40
59
395
1.50
2.32
1.4
1.7
1.22
1.27
nmol/l
0.14
48
295
335
2852
1.18
2.31
1.7
1.7
10.01
13.26
u/ml
0.69
56
806
2979
28529
1.07
2.30
2.0
1.9
1.40
1.40
mmol/l
0.22
2543
24769
160
1264
1.27
2.28
1.5
1.6
—
—
—
0
0
13
53
2.46
2.27
1.0
1.6
231.92
322.19
umol/24h
1.84
13
53
55
365
1.51
2.26
1.6
2.3
95.41
154.47
umol/l
1.01
27
185
425
3696
1.16
2.25
11.7
11.0
23.87
24.22
mmol/l
1.65
418
3631
51
334
1.53
2.23
1.4
1.3
70.00
76.09
titre
—
5
23
91
667
1.37
2.21
2.5
2.1
20.97
21.19
mg/l
0.02
39
254
264
2212
1.20
2.19
5.5
3.9
24.52
24.71
mmol/l
0.59
247
2059
15
67
2.24
2.17
1.5
1.6
5.39
2.02
mg/l
—
7
41
23
122
1.89
2.15
1.1
1.1
—
—
—
0
0
555
4939
1.13
2.12
1.5
1.4
—
—
—
0
0
57
388
1.47
2.10
1.3
1.2
—
—
—
0
0
77
555
1.39
2.09
1.1
1.2
105.19
110.33
pmol/l
0.41
77
555
20
103
1.94
2.04
1.9
1.6
—
—
—
0
0
93
695
1.34
2.03
5.9
5.7
7.03
7.28
mmol/l
0.28
81
589
63
444
1.42
1.96
1.5
1.4
5.64
6.38
u/l
0.65
50
387
24
134
1.79
1.94
1.7
1.5
1033.33
4295.00
u/ml
—
6
10
19
98
1.94
1.94
1.1
1.4
—
—
—
0
0
5
11
4.55
1.94
1.0
1.0
1.40
1.45
u/field
—
5
11
249
2104
1.19
1.92
1.2
1.2
3.47
4.15
0.74
35
348
70
505
1.39
1.91
2.8
2.6
38.01
28.04
mg/l
1.37
56
356
93
707
1.32
1.84
1.9
1.6
54.98
56.83
%
0.16
58
446
25
145
1.73
1.80
2.8
3.8
73.72
71.05
u/l
0.04
25
140
471
4200
1.13
1.79
3.2
3.0
183.01
166.49
ng/l
0.31
426
3770
514
4608
1.12
1.78
2.5
2.3
6.99
8.10
ug/l
0.66
463
4141
21
116
1.81
1.78
1.5
1.8
5.38
326810.71
nmol/l
0.88
16
97
444
3946
1.13
1.78
2.3
2.5
5413.16
6549.03
u/l
0.31
162
1556
14
67
2.09
1.75
1.6
1.6
1.65
4.89
mg/l
—
7
42
14
67
2.09
1.75
1.6
1.6
1.04
2.57
mg/l
—
9
45
86
1118
0.77
1.69
4.0
5.9
331.55
365.70
umol/l
1.37
73
990
32
204
1.57
1.64
2.7
4.3
4.78
4.90
kpa
0.27
32
204
32
204
1.57
1.64
2.7
4.3
10.40
10.57
kpa
0.14
32
204
162
1340
1.21
1.62
1.4
1.6
—
—
—
0
0
5
14
3.57
1.61
1.0
1.0
—
—
—
0
0
14
70
2.00
1.59
1.1
1.6
—
—
—
0
0
51
363
1.41
1.56
1.2
1.3
140.85
136.47
nmol/l
0.31
51
363
42
289
1.46
1.54
1.2
1.6
1.53
3.75
u/field
1.79
34
217
138
1131
1.22
1.53
1.1
1.1
2.67
2.94
0.17
17
234
33
217
1.52
1.50
1.1
1.4
143.51
129.77
nmol/l
0.16
25
164
156
1866
0.83
1.49
1.1
1.1
6.34
6.36
u/ml
0.01
79
1044
15
79
1.90
1.49
1.1
1.2
83.80
56.95
%
—
5
38
19
109
1.74
1.46
1.3
1.1
40.71
58.09
ng/l
—
10
66
354
3148
1.13
1.46
1.3
1.3
243.58
225.45
miu/ml
0.37
157
1471
180
2118
0.85
1.44
1.1
1.1
1.41
2.21
u/ml
1.00
91
1145
39
552
0.71
1.39
1.2
1.5
13391.12
73221.51
e6/l
2.73
25
310
11
53
2.08
1.38
2.1
6.4
—
—
—
0
0
166
1402
1.19
1.38
2.0
2.5
1.00
0.87
nmol/l
1.11
148
1195
46
330
1.40
1.38
1.1
1.1
94.88
95.61
%
0.07
34
272
25
385
0.65
1.37
3.6
3.3
35.00
45.01
%
2.50
25
385
41
289
1.42
1.36
1.5
1.4
—
—
—
0
0
41
289
1.42
1.36
1.5
1.4
—
—
—
0
0
25
384
0.65
1.36
7.2
6.5
10.64
8.55
%
1.22
25
384
87
690
1.26
1.33
1.4
1.3
1.57
1.48
nmol/l
0.30
75
620
47
639
0.73
1.32
1.3
1.5
2481.43
3899.36
e6/l
0.47
35
445
73
567
1.29
1.32
3.8
4.0
—
—
—
0
0
152
1798
0.84
1.32
1.1
1.1
0.46
1.29
u/ml
4.04
68
821
27
177
1.53
1.28
1.2
1.2
—
—
—
0
0
18
107
1.68
1.25
1.1
1.0
—
—
—
0
0
12
216
0.55
1.24
1.8
2.2
14.57
15.61
umol/l
0.13
12
216
39
278
1.40
1.24
1.7
1.9
—
—
—
0
0
29
195
1.49
1.23
1.1
1.1
—
—
—
0
0
12
63
1.91
1.22
1.6
1.5
—
—
—
0
0
14
78
1.80
1.21
1.0
1.2
2.74
1.69
iu/ml
—
8
37
32
221
1.45
1.20
1.4
1.6
41.54
40.36
g/l
0.53
32
221
178
1534
1.16
1.20
1.6
1.6
15915.19
12969.51
e6/l
0.21
134
1074
81
648
1.25
1.18
3.6
3.5
11.12
10.59
mmol/l
0.73
81
638
51
671
0.76
1.18
2.0
2.8
—
—
—
0
0
36
256
1.41
1.17
2.3
2.4
—
—
—
0
0
11
57
1.93
1.16
1.0
1.1
—
—
—
0
0
57
437
1.31
1.16
2.7
2.3
742.00
637.75
ml
0.98
43
311
233
2637
0.88
1.15
1.5
1.5
1.18
1.21
ratio
0.14
142
1607
233
2637
0.88
1.15
1.5
1.5
0.97
0.94
ratio
0.38
141
1598
229
2593
0.88
1.14
1.5
1.5
—
—
—
0
0
25
166
1.51
1.14
1.2
1.2
76.33
79.45
%
—
6
47
74
589
1.26
1.14
1.1
1.1
9.16
8.99
iu/ml
0.02
19
172
113
943
1.20
1.12
1.4
1.4
379.13
325.26
pmol/l
0.86
99
816
7
30
2.33
1.12
2.3
2.3
—
—
—
0
0
233
2630
0.88
1.12
1.5
1.5
1.09
1.16
ratio
0.52
141
1590
29
200
1.45
1.11
1.1
1.1
—
—
—
0
0
10
183
0.55
1.11
1.2
1.3
51.40
70.45
ug/l
—
10
183
82
663
1.24
1.11
1.1
1.1
18.04
18.63
u/ml
0.06
36
285
7
31
2.26
1.10
1.0
1.1
—
—
—
0
0
6762
67038
1.06
1.09
4.9
4.7
4.62
4.67
mmol/l
4.25
6474
63983
9
163
0.55
1.08
2.4
2.4
—
—
—
0
0
85
1031
0.82
1.02
1.3
1.4
6.76
7.00
mmol/l
0.41
73
934
32
439
0.73
1.01
1.7
1.6
—
—
—
0
0
284
2560
1.11
1.01
1.9
2.0
207.18
206.60
pmol/l
0.03
276
2447
139
1195
1.17
1.01
1.1
1.2
1.06
0.96
—
5
55
504
4671
1.08
1.00
1.4
1.4
25.80
23.99
iu/l
0.59
435
3955
1199
12547
0.95
0.98
2.9
2.9
0.72
0.72
ug/l
0.06
733
7339
101
848
1.19
0.97
1.1
1.1
—
—
—
0
0
556
5182
1.08
0.97
2.4
2.4
21.98
18.99
au/ml
0.36
68
650
27
190
1.42
0.96
1.1
1.1
—
—
—
0
0
324
3553
0.91
0.96
1.1
1.1
0.62
0.65
ratio
0.30
41
374
58
460
1.26
0.96
1.4
1.3
—
—
—
0
0
1212
11589
1.05
0.95
2.2
2.2
—
—
—
0
0
27
191
1.42
0.94
1.1
1.1
—
—
—
0
0
1154
11026
1.05
0.94
1.7
1.8
1.42
1.43
%
0.26
1006
9880
34
251
1.36
0.93
1.1
1.1
—
—
—
0
0
6
27
2.22
0.93
1.0
1.0
—
—
—
0
0
156
1781
0.87
0.93
1.1
1.1
1.25
1.83
u/ml
0.69
82
924
16
101
1.59
0.93
1.9
1.8
—
—
—
0
0
57
711
0.80
0.92
1.3
1.5
33.42
33.96
g/l
0.10
51
646
100
845
1.19
0.91
1.2
1.3
0.19
0.21
nmol/l
0.32
79
665
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
24
168
1.43
0.89
1.2
1.2
76.80
67.91
%
—
5
47
12
71
1.69
0.88
1.1
1.1
—
—
—
0
0
241
2174
1.11
0.88
3.6
3.5
514.01
409.70
mg/l
0.21
126
1053
11
64
1.72
0.86
1.0
1.1
—
—
—
0
0
84
704
1.20
0.85
1.2
1.1
—
—
—
0
0
166
1468
1.13
0.85
3.9
3.2
61.14
63.25
%
0.56
166
1462
8
45
1.78
0.84
1.3
1.0
—
—
—
0
0
514
5488
0.93
0.83
1.2
1.2
83.64
149.04
u/ml
6.67
196
2071
114
1316
0.86
0.82
1.0
1.1
0.23
0.45
u/ml
0.64
35
410
35
266
1.32
0.82
1.8
1.4
516.74
236.95
nmol/24h
0.27
35
266
11
177
0.62
0.81
1.0
1.1
—
—
—
0
0
13
81
1.61
0.81
1.1
1.1
—
—
—
0
0
299
3257
0.91
0.80
1.5
1.4
—
—
—
0
0
8
47
1.70
0.80
1.0
1.2
—
—
—
0
0
8
47
1.70
0.80
1.1
1.1
—
—
—
0
0
116
1007
1.15
0.79
1.2
1.3
1.37
0.26
nmol/l
—
6
53
62
510
1.22
0.78
1.2
1.3
4.26
5.58
umol/l
2.06
57
448
58
474
1.23
0.78
1.7
1.4
88.24
80.92
umol/l
0.43
58
474
33
251
1.32
0.78
1.2
1.2
103.46
88.72
%
1.45
13
127
34
260
1.31
0.77
1.1
1.1
101.46
90.24
%
3.00
13
131
85
722
1.18
0.77
1.5
1.5
—
—
—
0
0
256
2800
0.91
0.76
1.6
1.5
62.33
60.87
ug/l
0.18
215
2333
6
34
1.77
0.76
1.3
1.4
—
—
—
0
0
49
395
1.24
0.75
6.4
7.5
307.08
64.32
ug/l
0.46
38
265
34
262
1.30
0.74
1.1
1.1
—
—
—
0
0
20
141
1.42
0.74
1.0
1.1
—
—
—
0
0
65
541
1.20
0.74
1.3
1.4
393344.07
88267.72
e6/l
0.98
42
372
92
790
1.17
0.74
3.3
3.2
0.79
0.83
nmol/l
0.50
69
629
65
543
1.20
0.72
1.5
2.1
40.22
1534.86
pmol/l
—
6
79
13
84
1.55
0.71
1.2
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
34
264
1.29
0.71
1.1
1.2
119.04
105.58
%
1.29
28
246
16
229
0.70
0.70
1.8
1.9
—
—
—
0
0
27
203
1.33
0.70
1.1
1.1
—
—
—
0
0
22
160
1.38
0.70
1.0
1.2
—
—
—
0
0
368
3431
1.08
0.70
1.7
1.9
38.03
38.72
nmol/l
0.24
359
3355
12
180
0.67
0.67
1.0
1.1
0.18
6.51
u/ml
—
6
123
7
43
1.63
0.66
1.3
1.9
39.57
45.91
umol/l
—
7
43
5
28
1.79
0.66
3.4
3.8
—
—
—
0
0
19
137
1.39
0.64
1.2
1.4
1.16
1.18
mmol/l
0.64
19
137
1608
16541
0.96
0.64
4.1
3.9
21.51
21.76
%
0.26
737
7072
54
451
1.20
0.62
2.1
2.7
39.28
42.78
%
0.45
26
233
509
4824
1.06
0.61
1.3
1.3
62.90
49.90
au/ml
0.63
36
304
5
30
1.67
0.61
1.4
1.1
—
—
—
0
0
249
2303
1.08
0.60
2.3
2.4
275.70
576.34
ug/l
2.14
228
2176
8
51
1.57
0.60
1.0
1.2
40.00
11.27
u/l
—
8
51
198
1815
1.09
0.59
1.6
1.5
60.17
59.57
ug/l
0.07
198
1815
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
34
272
1.25
0.59
1.0
1.1
—
—
—
0
0
802
7703
1.05
0.58
2.3
2.4
13.56
13.55
nmol/l
0.02
743
7099
56
473
1.19
0.58
1.3
1.5
6.83
7.74
ug/l
0.35
50
424
188
1723
1.09
0.57
1.2
1.3
3.77
3.71
mmol/l
0.24
176
1635
7
116
0.60
0.57
1.1
1.1
—
—
—
0
0
66
567
1.17
0.57
2.3
2.6
—
—
—
0
0
130
1441
0.90
0.56
1.1
1.1
5.36
5.07
u/ml
0.06
52
659
5
89
0.56
0.55
1.2
3.6
18.12
44.88
umol/l
—
5
72
212
1959
1.08
0.54
1.2
1.3
510.85
518.68
mg/l
0.08
207
1872
23
178
1.29
0.52
1.1
1.1
—
—
—
0
0
9
65
1.39
0.50
1.0
1.1
—
—
—
0
0
1295
12604
1.03
0.50
2.3
2.3
—
—
—
0
0
46
389
1.18
0.50
1.5
1.5
0.58
0.51
e9/l
0.96
46
389
40
335
1.20
0.48
1.2
1.1
—
0.15
—
0
8
7
47
1.49
0.47
1.3
1.1
—
—
—
0
0
12
85
1.41
0.46
2.6
2.6
55.86
79.16
pmol/l
0.58
12
75
119
1082
1.10
0.46
1.2
1.3
—
—
—
0
0
13
94
1.38
0.45
14.6
9.2
58.75
69.64
%
—
8
74
142
1543
0.92
0.44
1.1
1.1
2.89
3.73
u/ml
0.36
67
791
37
311
1.19
0.44
1.1
1.1
94.44
277.65
ng/l
0.88
16
78
743
7181
1.04
0.44
4.3
4.4
32.06
31.59
%
0.57
558
5103
630
6074
1.04
0.43
1.9
2.1
—
—
—
0
0
6308
63410
0.97
0.42
4.1
4.0
1.30
1.30
mmol/l
0.10
5961
59863
6705
66751
1.03
0.42
4.7
4.6
1.44
1.42
mmol/l
1.96
6393
63411
5
32
1.56
0.42
1.4
1.8
—
0.00
—
0
5
0
15
0.00
0.41
0.0
1.2
—
1.14
—
0
7
6790
67620
1.03
0.40
5.2
5.2
2.73
2.79
mmol/l
7.44
6471
64284
0
18
0.00
0.40
0.0
1.4
—
23.75
—
0
12
41
352
1.17
0.40
1.2
1.3
155.68
169.13
mmol/24h
0.51
41
352
13
97
1.34
0.39
1.0
1.1
—
—
—
0
0
22
270
0.81
0.39
1.9
2.0
13.33
211.51
ug/min
—
6
67
163
1519
1.07
0.39
1.2
1.2
—
—
—
0
0
225
2121
1.06
0.38
1.9
1.8
—
—
—
0
0
124
1144
1.09
0.38
1.4
1.5
—
—
—
0
0
61
542
1.13
0.38
1.2
1.2
0.59
0.65
ratio
0.67
36
322
19
236
0.80
0.37
1.9
2.2
983.50
3821.69
e6/l
0.45
14
175
13
98
1.33
0.37
1.0
1.1
—
—
—
0
0
34
290
1.17
0.36
1.1
1.2
0.31
0.29
g/l
0.42
26
231
42
365
1.15
0.36
1.5
1.5
—
—
—
0
0
6361
63321
1.02
0.35
4.6
4.5
5.83
5.84
mmol/l
0.21
5974
59355
698
6775
1.03
0.35
7.5
6.0
—
—
—
0
0
246
2334
1.06
0.35
1.7
1.6
—
—
—
0
0
6
44
1.36
0.34
1.3
1.3
—
—
—
0
0
145
1550
0.93
0.33
1.5
1.5
0.41
0.41
nmol/l
0.02
111
1208
59
657
0.90
0.33
1.5
1.5
—
—
—
0
0
37
321
1.15
0.33
1.1
1.0
13.70
12.65
u/ml
0.08
23
221
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
44
387
1.14
0.33
1.1
1.1
—
—
—
0
0
66
596
1.11
0.33
1.2
1.3
0.39
2.00
u/ml
3.22
33
331
50
560
0.89
0.32
1.0
1.1
0.54
2.11
u/ml
0.64
13
133
47
417
1.13
0.31
2.1
1.9
1.42
1.52
u/field
0.11
31
229
12
92
1.30
0.31
1.3
1.2
—
—
—
0
0
17
138
1.23
0.30
1.2
1.2
272.42
288.17
pmol/l
0.09
12
100
146
1376
1.06
0.28
2.7
2.4
67.93
123.04
ug/min
1.49
89
889
39
345
1.13
0.28
2.6
2.2
112.07
112.92
ng/l
0.02
39
345
15
122
1.23
0.27
1.1
1.3
0.60
142.33
mg/l
—
8
84
6252
62284
1.02
0.27
5.9
5.6
38.39
38.45
mmol/mol
0.20
5958
59310
74
683
1.08
0.26
1.1
1.1
236.97
257.12
mg/l
0.63
67
610
10
77
1.30
0.26
1.3
1.3
—
—
—
0
0
10
77
1.30
0.26
1.2
1.1
—
—
—
0
0
13
160
0.81
0.26
1.1
1.3
—
—
—
0
0
134
1268
1.06
0.24
1.1
1.1
26.36
9238.18
iu/ml
0.64
30
292
10
78
1.28
0.24
1.2
1.1
—
—
—
0
0
35
312
1.12
0.24
2.5
2.5
12.16
20.86
umol/l
—
5
32
19
222
0.86
0.23
1.8
2.9
28.83
28.71
umol/l
0.02
13
158
48
438
1.10
0.22
1.5
1.9
5.99
2.87
u/ml
0.55
12
138
7
91
0.77
0.22
1.3
1.2
5.57
5.71
mmol/l
—
7
91
51
556
0.92
0.22
2.7
3.4
38.28
27.30
mu/l
0.77
44
524
5
41
1.22
0.22
2.6
1.7
10.20
18.82
%
—
5
22
22
191
1.15
0.21
1.0
1.1
28.65
39.26
iu/ml
0.64
22
191
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
118
1121
1.05
0.20
1.2
1.6
309.27
346.16
mu/l
1.17
100
888
38
345
1.10
0.20
2.3
2.8
25.65
166.23
ug/l
0.95
38
322
75
704
1.07
0.19
1.1
1.1
43.93
40.49
mg/l
0.25
64
595
132
1381
0.96
0.19
1.3
1.2
—
—
—
0
0
16
137
1.17
0.18
1.1
1.1
—
—
—
0
0
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
7
60
1.17
0.17
1.4
1.1
—
—
—
0
0
36
393
0.92
0.17
1.6
1.6
4.17
11.31
nmol/l
0.54
30
306
18
157
1.15
0.17
1.4
1.2
37.18
38.75
g/l
0.21
12
84
14
120
1.17
0.16
1.1
1.1
0.62
0.72
umol/24h
—
5
61
317
3093
1.03
0.16
2.3
3.2
43.26
50.73
u/ml
0.19
309
2989
31
283
1.10
0.15
1.0
1.0
0.25
0.98
u/ml
1.24
31
278
9
80
1.13
0.15
1.1
1.1
—
—
—
0
0
78
820
0.95
0.15
1.1
1.1
—
—
—
0
0
117
1125
1.04
0.14
1.2
1.3
29.91
32.68
u/l
0.13
104
983
11
93
1.18
0.14
1.4
1.4
—
—
—
0
0
56
594
0.94
0.14
1.0
1.1
0.91
3.03
u/ml
1.14
21
141
123
1277
0.96
0.14
1.3
1.3
26.10
23.19
u/l
0.47
107
1057
143
1383
1.03
0.13
1.2
1.4
2.48
3.83
ug/l
3.31
131
1259
64
607
1.05
0.13
1.2
1.6
—
—
—
0
0
318
3114
1.02
0.13
1.9
1.9
—
30.85
—
0
5
16
180
0.89
0.13
1.4
1.5
11.72
12.89
g/l
0.17
11
135
68
647
1.05
0.13
1.1
1.1
—
—
—
0
0
18
199
0.90
0.11
1.8
1.9
7537.10
13084.19
e6/l
—
10
111
40
376
1.06
0.11
1.0
1.0
289.32
310.94
ng/l
0.34
31
281
471
4643
1.02
0.11
3.6
3.6
4.61
4.55
pmol/l
0.60
431
4212
20
182
1.10
0.11
1.1
1.1
—
—
—
0
0
45
426
1.06
0.10
1.1
1.1
—
—
—
0
0
176
1718
1.03
0.10
1.2
1.4
80.91
24.79
e6/l
0.41
138
1263
13
146
0.89
0.10
1.1
1.3
24.90
24.37
g/l
—
7
111
37
392
0.94
0.10
1.2
1.4
5.33
5.60
mmol/l
1.11
31
372
5
44
1.14
0.10
1.8
1.4
314.64
531.63
nmol/l
—
5
44
313
3081
1.02
0.09
1.5
1.5
9.16
8.68
u/l
0.30
253
2474
5
48
1.04
0.09
1.8
1.4
12.42
34.54
nmol/l
—
5
48
129
1257
1.03
0.09
3.5
3.2
28.43
26.46
mg/l
0.24
98
846
28
262
1.07
0.09
1.1
1.1
—
—
—
0
0
11
97
1.13
0.09
1.0
1.1
—
—
—
0
0
14
126
1.11
0.09
2.7
2.9
705.21
1577.36
u/l
0.59
14
114
2090
20805
1.01
0.08
4.8
4.7
2.35
2.33
ug/l
0.02
1914
19060
244
2480
0.98
0.08
1.5
1.5
—
—
—
0
0
7
67
1.04
0.08
1.0
1.1
1.09
1.36
mom
—
7
67
8
77
1.04
0.07
1.3
1.3
29.37
446.16
u/l
—
8
58
74
718
1.03
0.07
1.9
2.4
20.85
20.13
nmol/l
0.26
68
686
491
4955
0.99
0.06
1.6
1.6
1121.99
1008.44
mu/l
1.43
417
4175
8
95
0.84
0.06
11.6
10.8
5.29
6.09
mmol/l
—
8
95
39
374
1.04
0.06
1.0
1.0
697.00
778.19
ng/l
0.58
27
270
148
1506
0.98
0.06
1.8
1.7
—
—
—
0
0
19
178
1.07
0.05
1.6
2.8
102.83
118.18
ng/l
0.21
12
112
177
1746
1.01
0.05
1.3
1.5
783.24
3161.25
e6/l
0.55
147
1372
39
376
1.04
0.05
1.0
1.0
35.49
42.18
ng/l
0.83
29
275
14
130
1.08
0.04
1.0
1.1
6.91
5.64
u/ml
0.27
14
130
42
433
0.97
0.04
1.4
1.3
—
—
—
0
0
360
3622
0.99
0.03
1.5
1.7
275.32
290.50
mu/l
0.50
331
3297
46
449
1.02
0.03
1.1
1.1
1.00
5.96
nmol/l
—
8
82
10
92
1.09
0.03
1.8
2.0
—
—
—
0
0
49
479
1.02
0.03
1.1
1.1
1.17
1.08
u/l
0.21
26
191
201
2025
0.99
0.02
2.1
2.1
3.28
6.52
iu/l
0.65
88
883
16
152
1.05
0.02
1.1
1.3
—
—
—
0
0
63
640
0.98
0.02
1.2
1.2
—
—
—
0
0
77
762
1.01
0.01
1.3
1.3
187.25
189.87
pmol/l
0.05
77
762
32
327
0.98
0.01
2.4
2.1
8.89
8.07
mmol/l
0.43
32
327
732
7313
1.00
0.00
2.1
2.2
—
—
—
0
0
15
153
0.98
0.00
5.5
6.8
5.75
5.42
kpa
0.19
15
153
10
96
1.04
0.00
1.0
1.1
—
—
—
0
0
68
676
1.01
0.00
5.4
5.1
54.53
82.65
u/ml
0.45
25
222
72
724
0.99
0.00
1.2
1.5
277.07
280.81
mosm/kgh2o
0.64
54
561
11
105
1.05
0.00
1.1
1.0
0.01
0.04
u/ml
—
6
64
72
718
1.00
0.00
1.5
1.5
0.91
1.32
promille
1.56
55
552
12
119
1.01
0.00
6.3
6.9
11.05
10.75
%
0.13
12
119
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
6
68
0.88
-0.00
1.0
1.5
5.08
14.37
pmol/l
—
6
59
8
81
0.99
-0.00
2.0
2.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
-0.00
1.0
1.0
—
—
—
0
0
8
84
0.95
-0.00
1.1
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
54.06
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
0.97
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint K11_UC_STRICT2 and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_UC_STRICT2 | 1.017 [0.9, 1.15] | 0.782 |
| Birth year | 0.995 [0.99, 1.0] | 0.231 |
During the follow-up period (1.1.1998 — 31.12.2019), 854 out of 14198 females with K11_UC_STRICT2 died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_UC_STRICT2 | 0.958 [0.87, 1.06] | 0.399 |
| Birth year | 0.984 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1501 out of 17157 males with K11_UC_STRICT2 died.
Mortality risk
Mortality risk for people of age
years, who have K11_UC_STRICT2.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.098% | 0.165% |
| 5 | 0.541% | 1.007% |
| 10 | 1.374% | 2.582% |
| 15 | 2.774% | 4.897% |
| 20 | 4.964% | 8.31% |
Relationships between endpoints
↥Index endpoint: K11_UC_STRICT2 – Ulcerative colitis (strict definition, require KELA, min 2 HDR)
GWS hits: 55
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data